Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
GPR32	RVDR1	ENSG00000142511	"G protein-coupled receptor 32"	O75388	19	50770464-50771732	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	52	"parathyroid gland: 63.4"	"Cell line enriched"	"Detected in single"	289	"BEWO: 28.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"																												"unprognostic (4.77e-1)"			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	63.4	0.0	0.5		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2			0.3		0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0										
GCM2	"GCMB, hGCMb"	ENSG00000124827	"Glial cells missing homolog 2"	O75603	6	10873223-10881941	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	24	"parathyroid gland: 110.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.2;HMC-1: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (1.55e-1)"					"unprognostic (4.94e-1)"				"unprognostic (2.18e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.63e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIAA1549L	"C11orf41, C11orf69, G2, MGC34830"	ENSG00000110427	"KIAA1549 like"	Q6ZVL6	11	33376466-33674102	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 30.4;parathyroid gland: 64.4"	"Cell line enhanced"	"Detected in many"		"TIME: 22.7;U-138 MG: 30.0;WM-115: 20.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010132, HPA051594"			Approved	Nucleoplasm,Vesicles		27000	27000	Nucleoplasm	Nucleoplasm	"HPA010132: , HPA051594: "	"unprognostic (3.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.34e-5)"	"unprognostic (2.63e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.59e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.09e-1)"	0.8	0.9	8.2	0.7	20.5	0.6	1.2	6.2	30.4	0.7	0.7	1.7	0.0	0.6	0.7	0.6	0.9	0.6	0.8	0.6	5.3	2.4	0.9	0.6	0.6	0.7	1.6	17.1	0.7	0.8	64.4	1.0	1.4	2.3	0.7	0.7	0.0	0.7	0.6	0.6	1.9	0.6	0.7	1.1	0.6	0.7	1.3	1.6	0.0	0.6	0.0	1.1	0.9	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	3.3	0.1	0.5	3.7	0.0	13.1	7.7	2.1	1.2	0.0	0.3	10.1	0.1	11.6	0.7	0.4	3.8	3.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.2	5.7	9.3	0.0	9.6	8.2	0.0	0.1	0.0	0.7	4.8	0.0	0.8	0.0	0.0	5.0	1.1	1.2	0.1	0.0	3.1	0.0	0.0	22.7	30.0	6.3	0.7	10.5	0.0	0.0	0.0	7.9	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.2	20.5	6.2	30.4	5.3	2.4	1.6	17.1	2.3	1.6
PAX1		ENSG00000125813	"Paired box 1"	P15863	20	21705659-21718486	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"lymphoid tissue: 70.7;parathyroid gland: 56.0"	"Cell line enriched"	"Detected in single"	6	"SCLC-21H: 5.6"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (9.74e-2)"				"unprognostic (3.45e-2)"	"unprognostic (3.01e-1)"		"unprognostic (2.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.12e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.08e-2)"		0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	56.0	4.2	0.9	70.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0
TMC3		ENSG00000188869	"Transmembrane channel like 3"	Q7Z5M5	15	81331217-81374213	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	15	"parathyroid gland: 66.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 4.6"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 1.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040265, HPA040510"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA040265: AB_10795379, HPA040510: AB_10796123"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.20e-5)"	"unprognostic (2.32e-1)"	"unprognostic (1.97e-7)"	"unprognostic (1.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.96e-2)"	0.0	0.1	0.0	1.7	0.0	0.3	0.2	0.4	1.4	1.5	1.5	0.0	0.0	0.2	0.8	4.6	0.7	0.8	0.2	0.2	0.0	0.1	0.1	1.3	0.0	0.1	0.0	0.0	0.2	0.2	66.9	1.5	0.7	1.6	1.0	0.1	0.4	0.2	2.9	0.0	0.2	0.5	1.7	1.9	0.1	0.8	3.0	0.0	0.0	1.5	0.0	0.0	1.3	3.6	1.6	0.7	0.2	0.2	0.2	1.8	0.7	0.9	1.0	0.5	2.7	0.4	0.2	1.9	0.8	0.3	0.2	0.3	0.7	1.9	2.3	0.1	0.0	0.7	0.3	0.2	0.1	1.7	1.4	1.9	1.1	0.9	0.3	1.5	1.1	0.5	0.1	0.4	0.3	0.0	0.6	2.8	0.2	0.8	1.0	1.4	1.5	0.9	0.7	1.0	4.3	0.2	0.6	1.1	2.0	0.9	1.0	2.0	2.3	1.1	0.4	1.5	1.8	1.3	0.5	4.6	1.8	1.4	1.1	2.5	0.9	0.1	0.0	0.2	0.7	0.1	0.6	1.2	0.8	0.4	0.1	1.6	1.8	1.3	0.2	0.2	0.2	0.7	0.9	0.7	0.0	0.0	0.4	1.4	0.0	0.1	0.0	0.0	1.6	0.0
MSS51	"FLJ39565, ZMYND17"	ENSG00000166343	"MSS51 mitochondrial translational activator"	Q4VC12	10	73423579-73433561	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	13	"parathyroid gland: 34.4;skeletal muscle: 66.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"cerebellum: 2.7"	"Cell type enhanced"	"Detected in some"		"gdTCR: 1.7;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA038564			Uncertain	Vesicles,Cytosol				Vesicles	Vesicles	"HPA038564: AB_10674687"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.50e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-7)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-2)"	2.8	0.3	0.4	0.4	0.4	0.3	0.4	2.7	0.4	0.5	0.5	0.4	0.4	0.2	0.6	0.4	0.9	0.6	0.4	3.9	0.4	0.1	0.4	0.4	0.6	0.4	0.4	0.4	1.1	0.5	34.4	0.7	0.4	0.4	0.8	0.3	0.4	2.3	0.4	66.9	0.8	0.8	0.4	0.4	1.4	0.4	0.4	0.4	0.6	0.4	1.2	0.4	0.5	0.6	0.1	0.0	0.0	0.5	0.0	1.7	0.4	1.2	1.3	3.0	4.7	4.2	6.0	2.6	1.4	1.1	0.6	1.3	0.7	1.5	3.8	0.5	1.5	2.3	1.9	0.4	1.7	1.8	1.5	3.3	2.0	1.1	1.5	2.2	3.1	4.7	1.5	1.3	3.5	0.6	1.1	2.0	2.5	0.5	1.8	3.0	0.9	1.6	1.1	7.7	0.2	1.8	1.9	0.6	1.2	1.0	2.2	1.7	1.9	1.8	2.6	2.3	1.4	0.9	3.0	1.2	3.4	2.0	1.0	3.8	0.6	0.0	0.4	0.0	1.7	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.3	1.2	0.0	0.0	0.5	0.0	0.0	0.4	0.4	0.4	2.7	0.4	0.4	0.1	0.4	0.4	0.4	0.4
PAX9		ENSG00000198807	"Paired box 9"	P55771	14	36657568-36679715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.0;HBEC3-KT: 8.0;HDLM-2: 30.0;PC-3: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	19	"T-cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB016239, HPA038462"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB016239: AB_2159984, HPA038462: AB_10672594"	"unprognostic (3.09e-1)"	"prognostic favourable (5.38e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.31e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	0.1	0.1	0.1	0.0	0.1	0.3	0.5	0.0	0.1	3.7	0.4	0.0	0.0	0.0	0.2	0.1	58.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.0	0.1	0.1	34.6	1.4	0.0	0.1	2.7	0.0	0.1	86.1	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.2	0.2	0.0	11.8	0.5	27.1	33.2	0.4	3.4	0.1	0.0	0.0	0.0	0.0	2.7	0.1	3.4	0.9	0.0	1.7	1.4	2.3	1.2	0.0	0.1	0.0	0.0	0.7	1.1	0.7	0.4	0.0	8.0	1.2	8.0	0.0	30.0	5.3	0.5	0.5	0.0	0.0	0.0	2.7	0.5	3.7	0.0	1.2	0.0	2.0	0.8	0.1	4.5	0.5	0.0	0.1	12.9	0.0	0.0	0.0	0.0	4.5	2.2	0.0	0.8	4.0	0.9	3.4	0.0	0.0	0.0	0.5	1.3	0.6	0.0	0.0	3.0	0.4	0.3	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PCDHAC1		ENSG00000248383	"Protocadherin alpha subfamily C, 1"	Q9H158	5	140926369-141012344	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"parathyroid gland: 33.3"	"Cell line enhanced"	"Detected in some"		"A549: 8.5;EFO-21: 3.6;hTCEpi: 11.0;PC-3: 6.2;SCLC-21H: 4.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA052775			Approved	Nucleoplasm,Nucleoli,Vesicles				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA052775: AB_2681942"	"unprognostic (2.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.29e-2)"	0.3	0.4	0.9	0.3	1.0	0.0	0.0	2.0	2.8	0.4	0.0			0.0	0.2	0.1	0.0	0.0	0.9	0.0	1.0	1.6	0.2	0.1	0.8	1.0	1.1		0.0	1.5	33.3	1.9	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.8			0.8		0.4	0.0	0.0	0.2	0.1	0.5	0.2	0.2	0.1	0.0	0.0	8.5	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	11.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.2	0.0	0.0	0.0	0.5	0.4	4.9	2.3	0.0	0.6	0.0	0.5	0.0	0.0	0.6	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.2	0.1	0.0	0.0										
FRMPD4	"KIAA0316, PDZD10, PDZK10"	ENSG00000169933	"FERM and PDZ domain containing 4"	Q14CM0	X	12138466-12724523	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 16.4;parathyroid gland: 28.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 4.2;LHCN-M2: 5.9;U-2197: 9.3;U-266/70: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.05e-1)"	"unprognostic (3.70e-2)"			"unprognostic (3.50e-2)"	"unprognostic (2.68e-3)"		"unprognostic (8.84e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.25e-1)"	0.6	0.6	5.5	0.6	10.9	0.5	0.6	3.8	16.4	0.7	1.1	1.0	0.0	0.6	0.7	1.0	0.7	0.6	0.6	2.1	8.1	3.5	0.6	0.6	0.6	0.5	2.7	6.9	0.6	0.5	28.3	0.6	0.5	2.9	1.1	0.8	1.9	0.5	0.6	1.1	0.6	0.6	0.6	0.8	0.5	0.6	1.0	1.5	0.0	0.6	0.0	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.7	0.0	1.1	2.1	3.4	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.3	2.2	3.4	0.0	0.2	0.0	0.1	0.0	0.0	1.5	0.0	1.3	2.3	0.0	0.0	0.7	5.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	9.3	1.0	8.6	3.9	0.0	2.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	10.9	3.8	14.6	8.1	3.5	2.7	6.9	2.9	1.5
PCDHAC2	PCDH-ALPHA-C2	ENSG00000243232	"Protocadherin alpha subfamily C, 2"	Q9Y5I4	5	140966235-141012344	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 14.1;parathyroid gland: 52.5"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 36.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA076190			Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA076190: AB_2686785"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.31e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.46e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-3)"	1.1	1.7	5.7	1.0	9.2	0.5	0.7	13.6	14.1	1.5	0.9	2.3	0.0	0.7	1.2	0.6	0.6	0.8	3.2	1.2	4.5	5.2	0.9	1.3	2.5	2.2	2.9	6.4	0.7	0.9	52.5	3.1	2.2	3.8	0.9	0.9	2.7	1.1	0.7	0.6	0.6	0.7	1.4	2.0	2.1	1.0	2.4	1.7	0.0	1.6	0.0	1.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.7	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.7	3.9	0.0	0.0	0.1	0.0	8.2	0.0	0.5	0.0	0.0	0.1	5.3	0.0	1.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.4	1.3	0.0	0.0	0.0	1.3	0.0	1.6	6.4	0.0	0.0	0.0	1.4	0.2	0.0	0.7	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.2	13.6	14.1	4.5	5.2	2.9	6.4	3.8	1.7
SIX3	HPE2	ENSG00000138083	"SIX homeobox 3"	O95343	2	44941898-44946077	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 40.2;parathyroid gland: 32.1;pituitary gland: 30.9;retina: 66.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;SCLC-21H: 36.7;SH-SY5Y: 14.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 40.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 38.7"	HPA067988			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA067988: AB_2685939"	"unprognostic (1.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-2)"		"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.73e-2)"	0.4	0.4	3.7	0.5	40.2	0.5	0.5	0.7	0.7	1.5	0.4	1.5	0.0	0.5	0.4	0.4	0.5	0.4	0.5	0.4	1.6	7.2	0.4	0.4	0.5	0.5	1.1	2.7	0.4	1.0	32.1	30.9	0.4	0.1	0.4	0.4	66.5	0.4	0.4	1.1	0.5	0.4	0.4	0.0	0.4	0.5	0.8	6.5	0.0	0.4	0.0	0.4	0.4	0.0	1.1	1.1	4.5	2.2	1.9	1.7	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	6.8	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.1	0.0	0.2	0.0	0.0	0.0	36.7	14.7	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.6	1.2	1.0	1.1	1.7	1.1	1.1	0.8	0.8	1.1	1.3	1.4	1.7	1.9	2.2	1.1	1.3	0.7	3.7	40.2	0.7	0.7	1.6	7.2	1.1	2.7	0.1	6.5
HMGXB3	"HMGX3, KIAA0194, SMF"	ENSG00000113716	"HMG-box containing 3"	Q12766	5	150000046-150053142	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 151.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005967			Approved	Nucleoli				Nucleoli	Nucleoli	"HPA005967: "	"unprognostic (3.66e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (3.37e-5)"	"unprognostic (9.72e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-2)"	12.0	14.2	8.2	14.5	14.4	15.3	16.1	14.5	17.4	11.3	10.3	15.0	15.4	8.3	13.9	20.0	9.3	13.5	12.1	9.4	8.6	8.3	11.6	11.7	14.7	10.3	10.1	11.0	15.0	13.8	151.8	15.3	11.8	12.9	17.6	10.8	16.8	12.4	18.4	12.5	13.1	9.9	12.8	8.9	14.4	12.0	17.7	7.3	15.3	14.7	10.1	12.0	11.2	10.1	5.8	6.2	5.1	5.9	2.2	8.1	3.7	12.2	14.4	10.2	16.1	14.7	12.5	17.8	11.9	22.0	17.9	22.6	20.2	15.0	11.7	14.0	16.2	9.1	19.4	20.4	15.5	10.9	13.9	10.3	15.2	9.8	20.4	19.6	23.4	16.3	15.3	26.2	20.7	12.7	13.4	12.3	18.8	9.7	12.2	10.2	7.7	21.7	10.6	14.2	11.3	10.7	15.4	13.2	13.3	10.4	25.5	26.4	11.9	12.8	10.9	26.8	11.4	12.9	21.9	14.6	13.7	16.7	31.3	15.1	13.8	5.1	4.7	4.0	7.0	5.9	5.5	5.8	5.7	4.9	6.2	5.0	4.4	4.6	0.5	2.2	3.9	4.6	8.1	3.7	8.2	14.4	14.5	17.4	8.6	8.3	10.1	11.0	12.9	7.3
CASR	"FHH, GPRC2A, HHC, HHC1, NSHPT"	ENSG00000036828	"Calcium sensing receptor"	P41180	3	122183683-122291629	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 155.3"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 4.0"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 5.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA039686, HPA050335"	Enhanced									"HPA039686: AB_10673536, HPA050335: AB_2681092"		"unprognostic (1.97e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.32e-2)"		"unprognostic (7.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-5)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.24e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	21.0	0.0	0.1	0.2	18.1	0.5	0.0	0.0	0.1	0.0	0.6	12.1	155.3	0.6	0.0	0.2	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.6	0.3	0.2	0.2	0.5	0.3	0.0	0.1	1.6	0.0	0.1	0.7	0.0	1.4	0.5	1.1	0.3	0.8	1.1	0.2	0.6	1.3	0.7	1.1	0.3	0.3	0.7	0.7	0.0	0.0	0.1	0.6	0.8	1.1	0.9	0.4	0.5	0.2	0.2	0.3	0.8	0.1	1.4	1.1	1.1	0.0	0.7	0.8	0.4	0.4	0.4	0.2	0.2	0.6	2.0	0.3	0.7	0.5	0.9	1.4	0.6	0.6	0.5	0.6	4.0	1.5	0.6	0.8	0.9	0.5	0.3	0.9	0.3	1.3	1.0	1.8	1.0	0.3	1.6	1.1	0.5	0.7	0.6	1.0	1.0	0.3	0.1	0.9	0.2	0.9	0.7	0.9	0.9	0.1	1.4	0.7	0.6	1.1	0.8	0.2	0.5	1.1	0.2	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.0	0.2	0.0
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"parathyroid gland: 203.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 61.6;BJ hTERT+: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane"		120000000	120000000	"Plasma membrane"	"Plasma membrane"	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavourable (2.65e-4)"	"prognostic unfavourable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (4.68e-4)"	27.4	1.5	1.6	1.9	2.2	1.9	6.5	0.4	1.9	15.0	7.1	3.4	2.0	1.5	22.5	8.5	22.4	3.4	2.4	8.2	1.8	1.4	3.5	1.4	14.5	1.4	1.7	1.4	2.8	1.2	203.4	0.6	5.0	3.0	7.1	2.1	0.6	4.2	2.2	4.1	12.4	2.4	12.6	4.5	1.7	1.5	3.3	2.8	6.3	1.7	16.8	4.7	8.7	8.0	0.3	2.6	1.4	0.4	0.6	0.4	0.3	9.2	8.3	0.5	0.0	12.7	61.6	0.0	8.4	37.8	2.8	6.1	0.0	5.4	0.0	5.2	17.3	26.1	0.9	16.9	3.7	2.5	1.4	3.3	6.8	1.4	2.7	0.0	0.0	16.9	13.4	5.2	21.1	20.0	0.0	0.0	12.6	0.2	0.2	0.0	0.6	5.4	0.7	2.4	11.4	1.2	1.0	0.0	0.0	19.1	0.1	8.3	0.2	1.5	18.5	26.4	3.7	4.7	7.2	0.1	5.2	0.0	10.6	0.0	23.4	0.6	0.4	0.3	0.2	0.2	0.1	0.2	0.3	0.2	2.6	0.3	0.4	0.2	1.4	0.6	0.2	1.4	0.1	0.3	1.6	2.2	0.4	1.9	1.8	1.4	1.7	1.4	3.0	2.8
PTH	PTH1	ENSG00000152266	"Parathyroid hormone"	P01270	11	13492055-13496181	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 963.9"	"Cell line enhanced"	"Detected in single"		"U-2197: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000072, CAB023409, CAB026363, HPA048540"	Enhanced				"Secreted to blood"					"CAB000072: , CAB023409: AB_619175, CAB026363: , HPA048540: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	963.9	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	129.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAB6D	"RAB6CL, WTH3DI"	ENSG00000233087	"RAB6D, member RAS oncogene family"		2	131361111-131364142	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 13.4"	"Group enriched"	"Detected in some"	4	"MOLT-4: 6.4;REH: 2.5;U-2 OS: 2.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.3"					"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA059131	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA059131: AB_2683916"	"unprognostic (4.19e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.08e-1)"	"unprognostic (4.79e-2)"		"unprognostic (4.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.12e-1)"	0.0	0.0		0.0		0.0	0.0		1.1	0.0	1.1			0.0	0.0	0.2	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	13.4		0.0		1.9	1.0		0.0	0.0	0.0	0.0	0.8	0.0		0.0	0.0	1.0			0.0		0.0	0.0		0.2	0.3	1.4	0.4	0.5	0.5	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	6.4	0.1	0.9	0.0	2.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	2.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.4	0.3	0.5	0.4	0.4	0.4	0.1	0.5	0.3	0.3	0.2	0.5	0.4	0.2	0.5	0.4	0.1	0.5	0.5										
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118238-22357144	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 67.0;parathyroid gland: 258.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.6;HUVEC TERT2: 24.6;SCLC-21H: 19.0;TIME: 13.9;U-698: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA057821: AB_2683538, HPA076772: AB_2686814"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favourable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	10.8	5.8	12.6	3.6	22.6	1.8	6.2	5.2	25.1	4.5	4.6	47.6	0.6	3.9	4.4	3.1	6.1	4.2	7.0	6.7	21.3	10.1	7.3	8.5	14.1	5.7	41.8	13.3	3.7	7.9	258.2	3.3	23.2	31.5	2.8	5.2	0.9	3.4	3.4	2.7	4.4	4.1	5.6	67.0	17.1	3.7	3.5	29.5	3.9	5.4	1.8	4.9	3.9	4.9	0.7	0.0	0.0	0.0	0.0	0.2	0.4	1.5	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	2.9	0.7	11.6	0.6	0.1	7.2	1.5	1.0	0.0	0.0	2.3	0.1	0.0	2.9	0.0	0.0	0.0	0.3	1.3	0.7	0.4	24.6	2.6	0.1	0.0	0.6	1.6	0.0	2.0	2.3	2.8	0.0	3.9	2.3	1.0	19.0	5.0	0.2	3.3	0.0	1.6	0.0	13.9	0.0	0.6	0.2	0.6	6.4	1.3	20.7	0.3	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.6	22.6	5.2	25.1	21.3	10.1	41.8	13.3	31.5	29.5
TDRD9	"C14orf75, DKFZp434N0820, FLJ36164, NET54"	ENSG00000156414	"Tudor domain containing 9"	Q8NDG6	14	103928462-104052667	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"parathyroid gland: 19.9;testis: 48.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.8;HeLa: 9.5;HMC-1: 44.1;RPTEC TERT1: 12.0;SK-MEL-30: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"classical monocyte: 4.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-4)"	"unprognostic (1.60e-2)"	"unprognostic (4.57e-3)"	"unprognostic (8.97e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (2.41e-2)"	0.4	0.4	0.7	0.4	1.5	1.2	0.5	1.5	1.5	0.3	0.3	0.8	0.6	0.1	0.3	0.3	0.2	0.7	2.1	0.6	0.8	0.7	1.8	0.5	1.0	0.3	0.8	1.3	0.3	0.7	19.9	0.9	0.4	3.4	0.3	0.1	1.8	0.9	1.0	0.1	0.1	0.3	0.4	1.6	2.8	0.6	48.0	0.5	0.2	4.2	0.0	0.8	0.4	0.2	0.0	0.8	0.0	4.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	9.5	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	4.0	0.0	0.0	0.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	1.5	1.5	1.5	0.8	0.7	0.8	1.3	3.4	0.5
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923080-92935293	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 577.6"	"Group enriched"	"Detected in some"	134	"SCLC-21H: 43.3;SH-SY5Y: 117.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 97.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	78000000	78000000	Vesicles	Vesicles	"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698"	"prognostic favourable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favourable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavourable (3.99e-4)"	2.0	81.9	6.6	3.1	18.7	1.3	1.3	0.5	97.9	1.9	36.1	4.0	0.0	15.8	1.3	1.3	1.2	1.3	1.3	1.2	11.2	14.0	1.3	1.2	1.4	1.2	8.0	36.1	1.2	15.9	577.6	81.1	1.2	17.1	2.0	7.9	0.4	1.3	1.3	1.2	1.3	38.8	1.3	2.5	1.3	51.9	32.5	0.7	0.0	5.9	0.0	1.2	1.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	43.3	117.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.6	18.7	0.5	97.9	11.2	14.0	8.0	36.1	17.1	0.7
LGI2	"FLJ10675, KIAA1916"	ENSG00000153012	"Leucine rich repeat LGI family member 2"	Q8N0V4	4	24998847-25030879	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 113.9"	"Cell line enhanced"	"Detected in some"		"AF22: 22.2;HAP1: 4.0;RPMI-8226: 10.2;SCLC-21H: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017140	Approved		Approved	Centrosome	"Secreted to blood"			Centrosome	Centrosome	"HPA017140: AB_1852833"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-5)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.03e-3)"	2.5	1.6	2.8	6.7	3.3	0.8	2.3	7.9	7.8	3.7	4.0	0.0	1.0	1.1	8.9	4.9	4.1	11.4	4.2	3.7	2.4	3.9	3.0	0.9	1.4	2.0	7.2	0.4	9.1	2.6	113.9	0.5	2.6	18.7	1.0	1.6	6.0	0.9	1.4	0.9	0.9	2.6	7.1	2.9	1.2	2.4	2.0	0.9	0.6	1.8	0.6	4.6	1.8	1.1	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.0	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.6	0.7	0.0	0.9	10.2	0.4	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.6	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	3.3	7.9	7.8	2.4	3.9	7.2	0.4	18.7	0.9
NLRP5	"CLR19.8, MATER, NALP5, PAN11, PYPAF8"	ENSG00000171487	"NLR family pyrin domain containing 5"	P59047	19	55999726-56061813	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"parathyroid gland: 19.3"	"Group enriched"	"Detected in some"	14	"Karpas-707: 3.0;U-2 OS: 8.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056271	Uncertain				"Intracellular and membrane"					"HPA056271: AB_2683083"	"unprognostic (9.67e-2)"			"unprognostic (2.22e-2)"								"unprognostic (5.03e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.72e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		3.1	0.0	19.3	0.6	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TINF2	TIN2	ENSG00000092330	"TERF1 interacting nuclear factor 2"	Q9BSI4	14	24239643-24242674	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"parathyroid gland: 268.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059061, HPA069807"			Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			"Nuclear bodies"	"Nuclear bodies"	"HPA059061: AB_2683895, HPA069807: AB_2686203"	"prognostic favourable (4.96e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.78e-2)"	"unprognostic (7.44e-2)"	15.8	27.8	10.4	17.0	11.3	13.3	18.2	10.1	16.7	14.5	13.1	17.9	12.9	9.5	16.8	16.1	22.4	12.6	13.7	12.4	9.3	8.9	14.8	11.4	18.8	27.0	13.7	9.8	15.4	17.1	268.9	11.9	15.3	10.9	13.5	12.5	11.3	14.8	15.5	14.9	13.9	12.9	15.1	11.7	21.0	14.5	7.7	12.4	26.1	16.6	12.6	19.5	14.9	14.2	27.3	17.7	46.9	21.4	25.4	27.4	28.8	11.6	10.7	15.5	8.1	17.1	12.8	7.9	12.0	15.2	17.6	16.5	4.6	13.1	17.1	6.9	16.9	11.5	8.7	10.7	11.2	21.7	4.4	10.7	9.8	18.3	14.8	11.3	15.5	14.0	17.3	14.1	13.5	19.0	4.2	21.9	14.2	12.8	17.0	5.6	3.6	13.3	14.0	9.9	12.4	15.7	16.8	9.5	8.8	12.5	11.9	10.7	8.5	7.3	15.2	8.3	10.1	14.0	9.3	16.9	12.0	9.7	9.9	6.4	12.2	41.6	20.6	46.9	27.4	21.4	21.8	25.7	21.6	25.5	17.7	27.3	22.8	22.8	26.0	25.4	19.6	15.0	25.2	28.8	10.4	11.3	10.1	16.7	9.3	8.9	13.7	9.8	10.9	12.4
ABCG4	WHITE2	ENSG00000172350	"ATP binding cassette subfamily G member 4"	Q9H172	11	119149012-119162653	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 20.7;parathyroid gland: 7.4;retina: 7.5;testis: 7.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.6;HAP1: 3.0;U-2 OS: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA057635	Enhanced									"HPA057635: "	"unprognostic (3.26e-2)"	"unprognostic (4.75e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.15e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (2.65e-3)"	0.7	1.6	3.9	0.7	5.7	0.3	0.4	20.7	12.8	0.8	0.8	0.8	0.0	0.9	1.1	1.3	1.9	0.6	1.2	2.2	4.9	6.6	0.8	0.5	0.5	0.5	4.7	5.2	0.5	1.2	7.4	0.3	0.7	12.7	0.9	0.7	7.5	0.4	2.0	0.4	1.2	0.7	1.4	1.5	0.5	0.5	7.2	0.5	0.6	1.5	0.0	1.5	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	1.2	5.6	0.8	0.0	0.1	0.2	0.1	0.7	1.5	0.0	0.1	0.0	0.6	0.2	0.5	3.0	0.3	0.7	0.3	1.0	1.0	0.1	0.0	1.9	0.0	1.6	0.5	0.0	1.0	0.0	1.2	0.1	0.1	0.9	0.2	0.4	0.0	2.4	0.6	0.1	0.0	0.1	0.0	0.0	0.5	1.1	1.7	0.2	0.1	0.4	0.0	0.2	0.4	2.9	0.5	0.2	0.3	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.7	20.7	12.8	4.9	6.6	4.7	5.2	12.7	0.5
ADAM23	MDC3	ENSG00000114948	"ADAM metallopeptidase domain 23"	O75077	2	206443539-206621130	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 30.5;heart muscle: 19.3;parathyroid gland: 67.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 21.8;RPMI-8226: 56.8;U-266/70: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory CD4 T-cell: 5.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033276	Approved				"Intracellular and membrane"	24000	24000			"CAB033276: AB_2305247"	"unprognostic (7.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.03e-3)"	2.0	4.7	8.5	2.5	30.5	2.3	1.7	14.2	27.4	3.4	2.4	3.4	0.3	2.0	2.5	3.8	3.8	1.2	4.0	19.3	8.7	11.4	1.5	1.4	2.0	2.3	9.8	13.5	2.4	5.7	67.6	4.8	1.0	22.4	1.8	2.6	2.4	1.5	2.8	8.1	1.6	2.4	4.2	3.9	1.4	2.0	6.5	4.0	0.8	1.3	1.6	2.7	3.2	2.4	0.4	0.0	0.0	0.0	0.0	5.7	0.4	0.0	0.3	7.6	0.0	4.1	6.0	0.3	0.8	0.9	1.1	0.2	8.9	0.1	1.0	0.0	1.2	11.4	4.9	0.2	0.1	4.3	4.2	0.0	0.6	0.1	4.0	0.0	0.5	2.2	0.0	0.0	0.0	13.2	0.0	0.0	2.7	0.1	0.1	0.0	14.9	1.5	0.0	21.8	56.8	0.0	5.5	5.9	2.4	0.0	0.0	4.2	0.0	0.0	11.4	3.8	3.5	2.0	1.7	15.5	0.0	0.0	7.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.5	30.5	14.2	25.6	8.7	11.4	9.8	13.5	22.4	4.0
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173609561-173669862	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8"	"Cell line enhanced"	"Detected in some"		"AF22: 11.8;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.2;SH-SY5Y: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"				Cytosol	Cytosol	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.5	1.3	5.9	0.4	14.6	0.5	0.6	1.1	7.0	2.8	0.7	9.0	1.3	0.4	3.3	2.5	0.5	24.8	1.0	0.9	7.7	4.7	2.7	0.5	2.8	0.4	2.4	5.3	2.4	1.0	16.8	7.9	0.4	9.2	1.9	0.5	1.8	0.4	1.2	0.4	0.4	0.5	2.4	2.7	1.3	0.5	20.8	4.2	0.0	1.3	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	11.8	0.0	0.0	0.9	2.0	0.1	4.2	3.8	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	2.3	0.0	0.1	0.2	0.2	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.4	0.0	1.6	10.7	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	2.2	0.1	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	14.6	1.1	7.0	7.7	4.7	2.4	5.3	9.2	4.2
CLCNKA	hClC-Ka	ENSG00000186510	"Chloride voltage-gated channel Ka"	P51800	1	16018875-16034050	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 46.9;parathyroid gland: 15.4"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 12.7"	"Group enriched"	"Detected in some"	7	"renal cancer: 4.4;thyroid cancer: 1.6"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057717	Approved									"HPA057717: AB_2683509"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.76e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.28e-1)"	0.2	0.7	0.2	0.2	0.2	0.0	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	46.9	0.2	0.2	0.2	0.2	0.2	0.2	1.2	15.4	5.8	0.2	0.2	0.2	0.0	0.2	4.4	0.2	0.2	0.0	0.2	0.2	0.2	0.2	1.6	1.1	0.2	0.2	6.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.2	0.5	0.0	0.0	0.1	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2
DIRAS1	"Di-Ras1, GBTS1, RIG"	ENSG00000176490	"DIRAS family GTPase 1"	O95057	19	2714567-2721418	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 48.0;heart muscle: 52.0;parathyroid gland: 13.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.4;REH: 24.2;SH-SY5Y: 14.4;THP-1: 16.9"	"Cancer enhanced"	"Detected in many"		"glioma: 17.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.2;naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	15	"B-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (7.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.60e-2)"	"prognostic favourable (4.78e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-4)"	1.3	2.9	12.8	1.7	20.1	1.2	2.0	20.6	48.0	3.4	1.7	3.0	0.1	1.7	6.9	2.8	5.2	2.8	1.3	52.0	14.8	8.5	2.5	0.7	1.0	1.2	10.0	16.2	1.8	6.1	13.5	8.2	1.0	19.1	3.1	1.6	2.4	6.0	2.3	1.4	1.6	1.8	6.8	2.9	2.2	2.6	4.2	1.3	0.0	1.0	1.8	1.3	1.6	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.6	12.3	0.4	1.7	0.0	4.1	1.4	0.2	0.0	0.7	0.2	0.0	0.5	10.9	0.0	5.1	0.0	0.0	0.0	8.0	0.2	0.4	0.4	0.5	0.0	22.4	0.7	2.6	0.0	0.1	0.0	7.2	3.6	1.4	1.8	0.1	0.2	7.7	1.7	24.2	0.0	5.8	0.0	0.0	1.6	14.4	0.1	0.5	7.7	0.5	16.9	0.0	2.8	3.5	0.1	1.3	8.5	5.9	4.4	6.1	0.2	12.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	20.1	20.6	48.0	14.8	8.5	10.0	16.2	19.1	1.3
ERVMER34-1	envMER34	ENSG00000226887	"Endogenous retrovirus group MER34 member 1, envelope"	Q9H9K5	4	52722618-52751640	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 32.0;placenta: 26.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 27.6;hTCEpi: 19.9;RPTEC TERT1: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA011423, HPA024053"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	5000000	5000000	Nucleoplasm	Nucleoplasm	"HPA011423: AB_2668510, HPA024053: "	"unprognostic (5.34e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-3)"	"unprognostic (5.86e-2)"	"unprognostic (4.08e-4)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.88e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.82e-1)"	0.3	1.3	1.2	0.4	0.7	0.2	2.8	0.5	3.0	1.3	0.5	0.0	1.4	0.5	0.9	1.3	3.7	0.7	0.4	6.2	0.8	1.0	4.4	0.3	1.8	1.9	0.6	0.2	3.9	1.7	32.0	0.2	26.9	0.8	0.7	0.7	0.8	1.3	3.0	0.2	1.0	0.5	0.4	1.5	1.9	1.1	1.7	0.3	0.0	2.5	3.7	1.2	1.0	1.8	0.6	0.4	1.2	0.1	0.4	0.3	0.0	4.4	0.2	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	27.6	5.9	0.0	0.6	0.1	0.3	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	1.3	19.9	0.0	2.9	0.0	1.5	0.0	0.1	0.3	0.0	0.0	1.8	0.8	0.0	0.0	0.0	14.7	0.4	1.2	0.2	1.8	0.8	0.0	2.4	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.1	0.5	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.3	0.2	1.1	0.4	0.1	0.4	0.2	0.0	1.2	0.7	0.5	3.0	0.8	1.0	0.6	0.2	0.8	0.3
FAM231C		ENSG00000268674	"Family with sequence similarity 231 member C"	"P0DMU3, P0DMU4, P0DMU5"	Unmapped	35407-35916	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 1.6;brain: 5.6;parathyroid gland: 3.2;testis: 1.4"	"Cell line enhanced"	"Detected in single"		"U-698: 1.4"									"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"											"HPA043267, HPA043292, HPA077864"	Uncertain		Approved	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA043267: , HPA043292: , HPA077864: AB_2686862"																		0.0	0.3	0.1	0.0	0.1	0.1	0.0	5.6	0.3	0.1	0.3			0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0		0.2	0.1	3.2	0.0	0.1		0.1	0.0		0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.4			0.0		0.0	0.0	0.0	1.6	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0										
FMN2		ENSG00000155816	"Formin 2"	Q9NZ56	1	240014348-240475189	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 41.0;parathyroid gland: 26.6"	"Cell line enhanced"	"Detected in some"		"BJ: 26.5;fHDF/TERT166: 26.1;LHCN-M2: 28.7;U-138 MG: 19.0;WM-115: 29.6"	"Group enriched"	"Detected in some"	8	"glioma: 5.9;testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA050649			Approved	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"	"Plasma membrane, Actin filaments"	"HPA050649: AB_2681202"	"unprognostic (1.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.11e-2)"	"unprognostic (8.03e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.40e-3)"	1.2	7.3	17.1	1.3	14.5	0.9	1.3	17.2	41.0	1.1	3.2	9.4	0.0	1.4	2.5	2.1	2.1	3.7	2.0	0.9	16.2	11.8	2.9	0.9	1.4	0.9	9.9	15.5	3.9	2.1	26.6	5.6	1.2	12.2	2.9	3.0	1.4	1.3	3.6	0.9	1.0	1.3	2.7	12.3	1.2	1.2	3.4	12.3	0.0	1.3	0.0	1.0	1.2	0.4	0.5	0.4	0.6	0.3	0.4	2.3	0.0	0.0	0.8	2.8	0.0	7.2	5.5	0.0	26.5	14.0	10.5	5.7	0.0	0.0	0.0	0.0	26.1	0.0	0.4	0.0	10.3	0.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.6	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.9	0.8	0.0	0.1	0.0	0.0	0.0	4.4	3.9	0.0	0.1	0.1	1.1	0.0	0.1	19.0	0.1	7.1	6.9	0.0	0.0	0.0	3.7	0.0	29.6	0.6	0.3	0.1	0.3	0.2	0.2	0.1	0.9	0.1	0.1	0.5	2.3	1.4	0.5	0.4	0.1	0.4	0.3	0.0	17.1	14.5	17.2	19.3	16.2	11.8	9.9	15.5	12.2	12.3
KANSL1L	"C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2"	ENSG00000144445	"KAT8 regulatory NSL complex subunit 1 like"	A0AUZ9	2	210021423-210171383	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 178.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043102, HPA046790"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA043102: AB_2678316, HPA046790: AB_2679808"	"unprognostic (3.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.55e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.99e-3)"	"unprognostic (4.65e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.95e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.30e-3)"	8.4	5.6	8.3	6.0	12.9	3.8	8.8	12.7	10.9	10.4	6.9	7.5	11.1	4.4	11.3	9.9	5.9	8.9	8.9	7.9	8.8	5.7	12.3	5.8	9.8	4.3	12.1	5.5	16.2	10.0	178.9	14.4	5.3	9.5	14.3	4.7	6.2	7.6	9.9	8.8	7.7	4.9	9.8	13.0	4.5	7.2	12.4	13.6	21.6	14.2	4.4	3.8	11.1	33.0	2.1	2.1	2.7	2.2	3.1	1.7	0.5	2.4	1.3	12.9	5.4	10.4	7.8	3.8	3.7	4.7	2.4	6.6	2.5	9.6	6.8	4.9	2.3	3.5	2.9	1.2	3.8	2.9	2.4	5.6	5.0	4.4	6.5	6.5	4.0	4.9	5.7	2.3	1.7	5.2	4.1	6.3	3.5	2.4	7.2	16.7	7.7	1.8	5.2	3.7	5.3	14.1	3.7	8.1	7.7	3.3	2.3	2.6	2.3	13.8	4.5	5.1	4.1	1.8	2.8	4.5	1.9	6.7	6.3	3.2	6.2	1.1	1.4	2.7	1.2	2.2	1.1	0.9	1.0	1.4	2.1	2.1	1.7	1.7	2.4	3.1	0.9	1.4	0.8	0.5	8.3	12.9	12.7	10.9	8.8	5.7	12.1	5.5	9.5	13.6
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5"	"Group enriched"	"Detected in some"	5	"HMC-1: 5.0;SK-BR-3: 9.4"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 11.6"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"												"Secreted to blood"						"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favourable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favourable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0.0	0.8	0.7	2.1	3.3	0.2	1.0	1.0	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1.0	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0.0	1.4	1.3	0.3	1.5	1.1	0.0	0.0	0.0	1.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	4.3	0.0	0.8	2.4	0.8	0.5	0.3	11.6	0.3
NCKIPSD	"AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH"	ENSG00000213672	"NCK interacting protein with SH3 domain"	Q9NZQ3	3	48673844-48686364	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 39.6;parathyroid gland: 123.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019267, HPA050005"			Enhanced	"Plasma membrane"		42000	42000	"Plasma membrane"	"Plasma membrane"	"CAB019267: , HPA050005: AB_2680988"	"unprognostic (1.55e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.50e-3)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (1.20e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"	11.7	11.9	14.4	4.9	18.5	4.4	7.8	17.9	39.6	7.0	7.9	10.3	3.5	7.3	7.8	8.6	7.8	9.6	9.3	17.8	12.9	16.0	8.7	6.8	7.4	5.9	11.1	17.8	17.7	8.5	123.9	10.0	8.0	16.9	8.1	7.4	9.6	8.9	11.7	6.4	9.8	7.3	8.7	9.2	5.7	6.2	8.4	10.9	2.9	7.7	1.9	5.4	7.7	6.5	4.9	8.5	1.0	5.3	4.8	6.4	4.7	11.6	10.2	10.5	10.7	14.3	8.7	14.6	11.7	13.1	13.0	16.6	15.1	7.1	8.6	6.4	6.9	7.9	13.3	15.5	7.5	9.6	16.3	15.4	38.1	11.9	12.5	10.4	17.4	8.3	13.5	18.0	11.3	7.3	5.2	11.5	10.4	8.6	9.4	8.8	12.1	18.2	4.8	4.8	14.4	7.1	12.0	11.0	8.9	12.2	11.5	9.8	10.2	12.7	4.1	11.3	12.7	13.3	15.4	10.4	7.6	9.6	12.8	13.9	17.2	1.0	4.6	0.2	3.5	5.3	2.6	4.9	4.2	4.1	5.8	2.6	6.4	4.1	0.3	4.8	2.8	8.5	4.6	4.7	14.4	18.5	17.9	39.6	12.9	16.0	11.1	17.8	16.9	10.9
PCDH11X	"PCDH-X, PCDH11, PCDHX, PPP1R119"	ENSG00000102290	"Protocadherin 11 X-linked"	Q9BZA7	X	91779261-92623230	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 7.0;ovary: 12.6;parathyroid gland: 5.2"	"Group enriched"	"Detected in some"	5	"AF22: 4.2;AN3-CA: 6.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077495	Approved									"HPA077495: "	"unprognostic (4.22e-3)"	"unprognostic (1.16e-1)"		"unprognostic (1.39e-4)"	"unprognostic (1.18e-1)"			"unprognostic (8.20e-3)"		"unprognostic (6.32e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.19e-2)"		"unprognostic (4.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.86e-1)"	0.0	0.3	2.6	0.1	7.0	0.0	0.2	0.0	4.8	1.7	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	4.2	0.0	0.0	0.0	0.2	1.3		12.6	0.0	5.2	0.3	1.2		0.0	0.0		0.0	0.4	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0			0.1		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PEX5L	"PEX5R, PXR2, TRIP8b"	ENSG00000114757	"Peroxisomal biogenesis factor 5 like"	Q8IYB4	3	179794958-180037053	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 41.9;parathyroid gland: 60.1"	"Group enriched"	"Detected in some"	4	"HDLM-2: 5.6;MOLT-4: 19.8;RPMI-8226: 15.8;SCLC-21H: 9.7;U-266/70: 12.7"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058026	Enhanced									"HPA058026: AB_2683582"	"unprognostic (5.21e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.67e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.66e-10)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.03e-3)"	1.3	1.4	17.0	1.3	26.6	1.2	1.2	1.8	41.9	1.3	1.2	24.5	0.0	1.3	1.2	1.5	1.3	1.4	1.2	1.3	16.9	8.1	1.3	1.2	1.3	1.2	38.4	18.9	2.9	10.6	60.1	5.3	1.1	24.1	1.4	1.2	0.0	1.3	1.2	1.4	1.2	1.3	1.1	32.3	1.2	1.3	5.4	36.5	0.0	1.3	0.0	1.2	1.2	0.4	0.8	0.4	0.8	0.1	0.4	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	5.6	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.1	0.0	0.0	1.0	0.0	0.0	2.9	0.0	0.0	19.8	0.0	1.2	0.2	0.1	0.0	15.8	0.0	0.0	9.7	0.5	0.0	0.0	0.0	0.0	1.5	0.0	2.0	0.1	0.0	0.5	12.7	0.4	0.0	0.3	0.1	0.5	0.6	0.1	0.2	0.6	0.1	0.5	0.0	0.1	0.0	0.0	0.8	0.2	0.3	0.8	0.4	0.1	0.4	0.0	0.0	17.0	26.6	1.8	26.0	16.9	8.1	38.4	18.9	24.1	36.5
PVALB	D22S749	ENSG00000100362	Parvalbumin	P20472	22	36800684-36819479	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 125.0;parathyroid gland: 137.5"	"Cell line enriched"	"Detected in single"	198	"RPMI-8226: 130.9"	"Group enriched"	"Detected in many"	10	"breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3"	"Region enhanced"	"Detected in all"		"cerebellum: 125.0"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.4"	"Region enriched"	"Detected in many"	5	"cerebellum: 2377.5"	"Low region specificity"	"Detected in many"			"CAB002515, HPA048536"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"				Nucleoplasm	Nucleoplasm	"CAB002515: AB_563948, HPA048536: AB_2680433"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (8.99e-3)"	0.9	0.8	1.2	0.9	3.9	0.8	4.3	125.0	47.2	0.8	0.8	6.6	0.0	0.8	1.1	0.9	0.8	0.8	0.9	0.8	4.5	9.4	16.7	1.8	1.2	1.2	28.6	2.5	0.8	0.8	137.5	0.2	1.2	22.9	0.9	0.9	27.3	1.2	1.0	5.0	0.8	0.8	0.9	12.6	1.2	0.9	1.1	1.2	0.0	0.9	0.0	1.4	1.2	1.0	0.0	0.5	3.4	0.4	0.0	0.3	12.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	130.9	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.4	0.0	0.0	0.5	0.3	12.2	1.2	3.9	125.0	47.2	4.5	9.4	28.6	2.5	22.9	1.2
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73654155	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 155.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.9;ASC TERT1: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (1.09e-1)"	7.2	5.8	6.4	2.9	6.8	2.9	9.6	6.3	6.8	4.9	7.8	4.7	12.5	6.5	5.1	17.2	5.0	3.4	6.2	6.2	4.5	6.7	24.3	13.2	7.6	4.9	5.0	4.5	3.4	8.7	155.6	9.3	12.6	6.7	6.9	8.6	6.6	15.5	8.6	3.5	4.8	12.9	4.6	5.9	4.3	6.0	4.1	4.7	3.0	30.5	2.6	7.1	5.9	4.3	5.2	9.9	12.4	10.6	12.0	9.4	6.0	2.7	3.8	3.8	6.1	40.9	30.5	5.1	9.2	23.1	2.5	8.7	2.5	6.8	2.5	4.4	12.8	4.9	5.3	2.3	4.4	1.8	6.1	1.1	2.0	5.8	8.2	2.1	4.3	13.9	3.4	5.6	3.9	6.3	2.7	2.8	8.6	1.8	0.8	1.2	2.8	2.2	1.8	4.7	10.9	6.4	7.7	1.5	2.7	1.8	5.5	5.3	2.5	13.0	9.2	1.2	1.1	4.9	2.1	8.0	11.2	0.7	4.1	4.5	3.6	12.4	10.6	4.2	8.5	9.7	8.3	5.2	9.4	8.1	9.9	3.7	7.8	8.6	7.4	12.0	6.0	7.4	8.2	6.0	6.4	6.8	6.3	6.8	4.5	6.7	5.0	4.5	6.7	4.7
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 82.3;parathyroid gland: 47.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.9;U-87 MG: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol		28000	28000	Cytosol	Cytosol	"HPA050510: AB_2681151"	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"	8.1	2.8	2.5	1.2	4.2	5.1	9.2	3.0	2.2	6.4	6.1	3.0	3.7	7.9	1.3	3.1	5.1	4.0	2.8	6.6	2.9	1.4	3.4	82.3	3.9	4.9	3.9	0.4	5.2	9.0	47.4	5.1	4.3	6.1	4.8	2.4	2.1	12.6	9.1	10.9	3.0	9.8	0.9	6.4	1.0	6.7	1.5	3.2	0.2	3.3	6.9	4.0	4.2	3.7	0.8	7.0	0.7	4.3	2.1	0.2	1.5	6.5	7.9	0.0	2.7	3.9	36.9	7.0	2.1	2.3	4.2	3.8	6.0	9.0	0.0	15.9	11.9	11.2	3.4	6.9	4.7	0.0	11.2	12.8	7.1	11.7	9.7	3.1	2.4	21.8	12.2	24.7	8.9	3.6	6.2	1.3	11.7	6.2	0.0	1.8	10.8	16.5	0.0	4.6	5.6	5.1	16.7	13.3	2.4	5.8	20.2	1.5	4.0	4.2	15.3	26.0	15.3	5.5	11.4	0.0	0.0	0.0	47.8	8.1	5.4	0.0	4.0	0.7	0.2	4.3	0.0	0.8	0.0	0.0	7.0	0.2	0.0	0.0	0.1	2.1	0.6	0.3	0.0	1.5	2.5	4.2	3.0	2.2	2.9	1.4	3.9	0.4	6.1	3.2
SYCP2L	"C6orf177, dJ62D2.1, NO145"	ENSG00000153157	"Synaptonemal complex protein 2 like"	Q5T4T6	6	10886831-10979320	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 54.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 8.9;HMC-1: 27.9;K-562: 7.0;NB-4: 9.6;THP-1: 7.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"basophil: 2.9;eosinophil: 5.5;plasmacytoid DC: 7.6"	"Group enriched"	"Detected in many"	17	"dendritic cells: 7.6;granulocytes: 5.5"									HPA034679			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA034679: AB_10669729"	"unprognostic (3.25e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.57e-3)"	"unprognostic (4.23e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-2)"	0.9	0.4	0.9	0.8	1.0	0.7	0.7	2.6	1.5	0.5	1.1	0.8	3.7	0.4	1.1	8.9	0.6	0.5	0.7	3.0	0.8	0.7	1.6	0.4	10.1	0.5	1.0	0.5	1.5	5.5	54.0	0.7	4.0	0.6	0.8	0.4	2.9	1.2	0.5	1.9	0.6	0.3	0.5	0.9	0.6	0.4	5.1	0.6	0.7	2.5	0.0	2.2	0.5	0.3	0.0	7.6	5.5	0.3	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.1	0.0	3.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.1	4.3	0.0	0.0	0.0	0.0	8.9	27.9	0.0	0.6	0.0	0.0	0.0	7.0	0.0	0.0	0.0	2.2	9.6	0.5	0.0	0.1	0.3	0.0	0.2	0.0	0.4	2.5	0.0	2.4	0.0	0.1	7.2	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	2.9	0.1	5.5	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.9	1.0	2.6	1.5	0.8	0.7	1.0	0.5	0.6	0.6
AAK1	"DKFZp686K16132, KIAA1048"	ENSG00000115977	"AP2 associated kinase 1"	Q2M2I8	2	69457997-69674349	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 109.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017931, HPA020289"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA017931: AB_1844406, HPA020289: AB_1844407"	"unprognostic (2.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.06e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (1.24e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.18e-1)"	5.1	5.9	11.0	5.7	11.9	7.8	6.9	25.2	26.5	4.8	4.2	3.9	6.3	3.8	4.7	7.1	3.8	4.9	4.3	7.9	14.4	12.8	7.2	3.1	7.5	6.8	9.4	11.6	3.3	6.7	109.7	10.3	6.9	10.2	5.0	4.6	4.7	3.6	12.3	6.8	3.7	3.7	5.4	9.3	5.5	5.4	4.1	6.9	4.7	16.0	2.1	5.3	4.9	5.8	1.0	0.8	4.1	3.9	2.8	5.6	1.3	16.5	9.9	9.1	8.8	8.7	9.7	29.3	13.5	10.7	8.2	7.2	10.0	6.6	0.5	3.3	17.5	7.7	7.0	7.0	16.7	12.3	2.9	9.0	6.0	6.8	7.9	6.3	21.4	8.3	6.2	15.4	19.9	17.3	1.9	9.3	14.2	2.8	5.8	3.3	4.4	5.5	3.9	9.9	1.4	6.4	34.7	3.0	4.8	7.8	6.0	7.0	3.5	8.9	17.2	18.3	12.3	13.1	13.2	9.2	2.4	1.0	15.3	10.7	12.5	2.5	1.4	0.6	4.5	0.6	4.2	0.4	4.0	3.0	0.8	1.0	5.6	4.5	4.1	2.8	3.9	0.7	3.1	1.3	11.0	11.9	25.2	26.5	14.4	12.8	9.4	11.6	10.2	6.9
ACSL3	"ACS3, FACL3, PRO2194"	ENSG00000123983	"Acyl-CoA synthetase long chain family member 3"	O95573	2	222860934-222944639	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 206.1"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 92.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011315, HPA071021"	Approved		Approved	"Nucleoli,Lipid droplets"				Nucleoli	Nucleoli	"HPA011315: AB_1848344, HPA071021: AB_2686335"	"unprognostic (1.87e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.35e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (2.75e-4)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (3.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.60e-1)"	14.7	17.0	22.8	9.9	26.0	16.3	51.5	19.4	45.9	15.3	16.5	16.1	11.6	12.7	10.9	18.4	28.3	9.0	11.8	22.7	20.9	22.8	17.9	22.3	15.6	10.5	19.6	21.2	11.7	10.3	206.1	8.8	19.1	24.4	44.4	16.7	14.4	34.2	15.5	19.1	11.4	12.7	12.2	22.2	9.7	28.3	13.7	14.2	13.5	17.3	11.2	8.7	14.6	15.4	15.0	22.5	21.8	16.8	16.6	20.1	16.5	9.9	17.6	27.0	29.3	11.8	29.3	7.5	12.7	33.0	15.2	32.2	15.8	25.7	4.8	7.4	12.1	29.4	5.8	28.3	19.8	8.6	11.1	11.2	14.3	17.7	26.0	7.4	5.5	15.1	40.1	25.2	44.0	16.6	21.2	18.3	21.5	21.2	14.4	8.7	13.7	9.2	7.9	22.9	8.1	21.9	40.9	14.2	10.6	7.5	20.3	92.7	10.2	18.1	11.4	10.2	16.3	8.8	9.3	6.5	3.1	16.5	11.0	6.9	30.9	16.6	14.6	21.8	20.1	16.8	19.3	11.6	12.8	14.6	15.7	15.0	18.7	16.7	21.8	16.6	15.9	22.5	9.5	16.5	22.8	26.0	19.4	45.9	20.9	22.8	19.6	21.2	24.4	14.2
CALCA	CALC1	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972354	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"parathyroid gland: 122.2;thyroid gland: 55.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;hTERT-HME1: 1.7;Karpas-707: 1.8;SCLC-21H: 3.4"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enriched"	"Detected in single"	48	"pons and medulla: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"pons and medulla: 60.6"					HPA059886		Supported			"Secreted to blood"					"HPA059886: "			"unprognostic (1.97e-1)"	"prognostic unfavourable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.2	0.0	0.1	0.3	0.4	0.0	0.8	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	6.2	16.8	0.6	0.0	0.1	0.0	0.0	0.1	122.2	0.2	0.0	19.8	1.2	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.3	1.5	4.6	0.0	0.0	0.0	0.6	55.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.1	0.2	0.0	0.2	0.1	0.0	19.8	0.0
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842071-60851081	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 200.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (7.36e-5)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	13.5	12.4	7.3	8.6	11.0	6.1	11.2	3.3	11.2	5.8	6.7	7.9	3.4	7.4	8.4	5.0	9.3	7.4	8.3	9.3	6.7	6.4	8.1	11.4	5.4	8.2	10.0	6.0	11.3	13.6	200.8	12.7	7.3	8.5	11.9	4.7	6.7	6.4	6.2	20.2	10.4	6.2	7.3	6.7	9.3	7.7	47.8	8.7	10.2	7.9	12.6	6.5	8.6	6.5	6.9	20.0	5.0	19.5	4.2	8.5	6.7	20.9	28.6	7.1	20.4	5.7	9.5	9.7	14.1	11.0	26.0	14.0	24.3	14.1	25.7	27.0	7.6	19.7	23.9	17.0	12.0	9.0	26.4	13.1	12.7	33.9	19.1	20.4	22.4	10.9	13.0	24.0	15.2	19.2	41.7	13.2	12.7	24.8	30.6	31.1	28.6	41.1	21.0	10.6	64.6	9.0	8.9	16.0	10.3	9.1	21.0	16.5	21.2	8.2	12.5	25.9	15.9	35.1	30.5	11.2	16.5	27.8	21.2	22.1	31.3	2.6	9.1	5.0	6.5	19.5	6.9	6.9	6.9	6.0	20.0	6.5	8.5	7.4	0.7	4.2	6.3	11.2	6.2	6.7	7.3	11.0	3.3	11.2	6.7	6.4	10.0	6.0	8.5	8.7
CHRNA4	"BFNC, EBN, EBN1"	ENSG00000101204	"Cholinergic receptor nicotinic alpha 4 subunit"	P43681	20	63343223-63378401	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 16.4;liver: 38.8;parathyroid gland: 21.6"	"Cell line enriched"	"Detected in some"	5	"U-2 OS: 7.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"midbrain: 22.6;pons and medulla: 19.3;thalamus: 29.6"	CAB034064	Uncertain									"CAB034064: AB_2080535"	"unprognostic (3.40e-1)"	"unprognostic (1.71e-1)"		"unprognostic (2.87e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.10e-3)"	"unprognostic (5.72e-4)"	"unprognostic (9.02e-3)"	"unprognostic (9.79e-4)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.81e-2)"		0.6	0.8	5.2	0.6	8.7	0.6	0.6	3.1	14.5	0.6	0.6	11.0	0.0	0.6	0.6	0.6	0.6	2.0	0.6	0.6	5.1	6.8	2.1	38.8	0.7	0.6	11.3	8.2	0.7	0.6	21.6	1.0	0.6	16.4	1.3	0.6	5.7	0.6	0.6	0.6	0.6	0.6	0.6	3.9	4.8	0.6	1.9	3.9	0.0	1.2	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	8.7	3.1	14.5	5.1	6.8	11.3	8.2	16.4	3.9
EPHA7	Hek11	ENSG00000135333	"EPH receptor A7"	Q15375	6	93240020-93419547	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 110.4"	"Group enriched"	"Detected in some"	4	"AF22: 8.7;HEK 293: 25.0;RH-30: 23.8;THP-1: 20.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010496	Approved				"Intracellular and membrane"	340000	340000			"CAB010496: AB_2099673"	"unprognostic (3.34e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.62e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.82e-2)"	1.3	1.3	6.0	1.7	24.6	1.2	2.2	21.6	8.6	2.4	24.6	0.0	0.1	2.5	2.0	7.5	14.7	1.7	3.1	4.2	13.8	2.9	6.9	1.3	1.5	1.3	2.4	5.8	3.0	1.3	110.4	5.6	1.6	6.7	17.9	3.6	0.4	8.2	1.9	1.3	1.4	6.5	20.2	4.8	4.7	14.9	2.1	4.4	0.0	1.3	0.0	1.3	9.7	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	25.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.5	0.6	4.4	23.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	24.6	21.6	8.6	13.8	2.9	2.4	5.8	6.7	4.4
GAREM2	"FAM59B, FLJ00375, GAREML, KIAA2038"	ENSG00000157833	"GRB2 associated regulator of MAPK1 subtype 2"	Q75VX8	2	26173091-26189663	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 21.2;parathyroid gland: 17.0"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.1;SH-SY5Y: 9.4;U-2 OS: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071575			Approved	Cytosol				Cytosol	Cytosol	"HPA071575: AB_2686420"	"unprognostic (1.70e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.04e-1)"	3.2	1.6	19.9	1.8	13.9	0.9	1.5	8.2	21.2	2.5	3.0	11.7	0.7	1.2	3.0	1.7	2.6	2.4	2.8	2.0	17.9	11.0	1.8	0.5	1.1	2.2	13.1	8.9	4.1	4.4	17.0	1.4	1.5	16.5	1.7	2.9	0.9	1.8	3.5	3.7	2.4	1.1	3.6	15.9	1.6	1.5	2.6	13.9	0.0	2.6	0.0	2.0	2.1	1.2	0.8	2.5	1.6	0.6	0.4	1.9	0.3	2.6	4.0	4.8	0.4	0.8	1.7	0.4	1.4	0.0	0.4	0.4	7.5	0.9	0.0	1.9	3.0	0.1	15.1	0.0	0.6	1.6	5.6	1.3	1.3	0.5	5.9	0.1	0.3	2.3	0.7	2.3	0.2	1.8	6.9	0.1	2.8	0.0	0.4	0.5	5.1	1.1	1.5	0.0	0.0	2.4	0.8	1.0	9.4	3.3	0.3	2.8	0.2	7.9	0.8	2.1	12.9	3.8	0.1	0.3	0.0	1.6	0.1	0.0	2.7	0.4	0.6	0.2	1.2	0.2	0.5	0.5	1.9	1.4	0.5	0.8	1.5	0.5	1.6	0.4	0.5	2.5	0.4	0.3	19.9	13.9	8.2	14.1	17.9	11.0	13.1	8.9	16.5	13.9
KIF13B	"GAKIN, KIAA0639"	ENSG00000197892	"Kinesin family member 13B"	Q9NQT8	8	29067279-29263124	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 40.5;parathyroid gland: 107.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025023, HPA049655"	Enhanced									"HPA025023: AB_1852471, HPA049655: AB_2732555"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-1)"	"prognostic favourable (8.92e-4)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"prognostic favourable (6.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavourable (4.77e-4)"	"unprognostic (9.76e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	7.4	10.5	12.3	8.2	21.5	4.8	8.7	3.2	13.8	8.6	15.1	40.5	15.4	13.6	6.1	9.1	6.9	7.1	10.5	4.6	16.5	10.4	16.3	12.5	7.6	4.3	25.9	7.1	7.2	9.7	107.1	10.2	4.4	22.0	10.0	12.2	4.9	12.9	8.9	3.9	15.2	18.0	7.3	29.3	7.7	15.6	6.1	25.1	4.2	8.4	5.1	7.9	9.4	5.9	2.9	5.4	4.1	3.8	2.0	4.1	1.0	9.0	9.8	3.5	2.9	5.7	3.4	5.1	0.5	2.2	3.0	4.8	6.1	5.2	1.9	5.3	0.6	6.1	2.8	1.6	3.8	2.8	2.7	4.7	1.4	6.1	5.6	1.3	14.8	3.9	3.0	6.6	2.8	12.9	6.1	7.2	9.6	2.8	7.0	2.2	1.7	1.7	4.0	8.0	3.5	13.0	9.8	1.0	6.9	1.8	6.1	8.5	4.5	2.7	17.0	2.1	5.9	0.6	4.0	5.3	7.8	3.2	12.6	2.5	9.9	0.3	3.8	4.1	4.1	2.9	2.0	2.9	1.6	2.4	1.2	2.0	1.3	1.7	2.0	2.0	1.4	5.4	1.5	1.0	12.3	21.5	3.2	13.8	16.5	10.4	25.9	7.1	22.0	25.1
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 19.0;parathyroid gland: 64.9"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 35.9;U-698: 11.0;WM-115: 24.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8"	"Cell type enhanced"	"Detected in single"		"gdTCR: 2.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1"	"Group enriched"	"Detected in many"	10	"amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	2.4	2.1	13.3	1.8	19.0	0.8	1.9	0.6	19.0	1.6	1.1	2.2	0.4	1.1	2.2	1.5	3.5	1.4	3.5	2.3	8.9	2.6	1.9	1.1	4.0	1.5	2.5	8.8	1.7	1.6	64.9	1.4	5.8	1.9	1.7	1.1	10.3	1.3	1.7	1.6	4.2	1.2	2.7	0.8	1.1	1.3	6.6	1.5	0.3	2.0	0.9	1.1	1.9	1.0	0.2	0.1	0.7	0.1	0.1	2.2	0.5	0.0	0.0	4.7	4.0	0.0	0.0	0.5	2.3	0.0	2.0	1.8	0.1	0.0	5.2	1.7	1.4	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.8	0.0	0.0	0.0	0.0	6.9	0.0	9.0	0.0	5.9	0.0	0.0	7.5	0.0	1.3	0.2	7.2	6.2	0.0	0.0	35.9	0.0	0.2	0.0	2.5	1.7	0.0	0.7	0.0	0.0	11.0	0.0	0.5	24.3	0.2	0.1	0.0	2.2	0.0	0.8	0.0	0.7	0.4	0.0	0.2	0.2	0.3	0.7	0.1	0.0	0.1	0.0	0.5	13.3	19.0	0.6	19.0	8.9	2.6	2.5	8.8	1.9	1.5
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952394	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.5;MCF7: 15.8;SK-BR-3: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	18000	18000	"Plasma membrane"	"Plasma membrane"	"HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	1.4	2.9	8.4	1.8	11.9	2.1	2.0	13.4	26.0	2.4	1.4	4.2	0.0	1.0	2.0	2.2	1.7	10.8	1.9	1.6	5.9	3.2	1.5	0.9	1.4	1.8	2.7	8.3	2.9	2.9	24.7	6.9	0.8	11.4	4.0	0.8	1.8	2.0	2.9	1.5	2.5	1.2	1.7	2.3	1.5	1.5	3.9	3.2	1.2	3.4	0.0	2.0	2.1	1.8	1.8	1.5	0.9	0.6	1.7	3.8	1.0	0.2	0.7	2.5	3.3	12.5	1.7	0.8	1.2	2.4	1.4	3.3	0.2	2.4	1.3	0.3	2.9	0.2	0.9	3.1	0.6	6.7	1.4	0.5	1.3	0.0	1.2	0.3	1.2	3.2	0.2	1.2	0.5	0.6	0.7	3.3	1.8	15.8	3.0	0.2	6.1	1.5	1.8	0.3	1.3	0.7	0.2	4.8	3.2	1.2	23.8	0.4	6.4	0.2	0.6	0.3	3.4	0.6	0.9	4.3	4.4	0.4	7.9	0.2	0.9	0.9	0.6	0.5	3.3	0.3	3.7	1.6	3.4	3.3	0.2	1.8	3.8	3.5	0.8	1.7	0.4	1.5	0.6	1.0	8.4	11.9	13.4	26.0	5.9	3.2	2.7	8.3	11.4	3.2
RAB6B		ENSG00000154917	"RAB6B, member RAS oncogene family"	Q9NRW1	3	133824239-133895836	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 86.5;parathyroid gland: 33.1"	"Cell line enriched"	"Detected in many"	4	"HEL: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 10.5"	"Lineage enriched"	"Detected in single"	54	"T-cells: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017713, HPA059131"	Uncertain		Approved	"Golgi apparatus"		11000000	11000000	"Golgi apparatus"	"Golgi apparatus"	"CAB017713: , HPA059131: AB_2683916"	"unprognostic (2.87e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.53e-3)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (3.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.80e-2)"	"prognostic favourable (3.97e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.05e-3)"	5.3	8.4	38.2	2.6	26.1	7.0	2.3	18.4	86.5	2.8	3.1	4.1	2.7	2.5	2.6	2.3	3.6	11.5	2.9	14.4	29.2	29.1	3.6	1.1	2.1	2.8	25.6	43.6	2.2	3.8	33.1	4.4	2.0	26.9	2.7	2.3	3.4	6.8	5.0	2.4	1.5	1.9	6.1	12.1	4.6	4.3	3.5	7.0	0.0	4.3	0.0	2.2	1.6	1.0	0.1	0.1	0.0	0.0	0.1	10.5	1.1	0.0	0.9	1.8	4.6	3.2	3.3	0.1	1.0	1.9	2.2	0.2	0.4	0.4	0.0	2.0	0.7	0.1	4.2	0.1	1.1	0.0	3.3	69.2	1.0	0.1	0.4	0.4	2.7	0.9	0.9	0.3	0.0	0.9	16.2	0.2	0.3	1.6	0.2	6.3	5.7	0.7	0.0	0.1	0.7	1.2	0.3	15.0	3.3	1.4	1.3	8.1	5.1	2.9	1.1	2.1	5.0	0.9	1.7	1.7	0.4	0.1	0.2	0.1	1.7	0.0	0.0	0.0	1.0	0.0	10.5	0.1	0.2	2.5	0.1	0.1	0.2	0.6	0.0	0.1	0.0	0.1	0.1	1.1	38.2	26.1	18.4	54.0	29.2	29.1	25.6	43.6	26.9	7.0
RNF217	"C6orf172, dJ84N20.1, IBRDC1, MGC26996"	ENSG00000146373	"Ring finger protein 217"	Q8TC41	6	124962545-125092633	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 63.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.9;myeloid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029598	Uncertain									"HPA029598: AB_10602297"	"unprognostic (2.96e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.07e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.22e-3)"	"unprognostic (4.94e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (4.60e-5)"	"unprognostic (8.29e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.52e-2)"	"prognostic unfavourable (1.92e-4)"	9.6	3.5	3.3	4.2	4.7	10.5	14.6	3.8	3.5	8.0	7.7	5.7	6.4	2.3	5.9	5.6	6.2	7.5	12.1	6.5	3.8	1.7	2.5	6.3	7.3	3.7	4.3	2.9	11.5	3.8	63.3	4.0	12.0	3.4	6.4	2.3	6.0	6.0	6.9	10.1	10.9	3.1	13.0	2.3	2.6	4.5	7.4	5.7	0.1	7.4	3.6	1.6	8.7	13.6	0.0	1.2	0.6	1.9	0.3	0.2	0.3	4.1	4.2	1.5	0.5	5.4	2.1	8.5	5.7	7.7	3.9	5.1	0.0	3.9	0.0	7.9	5.4	6.0	0.9	5.1	5.5	0.0	4.8	2.3	6.3	1.3	5.2	0.0	0.2	5.9	4.7	2.9	8.6	4.4	11.6	0.0	6.8	0.0	0.0	0.0	1.3	1.1	0.1	5.9	0.0	4.0	1.9	0.7	0.0	2.5	0.6	2.1	4.1	0.6	6.9	3.2	10.3	0.0	12.1	0.0	0.0	0.0	2.4	0.0	3.8	0.6	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.3	3.3	4.7	3.8	3.5	3.8	1.7	4.3	2.9	3.4	5.7
SLC7A8	"LAT2, LPI-PC1"	ENSG00000092068	"Solute carrier family 7 member 8"	Q9UHI5	14	23125295-23183674	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 204.0"	"Cell line enhanced"	"Detected in many"		"AF22: 21.1;ASC diff: 22.2;BEWO: 38.7;CACO-2: 21.4;K-562: 40.5;NTERA-2: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 7.6;eosinophil: 13.2;naive CD8 T-cell: 3.5"	"Group enriched"	"Detected in many"	46	"granulocytes: 13.2;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046015, HPA051950, HPA060672"	Enhanced									"CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: "	"unprognostic (1.50e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (1.97e-4)"	"prognostic favourable (3.15e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.39e-3)"	"unprognostic (9.44e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (1.52e-4)"	10.5	5.9	4.6	3.0	6.6	1.3	11.0	10.9	10.7	12.7	5.9	2.5	28.2	11.7	23.0	7.2	13.2	21.7	6.2	3.1	7.8	3.0	37.6	3.0	6.2	5.8	2.4	5.6	33.7	9.1	204.0	16.7	19.8	6.9	13.0	5.1	31.2	9.5	50.9	23.6	11.2	8.8	7.5	1.9	10.0	19.3	10.5	4.7	0.3	12.8	5.2	4.9	15.2	14.5	0.1	0.0	13.2	0.1	0.0	3.5	1.7	0.4	0.0	21.1	0.0	22.2	2.7	38.7	2.1	8.5	0.0	0.6	21.4	1.1	0.1	0.3	4.6	3.6	2.8	1.1	0.1	0.0	2.0	0.1	0.0	0.0	8.7	0.0	12.0	19.1	10.6	0.3	0.2	1.7	40.5	0.0	0.4	0.3	0.0	0.2	21.1	15.8	0.0	0.2	4.0	0.2	7.9	2.6	0.1	0.0	3.7	10.0	13.4	0.1	0.1	0.7	0.5	0.2	0.0	0.1	4.6	0.0	2.4	0.0	0.1	7.6	0.1	13.2	0.0	0.1	1.1	0.1	0.9	0.1	0.0	0.0	0.9	3.5	0.4	0.0	0.0	0.0	0.5	1.7	4.6	6.6	10.9	10.7	7.8	3.0	2.4	5.6	6.9	4.7
SPOCK3	testican-3	ENSG00000196104	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3"	Q9BQ16	4	166733384-167234796	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 46.8;parathyroid gland: 184.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.5;PC-3: 4.3;RH-30: 11.4;SCLC-21H: 4.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.3;intermediate monocyte: 1.8;myeloid DC: 4.5;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.5;monocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (3.54e-2)"	"unprognostic (8.69e-2)"		"unprognostic (2.90e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.09e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.94e-4)"	"unprognostic (8.92e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.64e-1)"	1.2	10.0	21.7	1.3	30.4	1.1	1.1	5.8	23.2	1.4	1.4	32.2	2.2	1.4	2.2	8.0	1.2	1.5	1.2	1.2	31.3	21.4	1.2	1.2	1.2	1.2	45.4	15.9	7.8	1.3	184.6	0.3	1.1	27.4	28.1	1.3	0.0	1.2	14.1	1.2	1.1	1.6	2.1	46.8	1.2	1.4	1.3	42.9	0.0	1.1	0.9	1.2	1.9	0.3	0.0	4.5	0.0	3.3	0.3	0.0	1.1	0.0	2.6	0.3	0.0	0.0	0.0	0.4	0.0	3.5	0.1	0.6	0.4	0.0	0.1	0.0	0.0	0.1	1.6	0.1	0.7	0.2	0.4	0.0	1.8	0.3	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.5	4.3	0.0	11.4	0.6	0.0	1.7	4.9	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.0	3.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.0	1.1	21.7	30.4	5.8	22.8	31.3	21.4	45.4	15.9	27.4	42.9
SYT12	SRG1	ENSG00000173227	"Synaptotagmin 12"	Q8IV01	11	67006778-67050863	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 29.9;parathyroid gland: 59.4"	"Cell line enhanced"	"Detected in some"		"HeLa: 25.7;MCF7: 17.7;SiHa: 22.8;SK-BR-3: 11.1;T-47d: 11.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011006, HPA074255"	Enhanced									"HPA011006: AB_2286996, HPA074255: "	"unprognostic (2.72e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavourable (4.13e-4)"	"unprognostic (2.75e-1)"	"unprognostic (9.86e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.42e-2)"	"unprognostic (9.85e-2)"	1.1	2.2	4.3	0.8	7.9	0.6	4.2	29.9	16.2	0.7	0.6	0.8	3.5	1.2	0.7	6.2	0.9	3.7	1.1	0.8	5.4	4.7	0.7	10.2	0.6	0.7	2.6	5.4	0.7	0.7	59.4	3.4	4.1	6.8	0.9	0.6	0.1	1.8	2.5	0.8	1.2	0.8	0.6	1.3	0.6	0.7	1.3	0.5	0.0	0.6	0.0	0.7	1.4	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.8	1.8	0.7	0.8	0.1	2.6	0.0	0.0	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	17.7	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.2	0.0	0.2	0.0	22.8	11.1	0.0	11.1	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	7.9	29.9	16.2	5.4	4.7	2.6	5.4	6.8	0.5
TCAF2C		ENSG00000283528	"TRPM8 channel associated factor 2C"		7	143639230-143647646	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	4	"blood: 2.2;parathyroid gland: 1.9;placenta: 1.3"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;U-266/70: 3.9;U-266/84: 1.8"									"Cell type enhanced"	"Detected in some"		"basophil: 2.2;T-reg: 1.8"	"Low lineage specificity"	"Detected in many"											"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA038756: AB_10960427, HPA038758: AB_10960353"																		0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	1.9		1.3		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.1		0.0	0.1	0.0			0.0		0.0	0.0		0.6	0.0	2.2	0.0	0.0	1.8	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	1.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.1										
ZBED6CL	C7orf29	ENSG00000188707	"ZBED6 C-terminal like"	Q96FA7	7	150329789-150332721	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"adrenal gland: 37.4;parathyroid gland: 11.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.1;K-562: 17.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA019724, HPA055805"	Approved		Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane"	"Nuclear membrane"	"HPA019724: AB_1845756, HPA055805: AB_2682929"	"prognostic favourable (9.48e-5)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (3.35e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.44e-1)"	"prognostic favourable (2.44e-5)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (1.38e-5)"	"unprognostic (1.86e-2)"	"unprognostic (7.82e-2)"	"unprognostic (8.52e-3)"	"unprognostic (1.50e-3)"	0.4	37.4	0.4	2.6	0.4	1.7	0.8	0.3	0.2	1.1	1.4			1.6	2.0	0.2	1.2	1.9	0.4	0.4	0.3	0.6	1.8	5.6	1.5	3.9	0.3		3.1	3.2	11.3	2.5	0.0		1.5	1.5		1.1	0.9	0.1	2.2	2.1	0.6	0.1	2.3	1.7	0.3			1.8		3.7	1.3	0.8	3.6	1.0	2.8	1.0	2.8	3.5	2.4	4.4	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.4	6.2	4.7	2.5	2.2	0.0	1.8	0.0	0.0	0.3	40.1	3.2	3.1	6.6	10.5	1.3	0.0	4.7	0.8	2.4	0.0	0.0	0.2	17.2	6.7	0.0	2.0	7.6	1.8	3.0	0.0	0.0	0.3	5.6	2.1	8.9	8.5	4.9	6.8	1.9	0.3	0.5	2.1	0.1	0.0	0.0	0.0	0.0	5.4	1.5	0.0	0.0	0.0	0.0	0.0	1.0	1.0	2.7	0.7	3.2	2.2	2.4	3.4	0.7	3.6	3.5	2.9	2.8	2.8	0.2	1.0	2.2	2.4										
AC093668.1		ENSG00000270249			7	102541501-102592444	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"parathyroid gland: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.8;Karpas-707: 4.1;MOLT-4: 2.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA046970			Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA046970: AB_2679882"																		0.4	0.7	0.6	0.8	0.6	0.7	0.4	3.1	1.1	1.0	1.0			2.5	0.9	2.5	0.4	0.6	0.0	0.3	0.6	0.5	1.4	0.1	0.7	0.5	0.3		0.7	1.2	6.9	2.9	0.4		0.5	0.6		1.1	0.2	5.4	1.7	1.4	0.0	0.3	1.3	1.1	0.2			0.3		0.1	0.4	0.7	4.0	3.5	1.3	1.0	0.7	5.3	1.2	0.1	0.0	1.0	0.2	0.2	3.8	0.5	1.1	0.7	0.6	0.0	0.0	2.1	2.4	0.7	1.7	0.9	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.4	2.7	1.4	0.5	1.0	1.4	0.0	0.5	0.3	0.9	1.6	1.2	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.3	0.0	1.8	1.5	0.4	0.4	1.0	0.0	0.0	0.7	0.4	2.9	0.9	4.1	4.0	3.8	2.9	1.7	3.1	5.3	3.0	1.3	0.7	1.0	3.5	5.1	1.2										
ACTR3C	ARP11	ENSG00000106526	"ARP3 actin related protein 3 homolog C"	Q9C0K3	7	150243916-150323725	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"parathyroid gland: 39.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.2;RT4: 17.9;SiHa: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (3.41e-1)"	"unprognostic (4.79e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.07e-6)"	"unprognostic (2.83e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.14e-2)"	"unprognostic (5.53e-3)"	1.5	9.0	3.1	8.7	5.0	1.2	4.4	5.7	3.2	3.9	7.5	0.8	8.3	3.5	2.9	6.4	5.9	3.9	8.1	2.4	3.1	3.1	21.7	22.5	8.4	5.6	2.1	1.1	1.8	17.5	39.0	19.6	13.2	3.0	4.5	4.9	5.1	5.0	9.8	1.4	2.4	7.5	1.9	1.6	2.6	4.0	3.2	1.2	2.1	4.2	2.6	8.0	4.3	7.4	6.5	4.5	3.3	1.7	4.1	7.5	2.0	4.4	0.4	0.1	0.1	0.0	0.0	0.8	0.1	0.1	0.7	1.0	3.4	21.2	1.7	5.6	0.8	9.2	0.0	0.0	0.5	4.6	1.3	1.2	5.5	3.1	2.3	0.0	0.8	0.8	2.9	0.0	0.0	0.2	8.5	4.8	0.0	6.2	4.8	0.2	2.4	0.0	0.0	3.3	6.6	3.5	17.9	4.6	3.7	12.0	2.7	1.7	5.7	1.1	0.1	0.0	0.0	0.2	0.0	1.8	2.2	0.0	0.1	0.0	0.0	0.3	1.7	3.3	7.5	1.5	3.5	5.7	6.4	4.7	2.6	6.5	6.9	5.5	2.0	4.1	0.6	4.5	4.6	2.0	3.1	5.0	5.7	3.2	3.1	3.1	2.1	1.1	3.0	1.2
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;parathyroid gland: 23.1"	"Group enriched"	"Detected in some"	4	"AF22: 29.6;EFO-21: 7.7"	"Cancer enriched"	"Detected in some"	8	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain									"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	4.9	7.6	19.7	1.6	19.0	0.4	2.7	11.3	30.5	7.3	4.8	5.0	0.4	3.3	4.9	2.6	1.6	3.3	2.3	3.2	13.1	12.3	2.4	0.9	3.4	0.8	11.8	11.9	1.8	0.7	23.1	0.9	4.9	9.8	2.0	5.0	0.4	0.8	5.6	0.8	2.6	4.4	3.9	8.5	0.8	3.9	4.8	6.1	0.0	0.9	0.6	0.6	2.2	2.9	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.7	0.0	0.0	4.1	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.3	0.0	0.0	0.7	0.0	2.8	0.1	0.1	0.0	3.2	0.1	0.0	4.5	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.1	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	19.7	19.0	11.3	23.3	13.1	12.3	11.8	11.9	9.8	6.1
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 122.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 64.6;U-138 MG: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 20.7"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced				"Intracellular and membrane"	1800000000	1800000000			"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (3.15e-4)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (7.76e-2)"	16.6	14.1	23.6	5.2	31.1	4.2	34.2	4.2	25.3	12.9	8.2	25.0	13.9	7.2	7.0	15.4	4.0	20.6	9.9	4.7	23.2	24.3	9.6	19.4	29.6	4.2	45.1	19.7	24.6	15.3	122.5	11.9	5.3	31.5	14.0	6.6	3.0	17.9	17.5	0.9	5.9	7.3	10.8	35.3	3.0	14.2	2.3	43.8	2.2	25.6	2.7	6.2	9.9	5.5	3.5	20.7	3.7	3.2	0.4	1.6	2.0	38.4	14.8	10.7	5.4	16.2	7.1	0.1	31.5	18.4	20.3	28.6	0.1	8.0	2.7	13.1	44.3	29.8	1.7	25.0	60.2	2.5	2.6	0.3	11.4	0.7	18.2	15.6	0.1	12.6	18.7	26.0	64.6	22.3	0.0	4.6	26.6	2.6	2.2	5.7	2.2	16.8	1.4	0.9	0.1	30.8	4.3	7.7	21.5	3.2	3.1	2.0	6.0	10.3	46.2	77.9	26.6	3.4	37.2	0.0	0.0	0.2	17.7	3.3	33.2	0.0	3.2	2.4	0.4	1.5	1.4	3.5	1.1	0.7	20.7	2.2	0.2	0.2	3.7	0.4	0.8	7.4	1.6	2.0	23.6	31.1	4.2	24.6	23.2	24.3	45.1	19.7	31.5	43.8
ANK3		ENSG00000151150	"Ankyrin 3"	Q12955	10	60026298-60733490	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 95.4;parathyroid gland: 74.4"	"Cell line enhanced"	"Detected in many"		"RT4: 24.3;SK-BR-3: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"CAB013249, CAB015179, HPA038455"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020"	"unprognostic (1.91e-1)"	"unprognostic (5.33e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.28e-2)"	"prognostic favourable (8.88e-16)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.83e-2)"	2.7	3.1	21.1	3.1	24.8	1.1	9.1	95.4	29.1	5.5	10.5	21.5	19.4	15.7	9.7	52.9	7.1	8.2	8.9	31.2	24.4	16.4	38.9	6.6	10.1	2.5	26.8	19.8	5.2	5.0	74.4	10.5	31.9	31.9	8.6	8.8	6.5	16.1	19.4	29.2	16.0	10.6	5.9	16.5	5.9	6.3	3.4	30.0	0.6	17.2	4.6	3.4	5.6	6.6	6.2	3.5	1.7	0.4	2.1	7.7	1.3	4.1	2.4	15.0	0.2	0.0	0.9	11.6	0.3	0.2	0.0	0.3	10.7	8.1	0.2	4.9	0.3	5.9	8.0	7.2	0.2	0.2	5.4	0.1	4.6	0.0	3.1	0.0	0.2	7.4	4.6	3.8	0.2	1.7	2.0	10.1	3.4	13.8	0.0	0.4	6.8	13.0	0.0	10.8	2.0	2.7	24.3	7.8	1.4	0.3	24.4	0.0	14.2	0.0	4.9	0.4	1.5	6.6	0.7	0.4	0.0	0.0	2.7	0.1	9.3	1.7	0.4	0.6	4.1	0.3	3.7	6.2	7.0	2.2	0.2	1.9	7.7	1.9	1.1	2.1	0.4	3.5	1.0	1.3	21.1	24.8	95.4	29.1	24.4	16.4	26.8	19.8	31.9	30.0
ANO5	"GDD1, LGMD2L, TMEM16E"	ENSG00000171714	"Anoctamin 5"	Q75V66	11	22193176-22283357	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.7;parathyroid gland: 26.9;skeletal muscle: 43.7"	"Cell line enhanced"	"Detected in some"		"A549: 6.5;HAP1: 7.1;HEK 293: 8.9;NTERA-2: 4.9;RPTEC TERT1: 4.4;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058857	Uncertain									"HPA058857: AB_2683835"	"unprognostic (5.25e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.55e-2)"	"prognostic favourable (2.50e-7)"	"unprognostic (3.65e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.77e-4)"	"unprognostic (7.94e-2)"	1.0	3.8	3.9	0.9	3.8	0.3	0.9	0.9	7.9	1.7	2.6	1.1	1.0	2.9	1.5	1.6	2.4	1.1	1.6	37.7	4.5	4.2	3.1	2.3	1.4	0.6	3.4	6.3	1.0	3.3	26.9	5.0	0.4	3.5	3.8	2.9	2.7	3.4	3.7	43.7	0.5	3.1	4.1	1.9	1.0	3.0	2.3	1.7	0.0	3.9	14.2	0.6	3.2	1.9	0.0	0.9	0.0	1.5	0.0	0.1	0.1	0.0	6.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	4.3	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	4.4	0.1	3.9	3.6	0.0	0.0	0.0	3.3	2.5	0.0	0.0	2.9	0.0	0.0	2.8	5.2	0.0	4.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	3.8	0.9	7.9	4.5	4.2	3.4	6.3	3.5	1.7
ANOS1	"ADMLX, KAL, KAL1, KALIG-1, WFDC19"	ENSG00000011201	"Anosmin 1"	P23352	X	8528874-8732186	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.5;lung: 37.1;parathyroid gland: 27.7"	"Group enriched"	"Detected in some"	5	"NTERA-2: 26.9;U-2 OS: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in brain"						"unprognostic (2.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.56e-2)"	5.4	4.0	13.8	1.3	14.0	0.6	3.6	1.3	18.0	4.5	1.0	7.3	1.3	0.7	0.9	3.2	1.6	1.4	1.9	4.6	11.1	7.9	1.1	1.1	37.1	1.8	5.7	6.0	0.9	0.8	27.7	1.0	1.4	19.3	4.1	1.3	6.0	2.8	4.5	10.9	3.0	0.9	1.1	25.5	1.1	1.1	5.0	8.5	1.3	8.5	1.0	1.2	1.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.5	3.0	0.1	4.0	0.4	4.4	0.0	0.0	0.0	1.1	0.1	2.2	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	26.9	0.0	0.0	0.0	0.0	1.5	0.5	1.5	0.0	1.3	0.4	0.0	0.0	0.7	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.0	1.3	7.6	11.1	7.9	5.7	6.0	19.3	8.5
AP000646.1		ENSG00000285509			11	121024125-121113108	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"pancreas: 2.0;parathyroid gland: 2.5"	"Cell line enhanced"	"Detected in some"		"HEL: 4.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038593, HPA038594"	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA038593: AB_10669647, HPA038594: AB_2676103"																		0.0	0.0		0.2		0.0	0.0		0.8	0.6	0.1			0.0	0.5	0.0	0.2	0.0	0.5	0.6			0.8	0.2	0.5	0.0			0.8	2.0	2.5		0.4		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	1.7			0.0		0.0	0.5		0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.3	0.7	1.7	0.4	0.3	0.4	0.2	1.9	2.4	2.3	0.3	1.1	1.2	0.6	0.7	0.8	0.0	0.8	0.5	2.5	0.1	0.4	4.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	1.1	0.0	0.6	1.6	0.0	0.0	0.2	0.1	0.3	1.4	0.2	2.5	0.7	0.2	0.7	2.2	3.0	0.8	0.1	0.0	1.4	0.2	0.0	2.0	0.2	0.5	0.9	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3										
ARFGEF2	BIG2	ENSG00000124198	"ADP ribosylation factor guanine nucleotide exchange factor 2"	Q9Y6D5	20	48921890-49036693	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 95.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026078, CAB026382"	Supported		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"CAB026382: , HPA026078: AB_1844983"	"unprognostic (1.50e-2)"	"unprognostic (9.56e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.94e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (6.15e-7)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.90e-2)"	12.9	29.8	9.4	16.6	15.9	15.6	18.7	14.2	21.8	12.7	15.6	12.5	19.2	15.8	13.8	12.4	15.2	10.4	12.8	19.2	11.1	11.0	17.1	20.1	11.5	14.3	11.5	12.6	12.2	21.6	95.3	17.1	15.4	16.1	12.6	17.6	13.4	15.1	24.7	16.2	15.5	16.5	11.6	11.9	14.0	17.4	23.2	8.5	15.5	23.6	11.6	16.0	16.1	11.6	2.5	2.4	7.3	1.7	1.8	2.8	1.0	9.4	10.9	5.1	3.3	9.6	8.7	12.8	7.9	10.7	21.1	10.5	19.8	11.1	13.5	12.1	11.4	11.4	10.0	12.6	18.4	5.0	3.7	10.0	11.1	18.3	12.3	12.2	11.6	9.0	13.9	14.0	14.8	14.8	7.6	13.5	11.3	4.2	7.6	6.7	5.0	10.0	8.0	13.2	16.5	11.0	13.7	4.6	5.5	23.1	38.1	15.2	15.2	12.6	18.5	20.4	9.3	10.3	7.3	20.7	18.7	10.0	13.3	6.6	6.8	7.3	1.7	0.7	1.6	1.1	2.8	1.6	1.9	1.8	2.4	2.5	2.7	2.4	0.5	1.8	1.1	2.4	0.5	1.0	9.4	15.9	14.2	21.8	11.1	11.0	11.5	12.6	16.1	8.5
ARFGEF3	"BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33"	ENSG00000112379	"ARFGEF family member 3"	Q5TH69	6	138161921-138344663	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.2;parathyroid gland: 24.5;salivary gland: 26.6"	"Cell line enhanced"	"Detected in many"		"MCF7: 11.2;RH-30: 10.6;RT4: 15.0;SK-BR-3: 17.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036350	Uncertain									"HPA036350: AB_10672084"	"prognostic unfavourable (8.20e-4)"	"unprognostic (4.31e-2)"	"unprognostic (9.91e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.69e-2)"	1.6	5.5	15.1	1.5	15.7	1.1	11.0	26.2	19.7	7.3	5.7	17.1	2.1	3.2	1.5	1.8	1.0	3.4	2.7	1.7	10.9	10.2	3.5	0.7	8.4	0.9	13.9	13.6	0.7	11.2	24.5	9.3	2.4	11.7	15.8	6.6	0.7	26.6	1.9	0.9	1.7	2.9	1.5	12.4	1.1	13.1	1.3	14.5	0.0	2.9	0.0	1.1	4.2	0.9	0.2	0.1	1.0	0.0	0.6	0.1	0.0	6.0	2.4	0.0	0.4	0.0	0.0	3.7	0.3	0.2	0.1	0.0	0.1	0.3	0.0	2.5	0.2	2.0	2.9	1.5	0.0	0.0	3.8	0.0	1.2	0.7	0.0	2.3	0.0	0.0	0.7	0.0	0.7	3.2	0.0	3.8	0.0	11.2	0.0	0.0	2.1	2.6	0.5	10.6	2.0	2.0	15.0	5.5	0.0	6.1	17.5	0.7	3.5	0.0	0.3	0.2	1.8	0.0	6.0	1.3	4.9	0.0	2.6	1.4	0.4	1.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.6	0.0	0.1	0.0	0.0	15.1	15.7	26.2	19.7	10.9	10.2	13.9	13.6	11.7	14.5
ARHGAP44	"KIAA0672, RICH-2, RICH2"	ENSG00000006740	"Rho GTPase activating protein 44"	Q17R89	17	12789539-12991643	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;parathyroid gland: 33.8"	"Cell line enhanced"	"Detected in many"		"HEK 293: 11.8;SK-BR-3: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038814	Approved									"HPA038814: AB_10673295"	"unprognostic (4.30e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.53e-3)"	"unprognostic (3.98e-1)"	"unprognostic (9.58e-2)"	3.6	2.5	13.5	4.3	17.2	0.5	2.0	23.6	24.7	2.5	15.4	2.7	3.8	7.5	3.3	3.7	1.6	10.6	5.7	4.5	16.8	11.5	3.2	1.0	12.3	2.0	7.1	11.1	5.1	4.5	33.8	11.3	9.8	15.5	3.7	12.5	4.6	5.6	4.8	2.6	1.5	7.6	3.6	3.4	1.2	3.7	2.5	2.8	0.0	7.3	0.0	2.0	2.3	3.6	0.6	0.0	0.0	0.4	0.3	0.6	0.0	0.5	1.8	1.5	1.1	0.1	0.8	5.0	1.2	5.9	0.3	0.6	0.9	0.3	4.6	0.5	1.9	0.8	3.1	0.0	0.1	0.3	11.8	0.1	1.9	1.9	0.2	0.0	0.4	0.2	0.5	0.3	0.0	0.0	0.3	0.1	0.0	5.8	0.6	0.5	4.9	0.4	4.3	0.5	1.1	0.1	1.7	4.9	0.4	0.2	9.1	0.2	1.3	1.7	0.0	4.7	2.7	1.8	0.1	0.0	0.0	0.5	1.0	0.1	0.7	0.0	0.0	0.0	0.1	0.4	0.3	0.6	0.2	0.4	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.6	0.0	13.5	17.2	23.6	24.7	16.8	11.5	7.1	11.1	15.5	2.8
ARMCX4	"CXorf35, GASP4, MGC40053"	ENSG00000196440	"Armadillo repeat containing, X-linked 4"		X	101418287-101533459	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"parathyroid gland: 10.8"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 9.8"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000429, HPA051930"	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA000429: AB_1078210, HPA051930: AB_2681665"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.81e-3)"	"unprognostic (7.28e-2)"	"unprognostic (3.67e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.29e-1)"	"prognostic favourable (8.20e-5)"	"unprognostic (1.94e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.92e-2)"	1.5	4.6	1.9	0.8	2.7	0.3	2.9	3.2	5.7	2.4	1.7			0.6	4.0	2.8	0.7	2.8	1.1	1.2	2.0	2.9	1.2	0.5	1.5	0.5	1.9		8.5	1.4	10.8	4.3	1.6		4.1	1.6		1.2	5.7	1.6	2.1	1.5	2.8	1.4	1.3	1.3	0.4			2.4		0.5	2.1	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	2.3	0.6	8.1	0.0	3.9	4.1	0.8	5.5	4.4	4.5	8.9	1.9	0.8	0.0	2.2	8.1	0.9	0.0	0.1	7.5	0.0	0.9	0.6	2.3	0.0	2.3	0.0	3.1	2.6	0.4	9.8	0.0	7.9	0.0	0.7	2.0	0.0	0.3	0.3	6.0	0.0	0.4	6.7	0.0	1.2	1.4	5.5	5.1	0.8	0.0	3.0	0.6	1.2	2.9	2.1	1.3	6.3	0.0	0.0	0.0	0.0	3.8	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0										
ARTN	"ENOVIN, EVN, NBN"	ENSG00000117407	Artemin	Q5T4W7	1	43933320-43937241	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 18.3"	"Group enriched"	"Detected in some"	4	"A-431: 29.1;HaCaT: 30.8;HBEC3-KT: 27.4;hTCEpi: 11.5;hTERT-HME1: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"olfactory region: 4.0"	"Region enhanced"	"Detected in single"		"olfactory region: 1.0"						"Secreted in other tissues"						"unprognostic (1.98e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.08e-1)"	"prognostic favourable (8.18e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.59e-6)"	"unprognostic (2.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.53e-1)"	2.4	1.1	0.7	2.2	2.5	1.2	2.1	4.3	1.7	3.9	3.7	0.5	7.6	0.6	3.6	5.6	4.1	2.0	5.1	2.0	0.6	1.6	6.2	0.4	2.1	0.5	1.0	0.1	2.4	14.4	18.3	8.0	10.4	4.8	10.0	2.5	0.7	5.3	12.4	1.0	1.2	1.1	2.0	2.0	0.6	1.7	2.2	0.7	0.6	1.8	4.4	1.5	4.7	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.1	0.7	0.5	0.4	0.1	0.1	0.0	1.2	0.2	1.2	1.1	0.1	0.6	0.3	0.1	0.4	30.8	0.0	27.4	0.2	0.1	0.8	0.4	2.9	0.0	0.0	0.1	0.6	0.0	11.5	0.5	8.8	0.0	0.3	0.9	0.1	2.0	0.1	1.7	2.6	1.1	0.5	0.0	0.4	0.1	0.5	0.6	0.2	0.1	0.0	0.6	4.9	4.4	0.2	0.5	0.2	0.2	1.1	3.0	2.2	0.3	3.9	1.3	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.5	4.3	1.7	0.6	1.6	1.0	0.1	4.8	0.7
AS3MT	CYT19	ENSG00000214435	"Arsenite methyltransferase"	Q9HBK9	10	102869516-102901899	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 92.8;parathyroid gland: 30.0"	"Cell line enhanced"	"Detected in many"		"AF22: 14.2;REH: 27.1;SH-SY5Y: 14.6;T-47d: 22.7"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017856	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA017856: AB_1847420"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.02e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-10)"	"unprognostic (1.04e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	2.0	92.8	3.7	0.7	8.6	0.5	2.6	4.5	6.4	4.0	2.0	2.2	0.4	1.3	3.8	3.2	2.1	2.1	5.2	10.0	5.7	3.1	7.4	22.4	1.7	0.9	2.8	4.4	3.9	8.7	30.0	2.4	0.5	4.6	4.2	0.8	8.9	2.2	3.4	6.0	1.8	1.3	3.9	2.7	5.6	1.7	3.5	1.6	0.3	3.2	1.0	0.7	1.8	1.8	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	3.9	14.2	8.9	0.3	0.3	2.6	4.1	3.5	6.2	7.6	10.6	0.6	0.2	1.2	5.3	0.2	12.1	0.7	6.4	0.0	3.5	0.0	1.7	10.4	4.1	0.2	0.1	1.9	1.6	0.8	0.0	0.2	0.0	0.2	5.5	0.1	2.4	0.3	6.8	0.6	27.1	0.0	0.1	1.3	0.1	0.4	14.6	0.0	0.2	1.9	22.7	0.3	0.1	1.3	0.0	2.0	0.0	0.3	0.2	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.7	8.6	4.5	6.4	5.7	3.1	2.8	4.4	4.6	1.6
ASCL4	"bHLHa44, HASH4"	ENSG00000187855	"Achaete-scute family bHLH transcription factor 4"	Q6XD76	12	107774385-107776644	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 2.5;parathyroid gland: 3.1"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.7"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"					"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.5"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 2.5"					"Not detected"	"Not detected"			HPA036116	Uncertain									"HPA036116: AB_10671833"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"			"unprognostic (1.86e-2)"	"unprognostic (8.88e-4)"		"unprognostic (2.09e-5)"	"unprognostic (1.40e-1)"		"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"		0.1	0.0	0.7	0.3	0.2	0.0	0.4	0.0	0.1	0.1	0.0			0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.9	0.0	0.0	0.7	0.4		0.0	0.0	3.1	0.0	0.0		0.3	0.0		0.2	0.1	0.0	1.0	0.3	0.0	0.4	0.5	0.4	0.5			0.0		1.4	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0										
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193402077-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 9.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051932			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.6	0.7	11.2	0.6	11.1	0.6	17.8	2.6	10.1	1.8	2.2	8.4	9.0	0.9	0.6	46.4	11.8	2.7	4.3	0.6	11.1	5.1	0.8	0.7	22.0	0.8	7.5	7.7	0.8	3.9	52.5	3.5	0.6	9.0	0.6	3.2	0.5	4.5	16.7	0.6	11.2	0.6	0.7	6.1	0.7	7.6	0.8	7.5	0.0	51.2	7.8	9.5	0.6	3.7	0.4	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.2	0.2	0.1	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.9	1.4	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	11.2	11.1	2.6	10.1	11.1	5.1	7.5	7.7	9.0	7.5
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 195.4;parathyroid gland: 194.4"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 248.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced					380000	380000			"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (6.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.65e-1)"	"prognostic favourable (8.98e-8)"	"unprognostic (4.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavourable (4.01e-4)"	17.4	25.6	22.4	16.2	40.3	10.5	26.9	74.2	67.4	17.8	121.9	14.2	56.1	92.3	13.1	38.3	34.9	17.7	65.8	41.1	26.1	18.7	162.7	34.6	35.1	9.6	19.2	27.6	17.4	78.6	194.4	25.0	19.2	34.1	22.1	65.7	24.1	84.4	53.7	19.0	40.5	195.4	17.7	20.7	13.7	25.0	17.0	13.9	9.1	101.2	13.7	16.2	14.2	23.1	10.3	22.0	6.4	29.7	10.4	30.2	17.2	32.9	12.2	12.7	6.3	25.5	24.7	65.2	19.8	39.4	24.4	34.7	48.7	23.7	26.1	28.0	23.4	43.1	25.0	41.7	35.5	9.6	27.7	15.2	23.0	41.1	19.5	38.1	21.4	27.5	69.9	28.4	37.5	29.9	25.0	25.3	21.6	65.6	15.4	13.8	29.8	24.5	14.9	29.6	23.1	88.1	34.0	12.5	11.0	30.7	58.4	248.8	15.3	22.1	26.3	13.9	19.5	35.9	40.0	12.2	9.5	20.1	42.7	22.0	81.6	6.4	13.3	6.1	23.2	20.9	24.8	10.3	26.4	24.9	22.0	5.3	30.2	22.0	1.6	10.4	29.7	11.1	20.3	17.2	22.4	40.3	74.2	67.4	26.1	18.7	19.2	27.6	34.1	13.9
ATP6AP2	"APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR"	ENSG00000182220	"ATPase H+ transporting accessory protein 2"	O75787	X	40579372-40606848	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 176.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003156	Approved									"HPA003156: AB_1078245"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.01e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.86e-2)"	25.0	23.8	33.8	17.4	39.3	30.6	31.7	31.5	76.0	35.0	24.0	22.1	13.0	10.0	30.8	25.5	21.4	22.7	23.9	19.3	35.5	36.7	48.7	30.0	30.2	37.9	32.1	34.7	22.3	16.3	176.7	16.1	30.2	37.8	26.4	25.0	21.0	16.8	31.8	8.7	24.0	16.8	35.7	27.8	22.6	15.8	11.9	17.2	16.2	56.1	12.6	19.1	25.7	20.0	16.1	53.2	60.8	78.0	20.0	29.6	85.8	14.7	19.3	14.1	19.0	93.6	59.6	8.8	33.2	51.5	24.5	28.7	11.1	24.2	8.5	16.5	48.4	15.2	21.7	25.8	33.5	16.6	17.1	10.6	18.8	10.7	34.4	18.8	19.8	51.6	34.6	30.1	24.2	32.6	10.7	23.0	37.0	18.5	8.1	16.4	13.0	21.8	7.7	24.8	28.5	31.6	16.5	10.2	9.5	32.3	20.1	20.2	26.1	17.3	32.0	30.9	16.9	36.8	11.1	7.1	12.3	8.4	25.5	15.9	24.0	34.4	78.0	60.8	25.9	55.1	27.0	16.1	26.4	26.6	53.2	15.7	29.6	27.0	39.5	20.0	54.1	19.3	24.7	85.8	33.8	39.3	31.5	76.0	35.5	36.7	32.1	34.7	37.8	17.2
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2;parathyroid gland: 65.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		21000	21000	"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favourable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (6.90e-4)"	9.4	15.6	19.3	9.3	46.1	9.9	9.1	55.8	66.2	8.0	11.6	25.8	5.1	17.9	11.4	11.1	9.6	9.7	12.2	9.9	23.8	32.8	20.3	11.3	12.7	6.6	23.6	24.8	11.4	9.3	65.6	23.6	11.2	43.3	9.9	11.3	19.7	8.2	10.7	28.9	14.7	12.4	11.7	23.7	11.1	8.8	9.8	13.1	5.2	16.3	6.7	7.8	6.7	6.9	6.3	9.1	14.2	10.5	0.1	2.8	4.2	6.5	13.5	8.3	14.8	14.0	12.1	4.8	4.6	8.6	9.9	13.0	8.6	14.7	1.2	8.5	9.5	14.2	12.7	7.8	11.5	10.1	13.4	10.5	10.2	6.8	8.6	4.5	19.2	9.0	11.3	15.8	6.8	7.0	38.1	41.4	14.7	5.6	1.8	4.0	5.3	0.1	0.1	8.6	18.2	11.4	5.2	22.9	12.2	7.2	6.6	13.7	15.9	6.8	4.1	8.4	0.3	12.3	5.5	16.9	22.9	2.5	11.3	0.1	9.8	12.1	10.5	8.0	0.8	3.4	1.2	3.5	0.6	0.1	9.1	6.3	1.0	0.8	14.2	0.1	2.4	4.7	2.8	4.2	19.3	46.1	55.8	65.9	23.8	32.8	23.6	24.8	43.3	13.1
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 38.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.8;Daudi: 27.6;HEL: 9.7;REH: 9.5;SH-SY5Y: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		20000	20000	Vesicles	Vesicles	"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favourable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	5.3	8.6	14.2	8.0	29.6	18.5	4.8	7.2	32.0	3.1	11.3	27.3	8.4	4.2	3.4	11.6	2.9	3.5	2.8	8.0	13.7	8.8	4.0	2.1	10.6	12.5	18.0	17.4	15.1	10.0	38.9	6.9	2.6	15.3	7.9	10.7	3.9	4.4	15.2	16.9	3.2	8.1	3.1	23.1	7.8	10.5	2.8	24.9	8.9	34.9	1.9	10.3	4.5	4.0	4.4	3.8	0.9	3.3	3.2	7.3	0.9	0.0	0.1	0.2	16.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	27.6	7.8	0.1	1.4	4.0	0.0	0.0	4.4	2.7	9.7	0.9	0.4	0.0	2.3	0.2	0.3	0.0	0.0	0.0	0.1	0.0	3.1	0.0	1.2	3.5	0.8	1.2	0.3	9.5	0.0	3.1	6.0	0.3	3.0	9.2	0.2	5.8	0.0	1.9	0.0	0.2	0.0	1.3	0.3	0.0	1.1	0.0	5.6	0.4	3.3	0.1	0.0	1.0	0.9	6.0	0.4	3.2	2.6	1.9	6.5	0.9	4.4	2.9	7.3	0.9	3.2	3.3	3.8	1.4	0.9	14.2	29.6	7.2	22.1	13.7	8.8	18.0	17.4	15.3	24.9
BPIFB4	"C20orf186, dJ726C3.5, LPLUNC4"	ENSG00000186191	"BPI fold containing family B member 4"	P59827	20	33079644-33111751	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 4.0;pituitary gland: 12.2"	"Group enriched"	"Detected in some"	4	"HSkMC: 5.3;U-2 OS: 8.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"							"unprognostic (1.32e-1)"		"unprognostic (1.16e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.31e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.98e-4)"			"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"		"unprognostic (8.97e-2)"	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.0	12.2	0.0		0.0	0.0		2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8			0.0		0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.5	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 67.7;salivary gland: 68.2"	"Cell line enhanced"	"Detected in some"		"A-431: 19.7;CAPAN-2: 12.7;MCF7: 29.4;RPMI-8226: 15.4;SK-BR-3: 14.8;T-47d: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"basal ganglia: 20.8"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042889, HPA077485"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favourable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.2	1.6	1.0	4.6	20.8	2.1	6.1	4.1	1.4	2.9	5.4	0.4	7.9	3.6	1.0	6.4	14.2	1.9	8.5	1.4	0.6	0.7	9.3	0.4	4.1	0.6	0.7	1.3	0.3	37.8	67.7	10.1	1.7	0.6	2.4	4.5	2.7	68.2	4.8	0.1	12.4	6.8	0.4	0.3	0.3	10.4	2.1	1.8	1.2	28.2	10.7	5.4	1.5	3.2	0.0	8.0	0.0	0.0	0.0	0.4	0.1	19.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	4.1	12.7	0.0	0.2	0.0	1.8	0.2	0.0	0.0	2.1	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	29.4	0.3	0.0	0.5	0.0	0.4	0.0	15.4	1.9	4.3	6.8	0.0	0.0	14.8	0.0	14.9	2.1	0.0	0.0	0.0	0.0	0.0	4.8	6.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.1	1.0	20.8	4.1	1.4	0.6	0.7	0.7	1.3	0.6	1.8
BTBD11	"ABTB2B, FLJ33957"	ENSG00000151136	"BTB domain containing 11"	A6QL63	12	107318413-107659642	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 61.8"	"Cell line enhanced"	"Detected in many"		"A549: 19.0;Hep G2: 10.0;MOLT-4: 12.7;PC-3: 9.0;RT4: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 7.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055898, HPA061334"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA055898: AB_2682964, HPA061334: "	"unprognostic (3.40e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.85e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.92e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.07e-3)"	0.9	1.1	3.7	2.4	6.6	3.3	2.7	4.6	10.2	6.8	1.0	2.2	3.2	1.1	1.3	1.5	24.1	0.8	1.2	1.0	2.9	9.4	3.7	1.4	1.0	4.0	8.3	3.0	0.6	1.2	61.8	3.2	2.0	19.0	3.1	1.0	1.7	6.2	1.6	0.9	8.4	1.6	1.0	4.9	1.5	1.0	1.1	1.2	24.8	14.4	9.5	9.0	2.3	7.9	0.3	1.3	2.8	0.8	0.3	7.2	1.2	0.1	19.0	3.9	0.0	1.4	0.4	0.0	0.4	0.0	0.2	0.0	0.2	3.1	0.0	4.7	0.1	6.9	3.9	7.2	0.2	0.0	1.2	0.0	0.1	10.0	0.0	0.1	0.0	1.5	3.0	0.0	2.3	0.5	0.0	0.0	0.1	0.6	12.7	1.5	4.0	9.0	0.0	6.1	0.0	0.0	8.6	5.0	1.9	0.0	0.2	0.0	0.4	0.5	0.8	0.0	0.2	0.0	1.5	0.0	0.0	0.0	5.0	1.9	0.0	1.3	0.8	1.1	2.1	0.3	7.2	0.1	2.4	1.4	1.3	0.3	3.0	2.7	2.8	0.3	0.6	0.2	1.1	1.2	3.7	6.6	4.6	10.2	2.9	9.4	8.3	3.0	19.0	1.2
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330722-68819022	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.3;parathyroid gland: 19.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.4;HEK 293: 5.7;LHCN-M2: 4.9;RH-30: 5.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA044420: AB_10963791, HPA053065: AB_2682030"	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	4.2	0.9	7.4	0.8	10.6	1.1	1.5	9.6	8.4	4.0	0.7	9.6	0.2	0.7	1.5	2.5	2.1	15.3	3.2	1.6	8.9	7.0	1.0	0.7	8.3	0.8	3.7	5.0	1.4	2.1	19.9	2.7	0.9	10.4	3.9	0.9	3.5	1.4	2.2	0.9	1.8	0.8	1.7	3.2	0.8	1.7	1.4	6.7	0.0	1.0	1.1	0.7	1.2	1.1	1.8	2.0	2.9	0.7	1.3	1.8	0.5	0.3	0.0	0.8	0.4	1.2	2.2	0.2	1.4	4.4	0.7	0.6	0.3	0.4	0.2	0.9	1.2	0.3	0.3	0.8	0.2	0.1	5.7	0.7	1.0	0.4	0.2	0.1	0.5	0.1	0.6	0.8	1.5	0.1	0.3	1.0	4.9	0.6	0.1	0.5	2.5	0.1	0.2	5.3	0.1	0.6	0.4	1.1	0.1	0.3	0.3	0.0	2.5	0.2	0.1	1.0	0.6	3.3	0.2	0.8	0.0	0.1	0.4	0.3	0.8	2.1	0.7	1.2	1.4	0.3	1.1	1.0	1.2	1.1	0.3	1.8	1.5	1.8	2.9	1.3	0.5	2.0	0.8	0.5	7.4	10.6	9.6	8.4	8.9	7.0	3.7	5.0	10.4	6.7
CA8	"CALS, CARP"	ENSG00000178538	"Carbonic anhydrase 8"	P35219	8	60187347-60281412	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 41.0;brain: 26.8;parathyroid gland: 56.8"	"Cell line enhanced"	"Detected in some"		"HEK 293: 12.6;K-562: 22.7;NB-4: 13.1;WM-115: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	20	"basophil: 41.0"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 41.0"	"Region enriched"	"Detected in some"	37	"cerebellum: 1413.4"	"Region enriched"	"Detected in all"	9	"cerebellum: 163.0"	"HPA024748, CAB025545, CAB047309"	Enhanced									"CAB025545: , CAB047309: , HPA024748: AB_1846003"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.46e-3)"	"unprognostic (6.67e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"prognostic favourable (5.79e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	2.3	1.5	9.2	1.1	11.6	1.1	6.5	26.8	6.9	6.3	2.2	3.6	0.6	1.8	2.8	12.8	0.9	2.5	1.0	3.8	7.8	6.0	7.4	0.6	1.6	1.0	4.2	5.3	0.7	3.0	56.8	9.8	8.1	3.4	3.3	3.1	1.5	6.6	0.9	2.0	0.9	1.7	1.3	1.9	1.3	5.9	9.3	6.2	1.7	0.7	1.3	1.0	1.3	2.1	0.1	2.0	41.0	0.0	0.0	0.0	0.0	0.0	2.9	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.1	0.0	12.6	5.2	0.0	0.0	4.2	2.1	1.4	0.0	0.0	0.0	0.0	0.0	22.7	0.2	0.0	0.0	3.6	13.1	0.2	0.0	0.0	0.0	0.3	0.5	1.0	5.8	0.0	0.0	1.2	0.0	5.3	0.8	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.6	41.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.2	11.6	26.8	6.9	7.8	6.0	4.2	5.3	3.4	6.2
CCDC148	MGC125588	ENSG00000153237	"Coiled-coil domain containing 148"	Q8NFR7	2	158171081-158456753	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 5.9;testis: 6.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HBF TERT88: 4.2;hTEC/SVTERT24-B: 2.7;RPTEC TERT1: 3.3;SCLC-21H: 4.1"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	9	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042626	Uncertain		Uncertain	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA042626: AB_10806244"	"unprognostic (1.88e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.94e-4)"	"unprognostic (3.29e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.35e-2)"	"prognostic favourable (2.54e-4)"	"unprognostic (6.57e-3)"	0.1	0.5	0.6	0.0	0.8	0.0	1.8	1.9	0.3	1.4	0.0			0.0	0.6	2.4	0.0	3.3	0.4	0.0	0.7	0.8	4.3	0.1	0.6	0.0	0.5		1.3	0.1	5.9	1.9	0.0		0.4	0.0		1.0	0.7	0.0	0.2	0.0	0.0	1.0	0.0	0.0	6.5			1.8		0.0	0.1	0.3	0.0	0.0	1.9	0.0	0.0	0.2	0.0	1.3	0.0	0.8	1.0	0.0	0.0	0.1	0.9	0.0	1.1	2.2	1.1	6.0	0.1	0.1	0.9	0.5	0.0	0.3	4.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.1	0.4	1.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	3.3	0.4	4.1	0.2	0.3	0.4	0.5	2.3	0.3	0.0	0.4	0.5	0.1	0.2	0.6	0.7	0.0	0.9	0.0	0.4	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCNA1	CT146	ENSG00000133101	"Cyclin A1"	P78396	13	36431520-36442882	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5;parathyroid gland: 24.2;testis: 50.4"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 85.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 20.7;ovarian cancer: 18.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	108	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	233	"granulocytes: 24.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA060646, HPA077614"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA060646: AB_2684336, HPA077614: "	"unprognostic (1.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.89e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavourable (1.70e-4)"		"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.04e-6)"	"unprognostic (7.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-2)"	0.4	0.8	7.3	0.4	6.2	1.3	0.6	0.2	4.7	4.0	0.3	1.6	0.0	0.4	2.6	4.7	0.3	11.1	0.6	0.3	4.5	5.9	0.3	0.2	1.0	1.0	1.9	5.5	1.2	0.5	24.2	4.8	0.2	3.1	0.3	0.3	0.1	0.4	0.2	1.3	0.2	0.3	5.1	1.0	0.3	0.4	50.4	0.4	0.2	0.4	0.0	0.5	0.4	0.6	0.1	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	3.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.7	85.1	0.0	8.3	0.1	0.7	0.2	0.0	0.1	0.0	1.0	0.1	16.6	0.5	2.1	0.0	2.0	0.0	0.5	0.0	0.6	1.4	0.0	2.0	0.0	0.0	16.6	1.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	21.0	0.1	24.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	6.2	0.2	4.7	4.5	5.9	1.9	5.5	3.1	0.4
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.9;parathyroid gland: 82.5"	"Group enriched"	"Detected in some"	6	"HEL: 44.3;HMC-1: 19.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdTCR: 19.4;MAIT T-cell: 7.3;memory CD4 T-cell: 16.1;memory CD8 T-cell: 11.8;naive CD4 T-cell: 9.0;naive CD8 T-cell: 9.7;NK-cell: 14.0;T-reg: 5.5"	"Group enriched"	"Detected in many"	11	"NK-cells: 14.0;T-cells: 19.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015715, HPA050348"	Supported		Uncertain	Midbody		27000000	27000000	Midbody	Midbody	"HPA015715: AB_1846278, HPA050348: AB_2732559"	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"	1.2	0.6	1.0	7.5	2.0	1.7	0.8	0.7	0.9	1.5	2.9	0.3	0.1	1.1	1.0	1.4	0.8	0.8	1.4	0.9	1.9	1.3	1.3	3.1	5.2	14.0	1.7	0.0	1.0	0.6	82.5	2.4	0.6	1.3	0.9	1.2	2.4	5.4	0.6	1.1	0.4	6.0	1.3	4.2	31.9	1.4	1.8	0.5	6.4	1.8	2.6	10.1	2.0	1.6	0.4	1.5	0.9	0.6	14.0	19.4	6.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	2.3	0.0	44.3	0.1	0.0	0.0	0.3	19.7	0.0	0.5	0.1	0.3	0.0	0.1	4.5	0.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	5.4	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.5	19.4	0.4	7.3	0.4	16.1	11.8	1.5	0.1	9.0	9.7	0.9	14.0	0.6	0.1	5.5	6.6	1.0	2.0	0.7	0.9	1.9	1.3	1.7	0.0	1.3	0.5
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820808	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 111.5;parathyroid gland: 78.4"	"Group enriched"	"Detected in some"	6	"HEL: 33.5;HL-60: 13.5;NB-4: 19.3;THP-1: 38.1;U-937: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"classical monocyte: 42.2;intermediate monocyte: 42.5;memory CD4 T-cell: 29.1;myeloid DC: 29.3;naive CD4 T-cell: 24.8;non-classical monocyte: 33.3;plasmacytoid DC: 46.7;T-reg: 26.4"	"Group enriched"	"Detected in many"	20	"dendritic cells: 46.7;monocytes: 42.5;T-cells: 29.1"	"Region enriched"	"Detected in single"	15	"basal ganglia: 41.4"	"Low region specificity"	"Detected in many"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: "	"unprognostic (1.39e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (7.76e-2)"	"unprognostic (4.82e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (7.45e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.65e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.95e-1)"	13.8	5.4	6.1	16.0	5.8	4.4	5.6	1.2	4.3	4.5	5.1	8.6	1.8	3.6	3.5	8.3	3.0	5.5	7.3	5.4	4.9	4.4	6.1	32.2	24.0	30.8	6.3	3.1	3.0	3.1	78.4	3.4	10.9	6.2	4.1	6.5	5.7	5.4	3.9	1.9	3.5	9.5	5.2	10.2	49.1	3.9	2.8	5.7	111.5	3.9	4.1	18.6	8.6	3.2	0.1	46.7	1.9	42.5	0.3	29.1	33.6	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	33.5	0.0	0.2	3.7	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	19.3	0.3	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.1	42.2	0.3	0.3	42.5	1.1	0.0	29.1	0.1	29.3	0.1	24.8	0.1	1.9	0.3	33.3	46.7	26.4	33.6	6.1	5.8	1.2	4.3	4.9	4.4	6.3	3.1	6.2	5.7
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27950966-28177446	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.6;parathyroid gland: 35.4"	"Cell line enhanced"	"Detected in many"		"AF22: 56.4;BJ: 40.7;fHDF/TERT166: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 4.4;neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		160000000	160000000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760"	"unprognostic (9.42e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.00e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-3)"	0.6	29.6	9.8	1.5	9.4	0.5	0.5	5.7	16.1	3.2	2.0	8.0	0.2	0.8	3.1	1.9	0.6	4.7	1.7	77.6	9.9	9.6	9.2	23.3	0.7	1.1	6.0	9.1	3.4	0.7	35.4	5.4	0.5	5.9	1.4	0.8	6.8	0.5	4.6	0.4	0.5	0.9	3.2	6.7	5.9	2.5	19.6	7.4	0.9	2.8	0.0	1.0	1.0	1.3	0.0	0.0	4.4	0.0	0.7	0.9	0.0	0.0	4.5	56.4	0.0	8.9	1.8	0.0	40.7	12.4	16.6	15.2	0.0	0.0	0.0	21.9	84.2	6.0	9.2	0.0	23.6	0.1	5.9	0.0	15.2	14.0	8.5	0.0	0.0	0.8	0.1	38.1	6.7	14.5	0.0	0.0	12.9	0.0	10.2	0.0	7.5	4.9	0.0	6.7	7.7	0.0	1.8	14.7	25.5	0.0	0.0	4.5	0.0	0.0	2.2	36.0	11.5	0.5	29.4	0.0	0.0	0.0	6.9	0.0	27.7	4.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	0.0	0.0	9.8	9.4	5.7	10.1	9.9	9.6	6.0	9.1	5.9	7.4
CHRFAM7A	"CHRNA7-DR1, D-10"	ENSG00000166664	"CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion"	Q494W8	15	30357766-30393849	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 6.2;parathyroid gland: 6.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.2;HEK 293: 3.6;HEL: 5.9;RH-30: 4.8;SH-SY5Y: 6.1;U-937: 6.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 5.2"	"Low lineage specificity"	"Detected in many"																						"unprognostic (3.61e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.53e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.71e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	0.9	3.5	1.3	1.1	1.3	6.2	0.4	0.0	2.5	0.6	0.4			0.7	0.3	0.2	0.1	0.8	0.4	2.4	0.9	1.6	0.2	0.0	1.2	0.5	2.8		0.6	0.9	6.3	1.0	0.0		1.0	0.6		0.2	0.5	0.1	0.4	1.8	0.6	1.6	0.8	0.9	5.5			3.2		0.2	0.8	0.5	0.2	2.8	5.2	2.1	1.0	0.3	0.4	0.0	0.5	1.9	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	6.2	0.0	0.0	0.0	3.6	5.9	0.2	0.6	0.1	1.2	2.0	0.4	0.0	0.2	0.0	0.6	0.6	0.0	1.8	0.0	0.0	0.6	0.6	0.0	0.0	4.8	0.0	1.5	1.9	0.3	6.1	0.0	0.0	0.0	0.1	1.3	2.6	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	2.1	5.2	0.3	0.7	0.1	0.2	0.0	0.0	2.8	0.1	0.0	0.3	0.0	1.0	0.1	0.6	0.1	0.4										
CISD1	"C10orf70, MDS029, mitoNEET, ZCD1"	ENSG00000122873	"CDGSH iron sulfur domain 1"	Q9NZ45	10	58269058-58289586	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 63.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA074383			Supported	Mitochondria				Mitochondria	Mitochondria	"HPA074383: AB_2686684"	"prognostic unfavourable (1.11e-4)"	"unprognostic (8.60e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (1.87e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.19e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (6.69e-4)"	4.7	8.9	14.0	5.4	21.6	1.4	5.4	14.8	24.9	6.2	10.3	3.7	3.6	17.8	5.2	3.9	9.5	5.7	6.4	32.1	16.2	17.6	20.8	13.2	4.1	4.9	14.7	19.5	6.4	4.8	63.1	10.5	5.0	16.6	6.9	7.7	5.8	8.0	6.7	43.9	7.2	16.7	8.9	9.0	4.2	6.4	3.0	6.0	3.5	8.7	20.4	5.1	8.3	4.4	7.6	9.5	3.0	5.8	6.1	8.3	5.1	11.9	6.1	4.9	8.9	6.6	7.4	2.9	10.2	11.7	10.2	14.1	14.4	11.3	21.4	8.6	10.5	7.9	13.2	9.1	9.2	9.6	17.9	5.6	10.2	11.5	7.5	9.9	4.4	9.2	7.5	9.7	14.9	11.9	12.4	10.0	7.1	4.0	8.4	10.7	5.2	19.2	6.5	18.1	11.2	13.7	4.2	15.5	5.5	7.8	20.9	7.2	13.9	5.3	11.7	4.4	7.9	12.6	12.0	10.2	16.7	16.1	11.8	9.9	4.2	0.0	5.8	0.3	5.7	4.2	6.7	7.6	6.6	6.6	9.5	6.0	7.7	7.5	3.0	6.1	2.6	6.2	8.3	5.1	14.0	21.6	14.8	24.9	16.2	17.6	14.7	19.5	16.6	6.0
CLEC2L	FLJ32986	ENSG00000236279	"C-type lectin domain family 2 member L"	P0C7M8	7	139523856-139544984	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.8;parathyroid gland: 15.5"	"Group enriched"	"Detected in some"	5	"U-266/70: 4.3;U-266/84: 15.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045050	Enhanced									"HPA045050: AB_10965839"	"unprognostic (1.18e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.20e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.29e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.31e-2)"	"unprognostic (7.94e-4)"	"unprognostic (3.57e-3)"	"unprognostic (4.03e-2)"	"unprognostic (8.42e-3)"	"unprognostic (3.02e-2)"	1.1	0.9	9.8	1.0	9.4	1.1	0.8	14.0	24.1	2.3	0.9	1.4	0.0	0.9	2.5	0.5	1.6	0.8	1.9	0.5	13.8	9.2	0.7	0.6	0.7	0.8	15.1	7.2	0.7	0.7	15.5	0.1	0.7	26.8	0.6	0.9	2.2	0.7	0.6	5.5	0.7	1.2	2.2	3.8	0.7	0.6	1.3	0.5	1.8	0.8	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	9.8	9.4	14.0	24.1	13.8	9.2	15.1	7.2	26.8	0.5
CNNM2	ACDP2	ENSG00000148842	"Cyclin and CBS domain divalent metal cation transport mediator 2"	Q9H8M5	10	102918293-103090221	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 35.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059954, HPA071631"			Enhanced	Vesicles				Vesicles	Vesicles	"HPA059954: AB_2684177, HPA071631: AB_2686427"	"unprognostic (2.18e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.51e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-1)"	"prognostic favourable (2.39e-8)"	"unprognostic (2.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.56e-1)"	5.7	19.8	9.5	6.6	13.8	13.3	5.0	16.8	15.1	6.0	11.8	12.5	8.0	6.9	6.6	5.8	3.3	8.9	9.4	4.1	7.8	10.9	15.6	7.9	6.4	4.1	10.4	8.6	8.8	6.8	35.6	10.6	14.3	9.6	5.0	11.2	7.7	5.2	7.1	3.0	7.2	7.7	6.9	9.3	4.1	5.4	8.0	12.7	3.3	10.0	1.9	3.0	6.2	5.4	1.3	1.3	2.8	0.8	4.5	1.1	0.4	4.6	7.7	3.1	8.1	7.8	3.1	8.3	2.2	9.3	3.0	3.8	5.4	4.2	1.8	3.4	3.2	6.2	6.5	4.3	2.3	3.0	11.5	2.6	4.2	11.0	4.5	1.8	3.5	4.2	6.3	3.0	10.4	1.8	4.4	10.5	1.7	7.9	2.1	2.1	4.9	4.8	5.1	3.9	2.2	2.3	2.8	4.4	5.6	5.5	1.3	5.8	10.0	3.5	1.5	4.2	6.2	2.9	3.9	11.4	12.7	3.3	7.3	6.2	1.7	1.9	0.8	0.7	1.0	0.8	0.8	1.3	0.7	0.5	0.6	0.7	0.8	0.7	2.8	4.5	0.4	1.3	1.1	0.4	9.5	13.8	16.8	15.1	7.8	10.9	10.4	8.6	9.6	12.7
CNTN4	BIG-2	ENSG00000144619	"Contactin 4"	Q8IWV2	3	2098813-3057956	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 29.2"	"Group enriched"	"Detected in some"	6	"BEWO: 8.5;CACO-2: 9.0;HEK 293: 5.6;SH-SY5Y: 17.2;WM-115: 5.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	89000000	89000000				"unprognostic (1.64e-1)"	"unprognostic (7.17e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.41e-2)"	"prognostic favourable (1.00e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-1)"	3.7	1.2	5.8	1.5	8.6	0.1	2.9	20.6	14.6	9.2	4.3	0.7	2.0	1.7	7.9	3.1	3.0	4.1	4.8	3.1	2.4	3.2	4.2	2.6	3.4	3.1	3.4	6.8	1.9	1.9	29.2	16.6	7.4	3.1	4.4	3.2	7.6	2.1	5.7	1.4	1.6	3.9	4.4	2.1	0.9	3.2	15.7	0.4	0.4	21.6	1.3	2.4	3.7	4.1	1.0	0.6	1.8	0.5	0.4	0.6	0.1	0.0	0.0	1.2	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.2	17.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.6	1.8	0.5	0.6	0.5	0.2	0.4	0.7	0.5	0.5	0.0	1.0	0.6	0.6	1.0	0.4	0.3	0.6	0.3	0.1	5.8	8.6	20.6	14.6	2.4	3.2	3.4	6.8	3.1	0.4
DIRC3	FLJ14199	ENSG00000231672	"Disrupted in renal carcinoma 3"		2	217284019-217756593	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 7.2;parathyroid gland: 5.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.8;HAP1: 1.1;SH-SY5Y: 1.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.29e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.44e-6)"	"unprognostic (3.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.31e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.88e-6)"	"unprognostic (8.05e-3)"	"unprognostic (1.51e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.83e-1)"	0.6	0.9	5.2	1.4	4.8	0.2	0.6	0.5	7.2	1.1	0.6	1.4	0.0	0.2	0.6	2.1	0.6	0.5	1.5	0.9	4.0	0.9	0.5	0.5	0.5	0.7	0.7	5.4	0.9	0.5	5.2	3.9	0.7	1.7	0.6	0.2	0.3	0.5	0.6	0.5	0.6	0.5	0.4	1.4	0.5	0.5	2.4	1.7	0.0	0.9	0.0	0.4	0.7	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	4.8	0.5	7.2	4.0	0.9	0.7	5.4	1.7	1.7
DMRT2		ENSG00000173253	"Doublesex and mab-3 related transcription factor 2"	Q9Y5R5	9	1049858-1057552	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 27.3;lymphoid tissue: 18.4;parathyroid gland: 52.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;RH-30: 5.2;RPMI-8226: 19.3;SK-MEL-30: 5.3;THP-1: 3.7;WM-115: 3.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	9	"cerebral cortex: 2.3;hippocampal formation: 0.9"	HPA029297	Uncertain									"HPA029297: AB_10600905"	"unprognostic (5.67e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.93e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.27e-3)"	3.8	0.5	1.9	0.5	6.5	0.4	4.5	0.5	4.5	0.5	1.6	11.0	2.6	0.4	0.5	1.3	0.6	0.6	0.4	0.5	3.2	1.3	27.3	0.4	2.4	0.6	7.0	2.5	0.4	0.4	52.9	0.7	0.6	3.6	0.6	1.1	0.0	1.4	1.5	9.0	0.6	0.4	0.5	3.0	0.4	0.4	0.9	6.2	18.4	0.4	6.6	0.5	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	5.2	19.3	0.0	0.8	3.0	0.0	0.0	0.0	5.3	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	3.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	6.5	0.5	4.5	3.2	1.3	7.0	2.5	3.6	6.2
DMRT3	DMRTA3	ENSG00000064218	"Doublesex and mab-3 related transcription factor 3"	Q9NQL9	9	976964-991731	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 34.2;testis: 11.7;thyroid gland: 11.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.1;HEK 293: 4.1;SCLC-21H: 2.4;THP-1: 6.6;U-2 OS: 1.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.6"	"Region enriched"	"Detected in some"	7	"hippocampal formation: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 0.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	HPA077685	Approved									"HPA077685: AB_2732357"	"unprognostic (2.42e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.28e-1)"		"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.12e-3)"			"unprognostic (2.91e-2)"	"unprognostic (5.84e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	4.0	0.0	0.4	0.0	0.2	0.0	6.4	0.0	1.1	0.2	0.0	1.8	0.0	0.0	0.1	1.0	0.6	0.7	0.0	1.4	8.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.2	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.5	0.7	0.0	0.2	0.4	0.0	0.0	11.7	0.0	0.2	11.5	0.6	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.1	8.0	0.0	0.0	0.0	0.0	0.0
DNAH11	"CILD7, DNAHBL, Dnahc11, DNHBL, DPL11"	ENSG00000105877	"Dynein axonemal heavy chain 11"	Q96DT5	7	21543215-21901839	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 22.2;parathyroid gland: 62.2"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.0;U-2 OS: 3.4;U-2197: 4.2"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.5;pons and medulla: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA045880, HPA056474"	Approved									"HPA045880: AB_10962003, HPA056474: AB_2683145"	"unprognostic (2.24e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.10e-1)"	"prognostic unfavourable (1.49e-7)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (4.79e-3)"	3.2	4.6	0.8	0.5	5.5	0.4	0.4	0.2	1.0	1.6	0.9	6.7	3.0	0.4	0.8	22.2	2.5	9.3	0.5	1.1	2.5	1.2	0.5	0.8	7.7	0.4	0.2	0.6	7.2	0.5	62.2	0.8	2.9	15.5	1.1	0.5	0.0	0.4	1.0	1.5	0.9	0.6	0.4	0.3	0.4	0.5	0.9	2.1	0.7	5.2	0.3	0.5	0.4	3.4	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.9	0.0	0.7	1.1	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.1	0.0	0.9	1.9	0.0	2.2	0.0	0.7	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.2	0.1	1.1	0.5	0.9	0.3	0.4	0.0	0.0	0.8	0.0	0.2	0.9	0.0	0.0	0.0	2.1	0.9	3.4	4.2	0.5	0.3	0.1	0.4	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	5.5	0.2	1.0	2.5	1.2	0.2	0.6	15.5	2.1
DNAH2	"DNHD3, FLJ46675, KIAA1503"	ENSG00000183914	"Dynein axonemal heavy chain 2"	Q9P225	17	7717354-7833744	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 14.3;parathyroid gland: 20.0;testis: 21.0"	"Cell line enhanced"	"Detected in some"		"A-431: 4.8;CACO-2: 7.5;CAPAN-2: 4.7;SCLC-21H: 4.5;SiHa: 4.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA067103	Enhanced		Approved	Microtubules				Microtubules	Microtubules	"HPA067103: AB_2685778"	"unprognostic (2.03e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.50e-3)"	"unprognostic (1.29e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.74e-3)"	"unprognostic (4.60e-2)"	0.2	0.1	1.5	0.2	4.8	0.5	0.5	1.8	0.9	1.3	0.2	7.9	1.1	0.2	0.7	5.7	0.2	14.3	0.4	0.2	2.1	1.9	0.2	0.3	5.5	0.2	0.2	0.6	3.0	0.5	20.0	1.2	1.8	7.0	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	21.0	0.7	0.2	0.3	0.2	0.2	0.2	0.2	1.2	0.6	3.2	0.7	0.6	0.7	0.1	4.8	0.2	0.2	0.3	0.1	0.0	0.8	0.2	0.1	0.0	0.1	7.5	4.7	0.2	2.3	0.1	0.4	0.0	1.1	0.1	0.1	0.2	0.1	0.5	0.1	1.2	0.3	0.2	0.4	0.0	0.7	0.1	0.0	0.2	0.3	0.0	0.9	0.1	0.4	0.4	1.6	0.2	0.5	0.1	0.0	1.4	4.5	0.3	4.5	0.1	2.3	0.4	0.3	0.2	0.4	0.8	0.1	0.0	0.4	0.1	0.2	0.1	0.1	0.8	0.7	0.7	0.4	0.7	0.3	0.5	0.5	0.4	0.6	0.2	1.2	0.5	0.7	3.2	0.6	0.3	0.6	0.3	0.1	1.5	4.8	1.8	0.9	2.1	1.9	0.2	0.6	7.0	0.7
DOPEY2	"C21orf5, KIAA0933"	ENSG00000142197	"Dopey family member 2"	Q9Y3R5	21	36156782-36294274	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 43.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034922, HPA072065"	Approved		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"CAB034922: AB_2277578, HPA072065: AB_2686486"	"prognostic unfavourable (7.08e-4)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	4.6	2.3	5.5	7.5	9.5	17.1	4.9	28.7	11.6	5.1	11.8	3.8	6.8	9.7	2.8	3.3	13.5	3.6	6.5	4.3	4.6	4.0	3.5	7.2	7.2	5.8	3.1	5.8	2.3	3.8	43.1	3.1	4.7	9.5	9.8	12.0	2.8	15.2	9.1	11.1	7.4	13.9	3.8	3.7	5.2	15.8	3.3	3.3	9.3	3.6	7.5	10.6	5.4	6.5	12.0	6.4	6.3	3.2	1.1	3.1	1.3	15.0	3.2	2.4	4.1	2.7	5.3	23.3	7.2	8.5	10.2	6.4	2.2	1.2	2.8	1.1	5.3	3.1	4.6	1.6	8.3	5.1	4.2	6.4	0.7	0.8	2.4	6.2	3.3	1.8	3.4	6.6	1.7	4.2	2.0	4.6	3.0	16.8	5.0	6.4	2.0	3.3	8.9	1.4	13.7	5.4	6.0	6.5	3.7	4.8	21.6	6.1	7.8	7.7	7.2	3.9	1.1	5.1	5.7	3.5	8.4	1.3	5.6	13.5	2.2	1.0	3.2	6.3	3.1	3.1	1.7	8.6	2.0	1.8	2.1	12.0	1.3	1.1	5.5	1.1	2.6	6.4	1.5	1.3	5.5	9.5	28.7	11.6	4.6	4.0	3.1	5.8	9.5	3.3
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992241-162074542	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 133.1;parathyroid gland: 75.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 41.8;ASC TERT1: 42.4;BJ hTERT+: 38.9;RPTEC TERT1: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 26.7"	"Lineage enriched"	"Detected in many"	10	"T-cells: 26.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB045970	Enhanced				"Secreted in other tissues"	170000000	170000000			"CAB045970: AB_11140529"	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (1.98e-4)"	"prognostic favourable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favourable (4.99e-4)"	"unprognostic (1.21e-2)"	9.5	2.9	0.3	3.2	0.5	0.0	5.0	0.3	1.4	2.2	50.0	0.2	36.9	19.1	2.2	3.5	1.2	1.2	5.2	2.1	0.4	0.3	29.1	12.2	5.4	2.1	0.4	0.2	2.7	1.8	75.5	0.3	24.0	0.2	21.1	2.8	0.6	46.9	38.8	2.4	4.4	133.1	0.9	0.8	5.0	1.2	0.6	0.1	6.2	1.0	1.4	1.1	1.0	2.6	0.1	2.1	0.3	0.0	2.6	26.7	2.5	0.0	0.0	0.1	0.0	41.8	42.4	0.1	7.7	38.9	2.1	7.6	7.8	0.2	0.0	2.9	13.4	0.2	0.1	0.0	1.3	2.4	0.1	0.0	0.0	11.7	17.1	0.0	0.0	4.8	0.0	13.1	0.1	1.2	0.0	0.0	0.7	0.0	0.7	0.1	0.4	16.0	0.0	0.0	0.1	56.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.9	4.5	0.2	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	3.2	0.0	26.7	0.1	8.3	5.2	0.6	0.0	8.3	3.3	0.3	2.6	0.0	2.1	0.9	2.5	0.3	0.5	0.3	1.4	0.4	0.3	0.4	0.2	0.2	0.1
ECE1	ECE	ENSG00000117298	"Endothelin converting enzyme 1"	P42892	1	21217247-21345504	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 114.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 101.6;TIME: 90.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001490, HPA013616"	Enhanced					2100000	2100000			"HPA001490: AB_1078718, HPA013616: AB_1847963"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-2)"	44.0	49.9	10.3	18.7	14.5	17.3	33.7	3.6	15.6	29.5	27.5	19.2	11.2	12.4	24.0	10.5	15.6	19.1	23.0	30.9	12.4	8.0	14.9	41.8	30.1	14.4	13.9	13.4	34.2	42.1	114.4	21.6	27.0	14.6	27.9	14.6	26.5	14.7	11.4	15.2	14.8	23.2	24.1	13.2	23.5	18.9	19.1	14.7	9.5	23.2	10.7	19.1	34.2	37.0	4.6	2.0	21.5	7.5	1.0	6.1	4.2	13.6	9.2	11.8	5.9	17.1	18.2	6.8	20.3	35.5	11.1	10.2	6.6	42.0	4.9	51.2	20.5	5.8	4.8	9.7	9.7	12.4	4.0	7.1	14.2	5.3	22.8	1.0	1.8	9.5	11.4	17.1	8.5	101.6	1.4	2.6	9.4	2.8	2.0	1.6	3.6	7.2	2.5	6.8	7.1	17.3	2.5	4.0	9.8	20.2	11.9	8.8	8.5	2.9	90.1	25.0	12.2	11.0	11.7	4.1	6.9	5.7	52.0	2.4	30.2	0.1	5.8	2.2	2.2	7.5	3.3	4.6	4.6	3.5	0.5	3.1	3.1	1.9	21.5	1.0	5.2	2.0	6.1	4.2	10.3	14.5	3.6	15.6	12.4	8.0	13.9	13.4	14.6	14.7
EFCAB14	KIAA0494	ENSG00000159658	"EF-hand calcium binding domain 14"	O75071	1	46675159-46719064	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 107.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011224, HPA011938"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		58000	58000	Cytosol	Cytosol	"HPA011224: AB_1852314, HPA011938: AB_1852317"	"unprognostic (2.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.46e-1)"	29.4	17.4	29.4	14.3	29.5	6.7	22.5	16.2	24.8	25.3	26.0	40.6	15.6	17.2	23.7	27.3	30.0	22.0	19.7	20.2	27.2	20.5	27.8	24.9	24.0	16.4	31.0	15.2	25.2	16.0	107.1	17.2	25.2	27.3	24.4	24.0	23.0	19.9	24.9	24.7	20.4	26.9	22.5	36.1	24.0	36.4	21.9	30.6	28.7	30.1	13.2	20.2	25.7	20.0	16.6	16.0	30.3	21.1	17.1	28.5	18.3	14.3	8.2	7.0	11.1	33.5	21.1	16.1	15.5	23.0	17.2	17.8	9.8	9.7	11.5	16.3	21.1	17.4	12.0	17.2	23.5	21.9	7.7	14.4	9.1	4.0	11.5	18.6	28.4	18.6	28.7	13.7	11.4	21.0	8.9	16.5	17.8	5.6	12.2	8.4	10.0	9.3	9.3	19.6	10.1	18.2	29.1	3.6	5.0	19.2	27.2	14.6	12.2	16.2	19.3	14.8	7.2	17.1	15.7	16.9	23.5	9.3	18.9	16.0	10.9	15.6	18.6	30.3	23.6	21.1	28.5	16.6	20.6	20.2	16.0	16.2	18.0	19.5	12.5	17.1	18.3	12.9	17.8	18.3	29.4	29.5	16.2	24.8	27.2	20.5	31.0	15.2	27.3	30.6
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24, autophagy associated transmembrane protein"	O14681	11	125569216-125584687	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 164.6"	"Cell line enhanced"	"Detected in all"		"HEL: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	13.4	10.2	13.3	8.9	16.2	4.6	16.7	11.2	22.1	12.7	17.0	14.4	13.8	11.3	13.6	12.9	22.7	12.1	15.8	16.4	10.6	10.7	14.6	55.5	12.1	11.2	12.0	11.1	13.1	34.2	164.6	9.2	11.9	11.0	13.7	18.9	13.2	20.9	14.3	26.5	17.2	16.1	15.9	9.2	10.5	17.7	10.4	10.5	9.9	12.0	14.2	13.0	16.2	12.9	8.5	15.5	5.4	7.3	6.5	10.0	4.9	24.5	18.7	21.4	25.8	35.2	26.8	26.8	25.2	19.1	17.4	15.7	28.4	49.6	24.7	42.9	23.7	28.4	32.5	53.0	22.6	6.5	20.6	117.8	13.4	26.6	26.2	26.5	12.8	25.0	48.6	26.1	38.6	36.7	53.4	10.1	24.4	17.3	12.1	13.6	28.2	20.5	17.8	25.3	21.0	29.0	44.0	20.0	19.2	29.5	35.2	9.5	71.9	26.5	30.5	22.4	15.2	15.6	20.3	6.3	12.7	32.2	9.8	40.8	29.8	4.1	7.3	5.4	8.2	7.0	8.1	8.5	6.5	10.0	11.6	7.3	9.4	7.6	0.9	6.5	5.1	15.5	9.0	4.9	13.3	16.2	11.2	22.1	10.6	10.7	12.0	11.1	11.0	10.5
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044314	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 17.3;HAP1: 12.0;HBF TERT88: 16.8;Hep G2: 12.8;RH-30: 18.2"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"prognostic favourable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.4	1.3	10.7	1.7	11.5	0.6	4.7	5.8	12.2	0.6	0.6	8.8	0.0	0.7	0.9	2.5	0.8	0.6	1.1	3.1	6.4	4.8	0.7	43.1	0.7	0.9	7.1	7.1	0.7	2.6	19.9	2.8	28.4	8.0	5.0	0.6	5.9	1.1	0.9	1.3	0.7	0.8	1.1	18.6	0.5	0.6	9.3	4.0	0.0	2.0	0.0	1.3	1.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.5	0.0	0.0	0.0	6.5	0.2	0.6	10.1	17.3	0.0	0.0	0.0	0.0	0.6	0.0	12.0	0.0	16.8	0.0	10.3	0.1	0.2	12.8	0.5	0.2	2.7	0.1	0.0	7.8	0.0	0.0	0.6	0.0	0.2	0.0	6.5	0.1	2.1	9.8	9.1	18.2	0.0	0.0	0.1	4.5	5.2	0.0	0.0	4.1	2.1	5.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.7	11.5	5.8	10.9	6.4	4.8	7.1	7.1	8.0	4.0
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847030-2915993	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 83.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 22.4;BEWO: 17.2;HL-60: 16.2;HMC-1: 27.6;HSkMC: 12.1;THP-1: 16.1;U-2197: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"midbrain: 9.1;pons and medulla: 16.9;thalamus: 6.3"	HPA064576	Supported				"Secreted to extracellular matrix"	600000	600000			"HPA064576: AB_2732717"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavourable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	32.3	1.4	0.9	8.4	0.7	4.9	14.5	0.3	0.8	5.8	3.9	1.1	2.2	1.1	6.8	6.7	3.9	5.2	4.3	9.6	1.0	1.1	2.0	1.3	10.9	24.4	3.1	0.0	11.0	1.8	83.7	0.6	34.9	3.7	4.6	2.0	2.4	2.9	1.0	3.9	3.0	2.4	5.7	16.4	6.9	1.9	2.8	0.3	2.8	3.0	4.1	1.8	7.9	6.6	0.5	2.1	8.0	2.3	3.1	0.9	0.6	0.1	0.1	1.3	0.0	22.4	9.3	17.2	3.5	0.0	0.6	1.1	2.4	0.0	0.0	0.2	8.5	0.0	0.4	0.0	1.2	0.0	1.2	0.2	0.0	0.1	0.7	16.2	27.6	12.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	2.2	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.6	0.0	16.1	0.2	0.0	2.4	21.1	0.2	0.0	0.0	0.0	1.4	4.0	0.4	8.0	2.3	0.6	0.9	1.6	0.7	0.4	0.9	0.6	2.1	0.5	0.5	0.9	2.3	3.1	1.4	1.4	0.6	0.6	0.9	0.7	0.3	0.8	1.0	1.1	3.1	0.0	3.7	0.3
EPHA1	"EPH, EPHT, EPHT1"	ENSG00000146904	"EPH receptor A1"	P21709	7	143390289-143408892	"Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 104.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.3;HaCaT: 9.6;HBEC3-KT: 7.8;MCF7: 8.5;NTERA-2: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 3.4;naive CD4 T-cell: 6.9;naive CD8 T-cell: 5.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.9"	"Not detected"	"Not detected"							CAB026144	Uncertain					24000000	24000000			"CAB026144: "	"unprognostic (1.54e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.58e-3)"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.24e-3)"	"prognostic favourable (1.14e-6)"	"unprognostic (3.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	0.4	0.4	0.0	2.0	0.1	0.5	1.2	0.9	0.3	5.7	7.9	0.0	3.3	3.3	0.9	1.4	29.3	1.6	7.9	0.4	0.0	0.0	2.8	10.6	2.9	5.8	0.0	0.0	1.2	2.9	104.4	1.3	5.5	1.1	2.1	0.9	1.3	5.8	3.9	0.3	9.5	12.3	0.4	0.2	0.5	1.8	0.8	0.0	5.1	6.0	16.4	17.2	1.6	11.8	0.0	0.7	0.2	0.1	0.2	6.9	1.6	4.9	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	10.3	4.1	0.0	0.0	0.0	9.6	0.0	7.8	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	1.0	32.1	0.0	0.0	0.0	0.0	0.6	3.9	0.1	0.0	0.0	4.8	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	3.4	0.9	0.4	0.0	6.9	5.1	0.2	0.2	0.0	0.7	0.2	1.6	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	1.1	0.0
ERMP1	"FLJ23309, FXNA, KIAA1815"	ENSG00000099219	"Endoplasmic reticulum metallopeptidase 1"	Q7Z2K6	9	5765076-5833117	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 57.6"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 26.9;RT4: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055582	Approved									"HPA055582: "	"unprognostic (1.93e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.59e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.81e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-2)"	"prognostic favourable (5.83e-10)"	"unprognostic (1.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	4.0	12.0	5.3	3.6	13.8	1.6	4.8	7.3	12.3	8.5	8.2	20.5	1.5	3.4	4.9	2.9	12.7	4.9	8.8	7.1	6.8	5.8	18.8	3.5	4.7	2.7	18.3	7.0	5.6	4.4	57.6	3.3	5.7	17.0	4.8	8.4	6.9	12.8	3.4	5.2	6.8	4.8	3.2	15.9	2.5	9.1	5.9	11.5	4.6	19.1	4.6	7.2	18.7	8.1	0.2	0.3	0.9	0.5	4.7	2.0	0.3	15.0	14.7	0.6	1.7	7.7	7.4	7.8	1.7	3.8	0.8	0.7	3.5	9.2	3.5	6.7	2.8	10.8	3.2	10.0	1.2	18.5	2.6	18.7	7.7	6.9	1.6	5.3	7.4	3.7	4.4	0.7	4.4	10.4	2.3	3.3	0.9	6.9	0.2	2.0	2.3	2.9	0.5	1.8	4.7	26.9	52.6	3.4	1.0	2.4	17.8	2.8	11.7	6.7	6.1	0.5	1.8	1.1	5.4	3.1	4.4	1.8	2.2	4.4	1.4	0.6	0.3	0.9	1.3	0.5	2.0	0.2	0.6	0.3	0.0	0.0	0.5	0.5	0.0	4.7	0.2	0.3	0.5	0.3	5.3	13.8	7.3	12.3	6.8	5.8	18.3	7.0	17.0	11.5
ESRRG	NR3B3	ENSG00000196482	"Estrogen related receptor gamma"	P62508	1	216503246-217137755	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5;parathyroid gland: 37.2;placenta: 40.8"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 15.1;SH-SY5Y: 28.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"pons and medulla: 49.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044678	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA044678: AB_10963215"	"unprognostic (6.48e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.06e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.79e-2)"	"prognostic favourable (1.13e-11)"	"unprognostic (3.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.65e-4)"	"unprognostic (2.05e-1)"	0.5	5.1	2.8	0.4	3.3	0.2	2.9	6.9	10.3	1.4	0.7	0.7	2.2	4.0	0.5	1.5	1.4	2.1	0.8	8.3	3.2	2.6	22.0	0.8	0.7	0.4	6.8	1.7	0.8	4.4	37.2	9.9	40.8	49.5	2.6	0.4	10.7	11.0	2.4	6.3	1.5	3.7	0.9	2.6	1.0	22.2	1.0	1.5	0.0	4.6	7.2	0.4	1.0	0.7	0.4	0.2	1.5	0.0	0.2	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	15.1	2.3	1.7	5.4	28.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.1	0.1	1.5	0.2	0.0	0.2	0.0	0.0	2.8	3.3	6.9	10.3	3.2	2.6	6.8	1.7	49.5	1.5
ETV5	ERM	ENSG00000244405	"ETS variant 5"	P41161	3	186046308-186110318	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 55.3"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009590, HPA063065"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB009590: AB_2101008, HPA063065: AB_2684936"	"unprognostic (3.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavourable (7.85e-9)"	"unprognostic (3.52e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.84e-3)"	5.8	30.3	13.2	5.5	21.7	1.6	11.3	12.1	35.2	4.7	3.0	15.7	1.3	5.1	6.8	6.2	3.8	4.6	4.8	8.8	13.6	9.4	7.1	6.2	21.9	8.9	9.9	11.0	2.5	25.4	55.3	28.1	24.3	11.5	6.3	3.1	7.4	5.5	5.1	9.8	5.3	2.8	6.1	9.6	10.0	11.9	7.2	6.1	2.0	16.6	1.7	3.6	3.6	3.6	0.6	1.8	0.9	3.1	0.1	0.3	0.5	12.8	8.9	11.4	24.8	7.0	7.3	0.8	11.0	12.4	8.7	9.5	9.7	7.9	0.3	14.8	10.7	2.2	0.2	8.4	13.0	2.8	0.3	3.7	0.3	10.9	11.7	9.3	7.0	6.4	1.3	13.9	17.1	12.8	3.4	4.6	14.9	5.9	1.2	14.3	17.0	10.1	26.2	11.4	8.6	7.2	3.0	0.5	14.7	2.7	0.1	55.7	0.0	5.2	12.3	4.8	7.8	12.1	21.6	3.5	14.4	0.0	14.7	7.5	28.6	0.0	0.3	0.1	0.3	3.1	0.0	0.6	0.0	0.0	1.8	0.1	0.0	0.0	0.9	0.1	1.5	1.6	0.0	0.5	13.2	21.7	12.1	31.7	13.6	9.4	9.9	11.0	11.5	6.1
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 45.5;pituitary gland: 30.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.4;RH-30: 12.7;SH-SY5Y: 31.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"NK-cell: 9.8"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028917			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA028917: AB_2672826"	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	1.0	1.1	2.8	0.6	16.8	0.5	0.6	0.2	6.8	4.0	0.6	1.9	0.0	0.7	0.6	2.2	1.0	2.5	0.8	4.6	2.8	2.2	0.6	0.5	1.0	0.6	2.9	2.8	0.8	0.6	45.5	30.8	0.6	4.2	12.4	0.7	15.3	1.2	4.6	3.2	0.6	0.7	3.9	0.4	0.7	0.9	1.3	5.1	4.4	0.9	2.9	0.6	3.5	5.7	0.8	1.9	1.8	2.3	9.8	2.3	0.2	0.1	0.0	3.7	16.4	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.9	0.0	0.0	2.7	0.0	1.2	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	1.2	0.9	0.0	12.7	5.4	0.0	0.0	1.3	31.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.7	0.0	1.2	1.8	0.3	0.6	0.9	0.9	1.9	0.8	0.7	1.9	0.7	0.8	1.3	1.4	1.6	9.8	2.3	1.9	2.3	0.2	2.8	16.8	0.2	2.8	2.8	2.2	2.9	2.8	4.2	5.1
F8A3		ENSG00000277150	"Coagulation factor VIII associated 3"	P23610	X	155456914-155458672	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 6.3;parathyroid gland: 10.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 23.3;U-266/84: 21.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"eosinophil: 6.3"	"Low lineage specificity"	"Detected in many"											HPA046960	Uncertain									"HPA046960: AB_2679877"	"unprognostic (1.83e-1)"	"unprognostic (9.94e-2)"			"unprognostic (3.30e-2)"	"unprognostic (2.08e-1)"		"unprognostic (2.94e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.38e-1)"		"unprognostic (7.03e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.53e-1)"	"unprognostic (7.96e-2)"	2.3	1.4		1.4		2.1	1.2		2.5	0.9	1.7			1.1	0.0	1.6	0.0	0.6	0.9	0.3			1.8	1.8	0.4	0.8			1.0	0.0	10.5		0.4		0.0	0.3		0.1	0.6	4.2	0.0	1.9	0.0		0.7	1.5	0.0			0.0		0.1	2.9		1.0	1.0	6.3	0.7	0.4	1.8	0.3	0.5	0.0	1.2	0.0	4.9	3.5	0.0	0.2	0.0	0.0	0.0	2.3	0.0	6.5	0.6	8.0	6.3	1.3	0.0	0.0	0.9	3.1	8.3	5.4	0.1	5.6	11.1	4.0	0.0	0.0	5.0	3.9	3.1	0.0	0.0	8.2	0.0	11.5	0.0	2.2	0.4	0.5	0.0	6.0	4.9	3.9	0.0	2.3	4.6	0.0	0.1	0.0	6.9	2.7	11.4	0.1	8.1	13.2	23.3	21.7	0.3	3.3	0.1	0.0	0.0	0.6	6.3	1.8	0.4	1.1	0.8	1.6	1.5	0.9	1.0	0.9	1.0	1.5	0.4	0.7	1.0	0.3	0.3										
FAM189A1	"KIAA0574, TMEM228"	ENSG00000104059	"Family with sequence similarity 189 member A1"	O60320	15	29120254-29570723	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.3;parathyroid gland: 6.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.2;HDLM-2: 15.2;REH: 3.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA009410, HPA010637"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA009410: AB_1852332, HPA010637: AB_1852333"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.12e-1)"	0.8	1.5	12.8	0.6	7.9	0.4	0.6	4.2	9.5	0.4	4.0	1.5	0.0	1.0	1.1	0.8	0.6	1.5	0.5	0.7	15.3	4.7	1.7	0.5	1.5	0.5	3.5	3.4	0.4	3.3	6.5	0.0	0.7	4.0	0.8	3.0	0.0	1.1	0.5	0.4	0.8	3.2	1.0	0.7	1.3	0.6	2.3	0.3	0.0	1.9	0.0	1.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.2	15.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.5	0.0	3.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	12.8	7.9	4.2	9.5	15.3	4.7	3.5	3.4	4.0	0.3
FAXDC2	"C5orf4, FLJ13758"	ENSG00000170271	"Fatty acid hydroxylase domain containing 2"	Q96IV6	5	154818491-154859252	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 77.9;parathyroid gland: 112.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.6;ASC TERT1: 16.3;HSkMC: 14.5;SK-MEL-30: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (6.38e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.70e-2)"	"prognostic favourable (3.87e-5)"	"unprognostic (8.29e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.42e-2)"	"prognostic favourable (9.71e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.94e-1)"	15.9	15.7	14.5	2.9	25.1	12.2	12.9	7.7	31.6	11.9	19.9	77.9	6.7	4.1	14.9	23.7	7.7	16.8	12.7	13.7	19.8	12.3	11.2	55.3	15.3	3.4	29.0	15.3	25.8	6.7	112.1	6.6	5.7	35.9	12.6	8.1	25.6	16.7	14.1	5.0	10.1	7.2	16.9	38.7	5.6	9.0	8.8	33.6	0.0	29.7	5.6	3.1	11.4	8.3	1.9	1.4	6.7	1.2	4.3	0.9	8.8	1.0	0.8	3.1	6.2	21.6	16.3	2.5	2.1	6.3	0.9	3.9	0.8	7.9	1.1	1.4	3.8	0.8	0.0	1.0	0.8	0.7	0.9	12.0	2.0	4.7	3.3	1.6	1.1	14.5	4.1	2.1	0.5	4.8	7.1	0.4	5.3	0.3	1.0	2.4	1.4	0.2	1.0	2.0	0.4	1.5	0.9	0.3	5.3	1.0	0.5	13.6	0.4	0.4	1.7	2.2	1.3	0.9	0.6	1.0	0.6	0.7	2.9	0.9	1.3	4.4	1.2	2.2	0.7	0.9	0.6	0.7	0.8	0.7	1.4	1.9	0.7	0.9	6.7	4.3	0.7	1.1	0.4	8.8	14.5	25.1	7.7	31.6	19.8	12.3	29.0	15.3	35.9	33.6
FGF13	"FGF2, FHF2"	ENSG00000129682	"Fibroblast growth factor 13"	Q92913	X	138614731-139222777	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7;parathyroid gland: 44.3;skeletal muscle: 37.0"	"Cell line enhanced"	"Detected in some"		"AF22: 19.5;fHDF/TERT166: 16.8;HAP1: 17.8;RPMI-8226: 15.1;U-2197: 31.4;WM-115: 16.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002809			Supported	Cytosol				Cytosol	Cytosol	"HPA002809: AB_1078855"	"unprognostic (3.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (9.92e-3)"	"unprognostic (2.97e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (5.22e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.96e-4)"	"unprognostic (4.36e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.48e-2)"	11.1	1.9	30.0	1.9	29.5	2.7	4.2	0.9	22.9	7.9	3.1	1.5	2.4	2.7	7.0	2.8	4.4	2.6	4.1	1.3	36.7	22.3	4.9	1.4	1.7	3.1	19.7	12.9	6.0	0.9	44.3	2.4	8.4	7.8	11.6	3.3	4.8	6.5	3.5	37.0	1.1	3.1	4.5	3.3	3.8	2.9	2.7	4.1	0.0	3.6	7.9	1.6	3.5	5.7	0.5	0.9	7.4	0.5	0.2	0.3	0.1	0.0	0.2	19.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	16.8	1.2	17.8	0.0	0.0	0.2	5.0	0.1	0.1	0.7	0.7	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.7	5.6	2.0	0.1	0.0	0.1	2.0	6.4	2.9	1.2	15.1	2.8	0.1	0.1	0.0	0.0	0.1	11.9	0.0	0.1	0.4	0.6	0.8	31.4	8.3	7.4	4.1	0.0	7.0	5.6	16.8	2.7	0.5	1.6	0.2	0.3	0.1	0.5	0.2	0.1	0.1	0.4	0.3	0.2	7.4	0.2	0.5	0.9	0.2	0.1	30.0	29.5	0.9	22.9	36.7	22.3	19.7	12.9	7.8	4.1
FIBCD1	FLJ14810	ENSG00000130720	"Fibrinogen C domain containing 1"	Q8N539	9	130902438-130939286	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;parathyroid gland: 10.7;testis: 9.5"	"Cell line enhanced"	"Detected in some"		"MCF7: 21.9;RPTEC TERT1: 17.0;THP-1: 8.4;U-2 OS: 11.7;U-251 MG: 9.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	11	"hippocampal formation: 19.2"	"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 5.7"	"Lineage enriched"	"Detected in single"	11	"monocytes: 5.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 18.2;hippocampal formation: 75.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 81.5"	HPA055353	Approved		Supported	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA055353: AB_2682791"	"unprognostic (1.18e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.42e-6)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.77e-1)"	0.0	8.5	1.7	0.1	1.1	0.0	1.1	0.1	3.0	0.0	1.8	0.3	0.0	0.5	0.0	1.4	0.4	0.0	5.0	2.0	19.2	1.2	0.0	0.0	5.3	0.0	0.6	0.0	0.4	0.0	10.7	0.0	1.7	1.5	1.0	1.4	1.1	1.6	0.0	0.0	0.0	1.6	2.1	0.0	0.8	0.1	9.5	0.8	0.0	0.3	0.0	0.0	2.9	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.2	0.3	2.4	0.8	0.0	0.0	0.0	0.0	5.2	6.1	0.3	0.8	0.0	2.6	0.0	1.9	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.2	0.2	0.0	0.1	2.8	0.0	0.0	0.6	0.0	0.0	21.9	0.0	2.3	1.5	0.5	0.0	4.6	0.3	17.0	0.0	0.1	0.0	0.7	0.0	0.6	1.4	8.4	0.0	0.9	11.7	0.1	9.5	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	1.7	1.1	0.1	1.0	19.2	1.2	0.6	0.0	1.5	0.8
FOXL2	"BPES, BPES1"	ENSG00000183770	"Forkhead box L2"	P58012	3	138944224-138947140	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 13.9;ovary: 55.5;parathyroid gland: 15.3"	"Cell line enhanced"	"Detected in some"		"A-431: 5.4;fHDF/TERT166: 6.3;HEL: 9.0;hTCEpi: 8.3;K-562: 9.2;SiHa: 6.4;THP-1: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA069613	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	Nucleoplasm	"HPA069613: AB_2686160"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-2)"		"unprognostic (4.76e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.16e-4)"		"unprognostic (3.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.63e-8)"	"unprognostic (2.16e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.61e-2)"	0.0	1.5	0.3	0.0	1.2	0.0	0.0	0.3	1.0	13.9	0.0	0.6	0.0	0.0	10.0	0.4	0.1	6.4	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.4	55.5	0.6	15.3	13.1	1.4	0.8	0.2	0.0	1.7	0.0	0.4	0.0	0.2	0.0	0.9	0.3	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	2.1	0.3	3.9	0.1	0.0	1.7	0.2	0.0	0.4	0.1	0.0	0.4	0.0	2.6	6.3	1.2	0.0	0.0	0.1	0.0	0.0	9.0	1.1	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	9.2	0.0	3.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	6.4	0.0	0.0	0.0	6.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.3	1.0	0.4	0.2	0.3	0.4	0.8	0.2
FOXL2NB	"C3orf72, FLJ43329"	ENSG00000206262	"FOXL2 neighbor"	Q6ZUU3	3	138947234-138953451	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 51.6;parathyroid gland: 25.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.4;fHDF/TERT166: 10.5;HEL: 10.4;hTCEpi: 4.9;SiHa: 8.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"											"HPA061017, HPA071790"			Enhanced	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA061017: AB_2684415, HPA071790: AB_2686447"	"unprognostic (3.32e-1)"	"unprognostic (1.13e-1)"		"unprognostic (3.86e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.40e-5)"		"unprognostic (3.30e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-10)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-2)"	0.1	1.0	0.6	0.1	1.4	0.2	0.1	0.2	0.9	15.3	0.1	0.5	0.1	0.0	12.6	0.9	0.2	7.3	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.5	0.4	51.6	0.4	25.0	9.4	3.2	1.0	0.1	0.0	1.3	0.1	0.5	0.1	0.3	0.1	2.5	0.3	0.1	0.0	0.4	0.3	0.1	0.4	0.3	0.1	0.4	2.3	0.6	0.5	2.8	0.4	0.7	0.4	0.0	2.1	1.4	0.7	5.4	0.3	0.1	2.3	0.1	0.0	0.2	0.0	0.2	0.4	0.2	1.1	10.5	0.5	0.2	0.1	0.2	0.1	0.3	10.4	3.2	0.1	0.0	0.1	0.4	0.2	4.9	0.2	0.1	0.0	4.0	0.2	2.6	0.2	0.1	0.3	0.3	0.1	0.1	0.0	0.0	0.5	1.5	0.2	0.2	8.1	0.2	0.0	0.2	3.0	0.2	0.3	0.2	0.3	0.1	0.4	0.1	0.1	0.3	0.3	0.1	1.3	0.4	0.3	0.4	0.3	0.2	0.4	0.3	0.3	0.2	0.6	0.4	0.3	2.8	0.7	0.2	0.5	0.4	0.0	0.6	1.4	0.2	0.9	0.3	0.2	0.5	0.4	1.0	0.3
GBA	"GBA1, GLUC"	ENSG00000177628	"Glucosylceramidase beta"	P04062	1	155234452-155244699	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 101.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006667, CAB037171, CAB037289"	Supported				"Intracellular and membrane"	200000	200000			"CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979"	"unprognostic (6.03e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.00e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.94e-2)"	19.2	29.7	14.8	13.9	24.5	21.9	15.3	8.7	33.4	16.5	20.1	25.2	18.1	13.8	16.9	30.4	18.9	12.7	16.5	13.6	15.8	18.9	31.8	24.6	17.9	15.4	18.5	16.5	13.1	19.2	101.2	32.1	46.2	28.1	14.4	23.5	25.3	22.3	24.3	6.0	21.6	16.6	17.7	19.3	24.5	14.6	9.7	13.1	13.7	22.2	8.7	17.5	16.3	15.2	7.3	13.9	17.9	22.3	6.6	14.0	12.4	8.5	16.5	5.9	8.0	61.7	13.6	6.8	15.1	53.7	22.5	28.5	9.6	31.3	5.9	16.8	35.3	17.3	8.3	10.7	12.0	12.4	5.8	4.9	10.9	5.2	17.7	5.8	20.6	17.8	9.0	47.3	7.2	20.0	5.1	10.0	26.4	18.5	7.1	2.6	3.7	11.7	6.0	9.6	24.2	15.1	6.6	5.6	7.7	13.2	31.7	33.4	23.8	14.1	15.1	17.0	7.6	21.3	12.0	20.0	16.9	4.6	29.7	5.3	13.0	12.2	21.6	9.1	13.4	22.3	8.7	7.3	10.3	9.0	13.9	5.5	7.4	7.8	17.9	6.6	21.2	7.8	14.0	12.4	14.8	24.5	8.7	33.4	15.8	18.9	18.5	16.5	28.1	13.1
GCNT1	"C2GNT, NACGT2, NAGCT2"	ENSG00000187210	"Glucosaminyl (N-acetyl) transferase 1, core 2"	Q02742	9	76419850-76507416	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.0;parathyroid gland: 57.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 25.8;HSkMC: 21.9;U-2197: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"cerebellum: 8.2;olfactory region: 30.1"	"Low region specificity"	"Detected in all"			"HPA003522, HPA003523, HPA031151"	Uncertain		Supported	"Nuclear speckles"		72000	72000	"Nuclear speckles"	"Nuclear speckles"	"HPA003522: , HPA003523: , HPA031151: AB_10602904"	"unprognostic (3.14e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (4.96e-4)"	5.6	1.1	1.6	7.9	3.9	2.2	8.2	10.9	2.7	5.3	24.5	0.7	3.0	23.2	5.2	1.2	2.1	1.8	4.1	3.1	2.1	1.4	1.4	1.0	4.5	9.2	1.6	2.1	0.9	2.0	57.8	1.9	3.9	1.0	4.9	4.6	0.5	9.1	1.8	0.8	1.5	32.0	2.5	1.2	7.6	18.6	1.4	0.6	2.8	16.9	1.2	6.4	2.4	3.3	9.4	4.7	16.8	6.4	4.7	1.9	1.6	2.4	0.2	0.1	0.0	3.1	14.9	3.6	10.0	4.5	8.1	5.8	2.5	0.6	1.7	1.0	7.4	2.1	5.0	4.1	9.1	1.2	0.8	4.2	0.2	0.4	25.8	3.1	1.4	21.9	1.1	7.9	8.5	7.4	0.0	1.7	8.1	3.7	1.6	5.0	4.7	0.6	2.8	5.0	0.8	9.5	4.4	1.0	0.0	1.2	1.3	0.0	0.0	2.1	3.0	5.1	3.3	18.3	4.4	2.6	0.4	0.0	10.3	5.3	1.2	4.3	2.7	16.8	1.3	6.4	0.4	1.3	1.5	1.3	4.7	9.4	0.2	1.0	0.9	4.7	5.7	2.3	1.9	1.6	1.6	3.9	10.9	2.7	2.1	1.4	1.6	2.1	1.0	0.6
GJA3	"CX46, CZP3"	ENSG00000121743	"Gap junction protein alpha 3"	Q9Y6H8	13	20138255-20161049	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.1;parathyroid gland: 6.2"	"Cell line enhanced"	"Detected in some"		"A-431: 5.6;CAPAN-2: 10.1;HL-60: 8.3;U-266/84: 5.9"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014821	Supported									"HPA014821: AB_2669097"	"unprognostic (2.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.65e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-2)"	"unprognostic (8.04e-3)"	0.2	0.0	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.3	0.1	0.8	0.1	0.5	23.1	0.1	0.0	1.2	0.1	0.2	0.1	0.1	0.1	0.1	0.3	6.2	0.1	3.9	0.2	0.4	0.0	0.2	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.0	4.2	0.1	0.2	0.1	1.0	1.6	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	5.6	0.3	0.0	4.9	0.2	1.5	0.0	0.7	4.6	0.8	0.9	0.5	10.1	0.0	0.2	1.7	0.1	3.2	2.7	0.7	0.2	2.5	2.4	0.0	0.0	0.1	8.3	0.0	0.3	1.6	0.2	0.4	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.7	1.9	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	4.9	1.1	1.9	0.0	0.0	0.0	2.0	0.3	2.2	5.9	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1
GLRB		ENSG00000109738	"Glycine receptor beta"	P48167	4	157076057-157172090	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 43.1;parathyroid gland: 37.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052363	Approved									"HPA052363: AB_2681800"	"unprognostic (7.36e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (4.89e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.66e-2)"	4.5	7.2	12.6	1.5	20.9	0.7	10.3	15.9	43.1	9.4	2.3	2.8	0.1	1.1	3.3	5.4	1.5	7.4	3.5	9.9	18.3	17.3	4.1	1.6	3.4	0.8	11.1	21.3	1.8	14.2	37.0	6.7	2.9	16.5	6.5	1.4	0.7	16.7	5.2	3.3	1.5	1.2	4.0	6.1	0.6	2.2	1.9	4.5	0.0	1.5	0.5	0.7	1.9	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.0	2.2	6.1	18.5	12.0	4.9	0.0	10.1	6.5	5.0	9.4	0.0	15.7	0.0	2.4	10.2	0.0	4.6	1.6	9.4	0.0	6.1	3.1	2.4	0.2	5.5	3.9	0.0	4.3	1.4	8.7	1.3	4.4	0.0	0.0	9.0	0.0	0.4	0.0	0.4	1.3	0.0	8.4	0.0	13.4	0.9	6.7	4.1	0.0	4.8	0.8	4.4	1.0	6.6	3.0	8.8	5.0	9.8	0.0	0.0	0.0	7.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	12.6	20.9	15.9	43.1	18.3	17.3	11.1	21.3	16.5	4.5
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037929-170085403	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.0"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 30.4;SK-BR-3: 24.2;THP-1: 47.8;U-266/70: 52.8;U-266/84: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA006970	Approved		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favourable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favourable (3.61e-4)"	7.0	1.4	3.1	21.7	2.5	23.6	8.2	0.9	1.8	2.6	31.2	1.5	7.9	18.0	1.9	21.5	2.6	1.8	16.2	3.0	1.9	1.7	27.4	2.1	23.2	25.6	2.7	0.4	1.6	14.7	71.0	3.5	2.9	1.8	10.7	18.1	11.8	14.2	4.7	2.0	1.8	43.2	0.9	4.7	17.9	18.0	2.9	2.4	6.6	3.8	1.0	10.7	9.1	6.9	11.2	2.9	10.1	1.1	0.3	3.0	1.2	15.6	0.3	0.0	0.1	0.0	0.1	3.9	0.1	0.1	0.1	0.5	2.8	2.0	7.2	3.3	0.1	0.1	2.1	0.1	0.2	11.0	4.3	4.7	0.2	5.8	0.0	9.2	6.4	0.0	0.2	0.5	0.5	0.3	1.5	18.8	0.1	10.0	0.6	1.9	2.5	0.6	1.3	0.3	30.4	8.2	21.6	1.5	0.4	0.1	24.2	1.1	14.2	47.8	0.4	0.0	0.1	1.8	1.1	52.8	30.3	12.7	0.2	10.0	0.7	1.5	1.1	8.1	0.5	0.4	0.9	6.8	0.9	0.4	2.2	11.2	3.0	1.1	10.1	0.3	0.1	2.9	0.3	1.2	3.1	2.5	0.9	1.8	1.9	1.7	2.7	0.4	1.8	2.4
GPR27	SREB1	ENSG00000170837	"G protein-coupled receptor 27"	Q9NS67	3	71754050-71756496	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 23.2;parathyroid gland: 29.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.8;HL-60: 12.2;MCF7: 10.5;NTERA-2: 21.1;RPTEC TERT1: 10.1;SH-SY5Y: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.7;neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029395	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA029395: AB_10602907"	"prognostic favourable (5.63e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-1)"	"prognostic favourable (1.21e-6)"	"unprognostic (2.97e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.79e-2)"	1.7	4.5	14.9	1.7	23.2	14.5	4.3	4.4	15.4	3.4	1.0	5.8	1.7	0.6	5.5	3.3	2.7	7.7	1.2	3.5	12.8	12.4	3.2	0.9	2.4	5.5	10.6	8.8	5.0	2.6	29.6	5.1	2.0	5.9	5.7	0.7	3.3	1.7	5.1	1.8	1.9	0.7	3.3	16.8	3.7	2.4	4.2	3.6	0.0	6.8	1.2	0.5	2.1	2.8	0.0	0.2	10.5	0.8	0.0	0.4	0.1	0.0	0.8	1.4	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	12.8	0.0	0.0	3.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	12.2	0.7	0.0	2.2	0.0	0.9	0.0	0.0	0.0	0.0	10.5	0.8	0.2	21.1	0.0	0.0	0.0	0.0	10.1	5.7	2.2	8.0	2.8	0.0	0.0	7.4	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	3.7	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.1	10.5	0.0	0.1	0.0	0.0	0.1	14.9	23.2	4.4	9.9	12.8	12.4	10.6	8.8	5.9	3.6
GREM2	"CKTSF1B2, DAND3, FLJ21195, Prdc"	ENSG00000180875	"Gremlin 2, DAN family BMP antagonist"	Q9H772	1	240489573-240612149	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 90.3;parathyroid gland: 31.4"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2;memory CD4 T-cell: 2.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB009920	Approved				"Secreted to blood"					"CAB009920: AB_2279266"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.07e-8)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-2)"	0.6	0.9	3.0	9.5	4.5	0.0	2.2	0.7	5.1	0.8	14.2	0.5	0.9	6.5	8.2	1.9	10.7	1.3	90.3	0.2	2.1	3.6	1.1	21.9	1.3	0.6	1.4	4.8	4.2	0.3	31.4	5.2	5.2	3.0	2.8	12.8	1.7	7.5	1.1	6.5	2.3	11.7	3.8	1.8	1.7	6.4	0.5	0.9	0.0	0.7	3.0	4.1	2.2	0.7	0.0	0.0	0.5	0.0	0.1	2.5	0.2	0.0	0.0	0.1	0.0	1.6	2.0	0.0	4.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	1.0	0.0	0.0	3.2	0.4	0.7	0.3	0.8	0.0	0.0	2.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	2.5	1.3	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.0	0.0	0.2	3.0	4.5	0.7	5.1	2.1	3.6	1.4	4.8	3.0	0.9
GRM7	"GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87"	ENSG00000196277	"Glutamate metabotropic receptor 7"	Q14831	3	6770001-7741533	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.8;parathyroid gland: 11.3"	"Cell line enriched"	"Detected in single"	11	"SH-SY5Y: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015964			Uncertain	Cytosol				Cytosol	Cytosol	"HPA015964: "	"unprognostic (2.04e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.37e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.84e-6)"	"unprognostic (1.45e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.59e-2)"	0.9	5.3	8.1	0.6	10.5	0.6	0.9	1.6	15.8	2.9	0.8	2.1	0.0	0.9	3.1	0.5	0.6	1.0	0.7	0.6	11.1	9.3	0.5	0.7	0.8	0.5	2.3	10.1	0.8	0.7	11.3	0.6	0.9	4.3	1.2	0.8	0.8	2.1	1.4	0.5	0.6	0.6	5.9	2.8	0.8	0.6	2.8	4.1	0.0	0.7	0.0	0.7	1.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	10.5	1.6	15.8	11.1	9.3	2.3	10.1	4.3	4.1
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666711-155732349	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 55.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.0;Karpas-707: 8.5;MOLT-4: 15.6;RPTEC TERT1: 10.7;RT4: 12.5;SH-SY5Y: 7.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.6;non-classical monocyte: 9.2;plasmacytoid DC: 11.6"	"Group enriched"	"Detected in many"	27	"dendritic cells: 11.6;monocytes: 9.2;NK-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		6100	6100	Nucleoplasm	Nucleoplasm	"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: "	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	10.9	5.3	12.4	10.2	19.9	0.9	11.1	3.4	11.6	13.7	31.2	7.3	2.8	5.6	14.7	6.0	7.0	6.8	8.3	21.0	9.0	7.2	11.6	5.1	13.2	7.3	4.7	12.5	5.4	8.5	55.2	5.8	16.3	6.3	17.2	6.9	39.7	7.0	9.8	4.5	3.6	10.1	18.8	6.6	8.5	12.9	2.1	8.5	4.5	8.1	7.3	5.9	6.4	10.6	0.1	11.6	0.3	9.2	7.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	6.0	0.0	0.0	0.0	4.8	1.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	15.6	0.0	0.0	0.2	3.5	0.0	2.6	10.7	12.5	2.1	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.3	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	7.6	9.2	11.6	0.0	1.0	12.4	19.9	3.4	11.6	9.0	7.2	4.7	12.5	6.3	8.5
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807591	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.6"	"Cell line enhanced"	"Detected in many"		"HEL: 24.8;Karpas-707: 13.1;MOLT-4: 15.6;RPTEC TERT1: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 5.6;non-classical monocyte: 17.8"	"Lineage enriched"	"Detected in many"	12	"monocytes: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol		5200	5200	Cytosol	Cytosol	"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	8.8	5.4	18.7	9.8	42.0	1.8	5.5	12.2	36.8	8.1	14.9	5.7	0.4	4.2	11.3	4.7	5.9	9.5	9.2	12.2	16.1	25.0	9.2	5.4	9.4	6.6	14.5	23.2	3.7	7.4	71.6	3.8	28.0	20.6	9.8	6.2	5.8	3.2	8.7	3.8	2.2	5.9	16.3	6.7	7.2	8.9	2.1	5.5	2.6	4.6	2.4	5.1	8.0	6.8	0.2	1.4	1.1	17.8	0.9	0.0	4.8	0.0	0.2	3.5	0.0	1.2	6.6	0.0	1.1	1.9	0.1	0.0	0.0	0.0	0.0	1.7	0.6	0.0	7.3	0.1	0.4	0.0	2.6	24.8	0.0	0.0	0.7	0.0	0.0	2.9	0.2	0.0	0.1	0.0	0.0	13.1	1.7	1.1	15.6	0.0	0.2	1.8	1.8	0.5	0.4	25.2	2.3	0.4	4.4	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.9	7.1	5.2	0.1	0.0	0.0	9.0	0.0	0.0	1.1	0.4	0.3	0.0	5.6	0.0	0.1	0.0	0.0	1.4	0.2	0.0	0.0	0.4	0.9	17.8	1.2	0.0	4.8	18.7	42.0	12.2	36.8	16.1	25.0	14.5	23.2	20.6	5.5
HCAR1	"FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR"	ENSG00000196917	"Hydroxycarboxylic acid receptor 1"	Q9BXC0	12	122726076-122730843	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 13.9;parathyroid gland: 41.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.3;MCF7: 6.1;RT4: 26.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"prognostic unfavourable (3.61e-5)"	"unprognostic (8.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.80e-4)"	"unprognostic (5.43e-4)"	"unprognostic (1.41e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-2)"	7.1	0.4	0.4	0.0	0.4	0.4	13.9	0.4	0.4	0.5	0.5	0.2	12.2	0.1	0.4	2.8	0.9	0.9	0.7	2.1	0.4	0.4	1.2	0.4	0.6	0.6	0.4	0.2	0.5	0.4	41.4	0.5	1.0	0.5	1.8	0.0	2.4	8.0	3.2	0.4	0.9	0.5	0.6	2.2	5.2	0.7	1.4	0.0	0.0	2.0	0.0	0.5	1.0	1.8	1.5	1.2	4.4	0.9	1.4	0.9	0.3	0.1	0.2	0.2	0.3	0.0	0.1	1.5	0.1	0.0	0.0	0.1	1.9	9.3	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.5	1.4	0.2	0.2	0.2	0.6	0.0	0.5	0.0	0.1	0.2	0.5	0.1	6.1	0.2	0.3	0.3	0.6	0.2	0.2	0.2	0.1	26.8	2.1	0.2	0.1	3.2	0.0	2.7	0.1	0.3	0.3	0.2	0.2	0.1	0.4	0.1	0.3	0.2	0.2	0.3	4.4	0.9	0.8	0.9	0.5	0.7	0.8	0.8	0.6	0.3	1.5	0.8	0.8	4.0	1.4	0.5	1.2	0.5	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.2	0.5	0.0
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90857698	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.8;testis: 14.3"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 8.1;hTCEpi: 7.3;hTERT-HME1: 24.5;LHCN-M2: 9.8;U-87 MG: 7.5;WM-115: 9.3"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"myeloid DC: 4.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA073617"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"CAB022708: , HPA073617: AB_2732228"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	1.0	0.5	2.4	1.1	2.5	0.5	0.7	0.3	4.3	0.6	0.8	1.7	1.2	0.8	0.4	0.3	1.0	0.4	1.3	0.6	9.9	5.1	0.3	0.6	0.5	0.7	1.7	1.8	0.4	1.4	30.8	0.2	0.5	3.1	1.0	1.2	0.4	0.6	0.3	1.7	0.9	2.2	3.6	1.5	1.3	1.5	14.3	1.0	0.0	0.3	0.1	0.6	3.5	2.1	0.0	4.6	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.2	0.5	0.7	0.0	0.9	0.0	0.0	0.1	3.3	0.9	8.1	2.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.4	5.8	7.3	2.4	24.5	0.0	0.0	0.0	9.8	0.0	0.0	0.1	0.9	1.2	0.7	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.0	3.8	0.0	0.2	0.2	4.5	0.0	0.0	6.8	0.0	0.0	0.0	7.5	0.0	9.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.1	0.1	2.4	2.5	0.3	4.3	9.9	5.1	1.7	1.8	3.1	1.0
ID2	"bHLHb26, GIG8"	ENSG00000115738	"Inhibitor of DNA binding 2"	Q02363	2	8678845-8684453	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 274.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 107.5;HEK 293: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 110.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027612			Approved	"Nucleoplasm,Nuclear bodies,Centrosome"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA027612: AB_10599729"	"unprognostic (2.53e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.24e-1)"	"prognostic favourable (9.95e-4)"	"unprognostic (4.39e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.92e-3)"	34.2	37.4	24.9	19.1	20.6	69.8	31.5	11.3	57.3	21.9	34.0	22.9	13.2	20.7	18.6	11.6	12.1	28.1	33.5	46.1	20.0	14.6	31.2	117.5	25.4	22.4	19.0	35.3	59.7	15.0	274.1	17.2	14.8	20.0	27.2	26.4	13.3	24.5	72.7	8.8	16.6	20.4	19.2	15.8	21.3	16.2	7.1	14.2	19.0	46.8	15.1	10.2	31.8	38.0	0.3	25.0	110.4	26.0	90.9	42.4	18.0	0.2	19.9	8.2	10.1	13.2	2.1	31.4	22.7	2.7	10.2	4.3	39.8	1.0	0.5	27.0	38.8	17.1	5.3	0.1	3.0	107.5	69.6	14.3	12.2	48.6	3.9	10.6	40.3	3.6	0.4	4.6	0.2	0.2	0.8	17.0	15.7	6.7	1.1	1.2	14.9	15.7	1.4	5.7	10.7	10.2	8.9	15.5	22.0	1.2	17.3	1.7	2.8	6.3	4.1	12.6	2.2	18.6	1.3	1.3	1.0	12.4	15.9	32.8	6.8	9.0	8.2	110.4	42.4	24.2	25.3	0.3	13.1	29.5	25.0	0.2	16.4	31.4	11.2	90.9	26.0	1.1	1.0	18.0	24.9	20.6	11.3	57.3	20.0	14.6	19.0	35.3	20.0	14.2
IGDCC3	"HsT18880, PUNC"	ENSG00000174498	"Immunoglobulin superfamily DCC subclass member 3"	Q8IVU1	15	65327127-65378040	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.8;parathyroid gland: 16.6;placenta: 12.2"	"Group enriched"	"Detected in some"	5	"AF22: 42.5;CACO-2: 10.7;Hep G2: 33.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015713			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA015713: "	"unprognostic (7.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.24e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.67e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.77e-5)"	"unprognostic (4.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-2)"	0.2	0.6	3.5	0.4	2.1	0.2	1.7	10.8	4.6	1.0	0.5	3.3	0.0	0.3	1.6	0.4	0.2	1.4	0.4	0.4	3.2	2.6	0.6	0.2	0.3	0.2	2.5	1.7	1.7	0.3	16.6	2.9	12.2	2.6	0.5	0.3	0.6	0.2	0.5	0.5	0.4	0.3	0.6	2.2	0.3	0.4	4.7	2.7	3.7	1.7	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.7	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.1	10.8	4.6	3.2	2.6	2.5	1.7	2.6	2.7
IL1RAPL2	"IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1"	ENSG00000189108	"Interleukin 1 receptor accessory protein like 2"	Q9NP60	X	104566315-105767829	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 8.0;parathyroid gland: 8.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.7;hTERT-HME1: 10.8;NTERA-2: 2.0;RT4: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036128, HPA036129"	Uncertain									"HPA036128: AB_10669983, HPA036129: AB_2674957"	"unprognostic (1.62e-1)"	"unprognostic (1.50e-1)"		"unprognostic (1.66e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.48e-4)"	"unprognostic (9.32e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-5)"	"unprognostic (1.78e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.91e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.84e-2)"	0.2	4.2	1.5	0.0	5.0	0.0	1.2	1.1	8.0	0.4	0.6	0.0	0.8	0.4	0.1	0.2	0.2	0.4	1.9	0.5	0.4	0.8	0.4	2.8	0.1	0.0	1.1	2.2	0.9	0.2	8.9	0.1	1.1	2.2	0.4	0.1	0.0	0.8	1.1	0.1	0.3	0.2	0.4	0.3	0.1	0.4	1.9	0.5	0.0	0.2	0.0	0.1	2.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.8	0.0	0.0	0.0	0.4	0.4	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	3.7	0.7	0.2	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.0	1.1	8.0	0.4	0.8	1.1	2.2	2.2	0.5
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.2;thyroid gland: 71.2"	"Cell line enhanced"	"Detected in many"		"HL-60: 12.1;SK-BR-3: 26.2;T-47d: 16.5;U-698: 11.4"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034539			Approved	Nucleoli,Cytosol				Cytosol	Cytosol	"HPA034539: "	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favourable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favourable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	0.9	4.6	0.8	6.3	0.5	3.7	27.4	13.4	1.5	6.4	0.8	16.7	7.9	1.3	0.8	1.0	1.0	1.0	9.5	7.4	2.0	9.5	0.5	1.5	0.7	2.3	4.6	0.8	5.3	65.2	3.7	0.5	5.5	3.5	2.2	5.6	15.5	19.2	1.6	1.7	21.7	1.2	0.9	0.6	3.8	1.6	1.1	0.0	71.2	0.0	0.7	1.1	0.9	0.3	2.4	0.0	0.4	0.0	0.0	0.2	1.3	1.3	0.8	1.4	0.2	0.1	0.7	0.5	0.5	2.6	2.6	0.7	0.8	0.0	0.6	0.2	1.5	1.6	0.7	1.1	0.0	4.2	0.0	5.5	0.2	0.5	12.1	0.1	0.1	0.8	2.2	0.2	0.1	1.1	1.8	0.0	4.0	0.1	0.0	1.4	0.2	0.0	0.3	2.8	1.1	1.6	6.4	4.8	1.0	26.2	0.3	16.5	1.0	0.0	0.1	4.8	0.5	0.3	0.0	2.0	11.4	0.4	0.0	2.0	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.2	4.6	6.3	27.4	13.4	7.4	2.0	2.3	4.6	5.5	1.1
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493348-4847840	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 46.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.3;HeLa: 25.0;HMC-1: 16.5;U-87 MG: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 782.1"	"Low region specificity"	"Detected in all"			"HPA014765, HPA016487"	Approved		Approved	Vesicles		37000	37000	Vesicles	Vesicles	"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (2.40e-1)"	4.8	8.2	6.1	7.4	18.6	3.2	11.9	39.5	30.2	10.2	7.4	1.7	21.5	2.4	18.4	13.2	7.8	10.1	11.8	5.3	8.7	5.1	8.7	2.5	6.4	7.1	4.8	10.4	14.2	2.7	46.6	7.3	4.6	3.8	15.0	3.7	12.5	9.6	27.4	3.2	3.2	5.0	17.4	3.7	6.0	5.5	3.0	4.3	7.0	19.3	0.6	8.6	14.1	10.6	8.9	3.6	5.4	1.6	1.2	2.2	1.2	0.0	1.2	0.2	0.6	9.8	0.4	3.2	0.2	0.2	0.3	0.3	0.3	0.3	4.3	0.4	0.4	0.0	0.9	1.1	0.5	34.3	1.3	12.4	25.0	1.6	13.5	5.2	16.5	2.6	0.7	1.7	0.5	1.4	1.3	5.0	1.3	0.5	2.3	1.8	0.9	3.8	1.4	0.2	0.3	1.1	1.1	0.1	8.3	2.2	1.4	2.3	0.9	7.5	1.7	0.8	1.4	1.1	1.0	7.6	3.7	2.9	20.4	5.6	1.7	5.4	1.6	1.9	1.5	1.0	1.9	6.6	1.7	1.5	2.1	8.9	2.2	1.9	0.8	1.2	0.7	3.6	1.3	1.2	6.1	18.6	39.5	30.2	8.7	5.1	4.8	10.4	3.8	4.3
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236979-62319414	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 26.0;CACO-2: 3.7;Hep G2: 10.9;SCLC-21H: 5.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol				Cytosol	Cytosol	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.6	0.7	0.9	1.0	3.1	0.1	3.1	0.5	2.2	0.6	1.2	8.9	1.0	0.4	0.3	1.0	0.4	0.7	0.6	0.6	1.9	2.7	1.7	3.6	2.9	0.1	11.1	0.1	0.4	18.4	20.4	0.4	14.4	23.2	1.8	1.2	2.6	10.4	0.8	0.5	0.8	0.6	0.2	13.4	0.8	2.4	1.0	4.9	0.1	0.7	0.8	0.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	26.0	0.1	0.0	0.1	0.0	3.7	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	10.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.8	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.1	0.5	2.2	1.9	2.7	11.1	0.1	23.2	4.9
KATNAL2	"DKFZP667C165, MGC33211"	ENSG00000167216	"Katanin catalytic subunit A1 like 2"	Q8IYT4	18	46917492-47102243	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 30.3;testis: 33.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.8;Daudi: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040712, HPA042029"	Approved		Approved	"Nucleoplasm,Intermediate filaments"				"Nucleoplasm, Intermediate filaments"	"Nucleoplasm, Intermediate filaments"	"HPA040712: AB_2677092, HPA042029: AB_2677807"	"unprognostic (3.40e-1)"	"unprognostic (7.75e-2)"	"unprognostic (9.00e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.52e-6)"	"unprognostic (1.28e-1)"	"prognostic favourable (1.24e-7)"	"unprognostic (1.64e-1)"	"unprognostic (7.14e-4)"	"unprognostic (1.06e-3)"	"unprognostic (1.61e-1)"	5.5	2.9	8.2	4.1	9.7	2.8	7.1	4.0	7.5	2.5	2.4	11.3	2.5	1.8	2.8	7.1	2.7	8.6	5.1	4.3	8.1	7.6	9.5	5.2	4.6	3.4	9.6	6.2	3.1	3.3	30.3	7.0	2.2	9.0	3.4	3.1	6.4	3.4	3.7	6.0	8.0	1.5	2.3	8.7	3.3	2.0	33.2	6.3	2.4	15.5	1.1	3.0	2.3	2.5	3.1	0.6	2.7	1.3	0.8	1.5	0.3	1.9	4.3	2.3	14.8	4.8	5.9	1.1	1.8	1.6	1.5	1.9	0.2	5.0	19.6	1.5	2.8	0.6	4.7	0.5	1.1	2.0	2.5	0.8	1.3	0.3	2.0	1.2	1.9	12.1	1.8	2.5	0.6	0.5	0.7	1.5	8.4	1.9	1.1	2.6	5.3	2.6	5.4	1.1	0.0	4.7	0.4	5.4	5.9	1.9	0.4	0.6	11.2	10.9	1.0	5.0	0.5	1.9	1.2	1.3	1.0	13.2	2.7	12.4	9.5	1.7	0.7	0.5	1.1	1.3	0.9	2.2	0.9	0.5	0.3	3.1	1.5	1.4	2.7	0.8	0.9	0.6	0.2	0.3	8.2	9.7	4.0	7.5	8.1	7.6	9.6	6.2	9.0	6.3
KCNC3	"Kv3.3, SCA13"	ENSG00000131398	"Potassium voltage-gated channel subfamily C member 3"	Q14003	19	50311937-50333515	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 32.1;parathyroid gland: 31.1;thyroid gland: 23.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.7;CAPAN-2: 7.6;HDLM-2: 7.9;HMC-1: 20.9;K-562: 7.7;SK-BR-3: 14.2;T-47d: 13.5;U-2 OS: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018041	Approved									"HPA018041: AB_1855579"	"unprognostic (8.05e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.01e-4)"	"unprognostic (4.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.10e-5)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.19e-1)"	1.4	2.2	7.2	5.4	9.4	1.4	2.3	32.1	31.2	3.1	1.1	3.4	3.0	1.8	4.5	5.8	1.1	12.8	1.4	1.7	6.9	4.2	10.6	2.5	4.5	4.7	4.0	6.6	0.6	3.7	31.1	9.7	2.4	15.6	2.4	1.4	3.0	2.3	15.1	1.2	2.1	1.8	1.7	3.8	6.5	2.1	2.4	2.9	1.1	23.9	0.0	3.4	1.8	1.0	0.4	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	4.1	0.0	0.0	0.0	0.0	8.7	7.6	0.7	1.0	0.0	1.1	0.2	0.0	0.0	7.9	1.8	0.0	0.0	1.7	0.0	0.0	20.9	0.1	0.0	0.0	0.0	0.1	7.7	0.0	0.0	2.7	0.1	0.0	1.1	3.3	0.0	0.1	0.0	0.5	0.2	0.0	1.4	1.6	14.2	0.0	13.5	2.1	0.1	0.0	9.3	0.0	0.0	0.0	0.1	0.4	0.3	1.7	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	7.2	9.4	32.1	31.2	6.9	4.2	4.0	6.6	15.6	2.9
KCNIP3	"CSEN, DREAM, KCHIP3"	ENSG00000115041	"Potassium voltage-gated channel interacting protein 3"	Q9Y2W7	2	95297304-95386083	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.8;parathyroid gland: 32.5"	"Cell line enhanced"	"Detected in many"		"A-431: 9.1;BJ hTERT+: 12.4;RPTEC TERT1: 24.4;U-138 MG: 11.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066717, HPA069797"	Enhanced		Approved	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA066717: , HPA069797: AB_2686199"	"unprognostic (1.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.33e-3)"	"prognostic unfavourable (1.58e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.44e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-1)"	4.2	1.8	19.8	1.5	20.1	0.7	2.8	3.7	39.8	6.0	4.6	12.9	0.6	2.1	5.8	4.9	3.5	5.3	2.4	3.4	16.7	7.8	4.6	1.2	1.5	1.1	9.1	19.5	8.8	2.5	32.5	5.6	6.5	8.2	5.7	1.8	1.4	6.9	18.6	2.2	3.9	1.9	6.4	6.3	2.2	2.9	9.2	15.9	5.4	19.5	0.0	1.3	4.5	5.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.1	0.0	0.6	4.2	3.7	3.0	0.0	4.3	12.4	7.0	6.5	0.0	0.0	0.0	0.4	5.6	0.1	2.7	0.7	3.0	0.0	1.0	0.0	1.1	0.0	1.5	0.0	0.0	2.1	2.5	1.5	7.0	0.0	0.0	0.0	0.6	5.3	0.0	0.0	0.1	2.5	0.0	0.0	0.0	24.4	0.0	0.5	0.1	0.2	0.2	4.7	0.2	0.0	0.2	11.4	2.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	20.1	3.7	39.8	16.7	7.8	9.1	19.5	8.2	15.9
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium voltage-gated channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4"	"Cell line enriched"	"Detected in some"	23	"RPTEC TERT1: 78.9"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favourable (6.58e-4)"	"unprognostic (3.88e-1)"	0.4	0.3	4.1	0.3	4.4	0.4	1.5	22.6	6.1	0.3	0.4	1.7	12.6	0.4	0.4	6.4	0.3	2.0	6.5	0.4	6.0	7.2	96.5	0.9	0.5	0.4	8.3	3.4	0.4	15.8	59.4	0.8	0.5	25.5	1.0	0.3	0.0	4.1	14.3	0.4	0.5	1.2	0.2	7.5	1.1	7.4	0.8	5.3	0.0	60.4	0.0	0.2	0.3	0.3	1.1	0.5	5.1	0.2	0.9	1.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	78.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.6	0.9	0.1	1.2	1.0	1.0	0.5	0.1	1.1	0.7	0.6	5.1	0.9	0.1	0.5	1.1	0.3	4.1	4.4	22.6	6.1	6.0	7.2	8.3	3.4	25.5	5.3
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium voltage-gated channel subfamily J member 2"	P63252	17	70168673-70180048	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;parathyroid gland: 34.8"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 5.1;REH: 6.0;RH-30: 24.2;U-138 MG: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 20.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029109	Approved									"HPA029109: AB_10602913"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.49e-3)"	3.0	1.5	6.2	6.3	17.9	2.5	6.6	1.3	12.8	1.8	5.0	23.7	5.1	1.6	1.5	1.2	4.7	8.4	2.2	11.4	6.4	4.4	1.7	1.9	3.9	4.4	22.4	8.5	1.4	1.0	34.8	1.6	9.0	11.7	2.6	4.3	3.1	2.7	2.9	10.3	6.0	2.1	1.6	14.9	10.4	2.0	0.9	18.2	0.5	1.9	6.0	2.2	2.6	3.3	0.1	0.7	20.8	4.7	0.0	0.0	0.4	0.0	0.7	1.5	0.0	1.6	0.4	0.0	0.5	3.7	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.5	0.0	4.6	0.0	0.0	1.7	0.1	2.3	0.2	5.1	0.0	0.0	1.5	0.0	0.5	0.0	0.1	0.1	6.0	24.2	0.0	0.6	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.4	0.1	8.9	0.1	0.0	1.9	0.0	0.0	0.1	1.9	0.0	1.2	1.8	2.5	3.6	0.0	4.7	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	20.8	0.0	4.6	0.1	0.0	0.4	6.2	17.9	1.3	12.8	6.4	4.4	22.4	8.5	11.7	18.2
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium voltage-gated channel subfamily J member 3"	P48549	2	154698299-154858352	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;parathyroid gland: 22.1"	"Cell line enhanced"	"Detected in some"		"BJ: 5.3;SH-SY5Y: 3.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Region enhanced"	"Detected in many"		"cerebellum: 33.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA024231	Uncertain									"HPA024231: AB_1855558"	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.3	1.0	4.5	0.0	3.4	0.0	0.2	33.8	13.6	1.3	1.5	1.4	0.3	7.9	0.2	0.9	0.1	0.4	0.9	10.8	8.4	4.0	8.0	2.3	0.2	0.4	1.8	4.9	0.2	1.5	22.1	9.0	0.0	3.0	5.1	0.6	1.0	0.1	9.2	3.5	0.2	6.7	0.1	1.5	0.4	0.5	0.2	0.9	0.0	0.2	0.0	0.0	0.5	0.6	1.2	0.9	3.3	1.1	1.8	1.0	0.4	0.2	0.3	0.0	0.1	0.2	0.1	0.4	5.3	0.2	0.0	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.4	0.4	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.8	0.0	0.7	0.5	0.5	0.1	0.0	0.4	0.2	0.3	1.7	3.3	0.1	0.5	0.2	0.4	0.1	0.0	0.3	0.4	0.4	0.3	0.3	0.2	0.1	1.2	0.2	0.5	3.3	0.7	0.9	0.7	0.8	0.9	1.0	0.9	0.6	0.6	1.2	1.0	0.9	1.9	1.8	1.1	0.9	0.7	0.4	4.5	3.4	33.8	12.0	8.4	4.0	1.8	4.9	3.0	0.9
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061765-90185857	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.3;parathyroid gland: 14.3;testis: 13.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.3;RT4: 5.1;SCLC-21H: 2.2;SK-BR-3: 2.2;U-2 OS: 2.5;U-266/84: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;monocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"				"Nuclear speckles, Cell Junctions"	"Nuclear speckles, Cell Junctions"	"HPA003514: AB_2666978"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.8	1.1	2.9	2.2	3.5	0.1	0.4	0.2	4.2	0.4	0.6	4.0	0.0	0.6	0.3	1.5	0.3	0.4	0.5	2.7	2.9	2.4	4.8	0.7	0.7	1.6	6.3	1.4	0.4	2.7	14.3	0.6	1.2	3.6	0.4	0.7	0.1	1.1	0.7	0.1	0.1	0.7	0.4	8.3	1.1	0.5	13.2	5.4	0.7	2.7	0.0	0.6	0.8	0.1	0.0	3.8	0.0	1.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.9	1.2	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.5	5.1	2.2	0.7	0.0	2.2	1.4	0.0	1.9	0.0	0.0	2.5	0.0	0.8	0.7	2.2	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	2.9	3.5	0.2	4.2	2.9	2.4	6.3	1.4	3.6	5.4
KLHDC7B	MGC16635	ENSG00000130487	"Kelch domain containing 7B"	Q96G42	22	50548033-50551022	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 8.4;parathyroid gland: 12.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 46.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 42.3;urothelial cancer: 40.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA000518, HPA076540"	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA000518: AB_1079213, HPA076540: "	"prognostic favourable (1.30e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	0.4	0.4	0.3	3.9	1.2	1.2	0.7	0.3	1.5	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7	0.2	0.3	0.3	0.3	0.1	8.4	1.1	1.1	4.0	0.3	0.3	0.8	0.3	12.5	2.2	0.3	0.9	0.7	0.0	0.8	3.0	0.3	0.3	0.3	2.0	0.3	0.3	5.4	0.5	0.3	0.3	6.5	2.9	0.3	1.7	3.0	0.3	3.8	2.0	2.4	4.0	1.4	5.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	46.4	0.0	0.5	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.4	2.2	0.2	4.5	4.0	3.3	3.8	4.7	5.7	2.0	3.1	5.2	4.3	0.4	1.4	2.8	0.7	4.1	2.5	0.3	1.2	0.3	1.5	0.3	0.1	0.3	0.3	0.9	0.3
KRTAP13-4	KAP13.4	ENSG00000186971	"Keratin associated protein 13-4"	Q3LI77	21	30430230-30431026	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.3;adrenal gland: 1.5;parathyroid gland: 1.3"	"Cell line enriched"	"Detected in single"	31	"NTERA-2: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																	200000	200000																					2.3	1.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0		0.0	0.0	1.3	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LCA5	C6orf152	ENSG00000135338	"LCA5, lebercilin"	Q86VQ0	6	79484991-79537458	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 42.4"	"Cell line enhanced"	"Detected in many"		"HEL: 15.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029053, HPA029055"	Supported									"HPA029053: AB_10602020, HPA029055: AB_2672889"	"unprognostic (8.96e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (4.69e-4)"	"unprognostic (7.09e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.21e-2)"	5.2	3.4	8.8	2.9	9.9	4.7	7.4	16.4	9.7	7.6	4.3	5.7	9.1	2.2	8.2	6.0	4.9	13.9	4.9	3.9	9.1	7.8	4.8	2.4	6.2	2.6	7.4	7.7	11.0	4.3	42.4	11.4	5.1	17.2	7.5	3.0	4.4	7.6	9.3	2.7	2.0	2.5	6.6	13.6	2.9	2.9	9.5	8.0	0.1	13.4	2.1	2.2	7.6	8.8	0.3	0.1	0.0	0.6	0.0	1.0	0.2	1.8	1.4	4.3	2.4	5.3	6.0	1.9	3.1	3.8	2.0	4.0	10.4	2.0	0.5	4.3	2.5	2.0	3.2	1.9	3.6	0.0	2.4	15.3	2.1	1.4	5.6	0.3	1.3	5.6	2.2	3.4	4.4	5.9	2.3	0.9	3.2	0.0	0.0	0.0	1.2	1.6	0.0	7.4	0.7	4.3	0.6	3.2	3.8	2.9	0.5	2.0	0.3	0.9	4.1	2.1	2.5	0.6	2.7	4.0	1.4	0.0	1.0	0.0	1.6	0.0	0.2	0.0	0.5	0.6	0.0	0.0	0.2	0.0	0.1	0.3	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	8.8	9.9	16.4	9.7	9.1	7.8	7.4	7.7	17.2	8.0
LRFN5	"C14orf146, FIGLER8, SALM5"	ENSG00000165379	"Leucine rich repeat and fibronectin type III domain containing 5"	Q96NI6	14	41607570-41904549	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;parathyroid gland: 38.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 17.3;HSkMC: 3.5;RPTEC TERT1: 5.9;SCLC-21H: 9.1;U-138 MG: 11.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001177	Uncertain				"Intracellular and membrane"					"HPA001177: AB_1079274"	"unprognostic (5.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.61e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.02e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.92e-3)"	1.5	3.3	7.9	1.7	9.3	0.5	2.4	3.1	19.1	13.7	2.2	0.8	1.3	0.8	3.8	1.5	1.2	5.0	1.9	0.9	12.2	9.5	0.9	0.6	1.2	0.6	4.3	11.9	2.7	0.9	38.4	1.0	1.8	8.7	3.7	1.9	0.9	0.8	9.3	0.8	1.0	0.9	9.3	1.6	1.2	1.0	1.7	1.2	0.0	1.0	0.0	0.8	7.8	6.3	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.9	9.3	3.1	19.1	12.2	9.5	4.3	11.9	8.7	1.2
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362685	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 61.7;parathyroid gland: 61.4"	"Group enriched"	"Detected in some"	12	"AF22: 21.4;CACO-2: 35.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria				"Vesicles, Mitochondria"	"Vesicles, Mitochondria"	"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favourable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.7	0.4	2.7	0.4	12.9	0.5	7.4	0.7	5.7	0.6	0.4	18.5	0.0	0.4	0.5	4.8	0.4	0.4	0.6	0.5	6.2	3.4	61.7	0.6	1.8	0.4	20.7	1.9	0.4	0.4	61.4	0.4	10.5	8.5	0.5	0.4	7.9	1.1	0.5	0.5	0.5	0.4	0.4	17.2	0.4	0.5	0.6	17.0	0.0	18.2	0.0	0.4	0.4	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.7	12.9	0.7	5.7	6.2	3.4	20.7	1.9	8.5	17.0
LRRC3C		ENSG00000204913	"Leucine rich repeat containing 3C"	A6NJW4	17	39941474-39944747	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"parathyroid gland: 1.9;testis: 3.0"	"Group enriched"	"Detected in some"	6	"HDLM-2: 2.1;Karpas-707: 3.8;U-266/70: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071271	Uncertain									"HPA071271: AB_2686378"	"unprognostic (1.59e-1)"			"unprognostic (6.57e-2)"	"unprognostic (6.17e-2)"		"unprognostic (2.81e-1)"	"unprognostic (3.16e-4)"		"unprognostic (9.20e-2)"		"unprognostic (4.27e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.90e-2)"		0.2	0.0	0.3	0.3	0.2	0.1	0.2	0.0	0.2	0.6	0.1			0.0	0.4	0.3	0.0	0.8	0.0	0.6	0.2	0.0	0.2	0.5	0.2	0.0	0.1		0.3	0.1	1.9	0.0	0.0		0.4	0.0		0.3	0.2	0.1	0.4	0.1	0.1	0.2	0.0	0.2	3.0			0.7		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.0	0.0	0.4	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.6;parathyroid gland: 154.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 15.8;hTCEpi: 33.3;SCLC-21H: 9.1;SiHa: 8.2;U-138 MG: 9.0;U-2197: 13.1;U-87 MG: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 27.4;non-classical monocyte: 36.7"	"Lineage enriched"	"Detected in many"	14	"monocytes: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	38.3	7.9	3.2	13.0	4.0	17.0	19.5	1.0	9.7	10.6	6.9	3.0	1.2	3.3	5.6	8.9	16.8	7.0	9.2	12.4	3.6	2.3	10.9	14.0	21.9	28.9	4.7	3.4	7.0	6.1	154.1	2.3	9.4	5.0	7.6	3.3	5.6	10.4	2.7	11.0	41.6	7.6	5.5	7.7	87.6	4.7	7.5	3.8	6.9	18.2	20.5	11.4	8.2	10.9	0.0	2.5	0.7	36.7	0.0	0.0	2.5	0.0	0.0	0.0	1.4	0.8	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	1.0	0.2	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.1	0.5	0.0	0.1	15.8	33.3	0.1	1.1	0.2	0.0	0.0	0.0	0.5	0.1	3.8	1.4	0.0	0.0	0.0	0.0	0.3	0.2	9.1	0.7	8.2	0.8	2.0	0.8	0.1	0.2	9.0	0.1	13.1	0.0	0.0	0.0	0.0	8.7	0.3	0.0	0.1	7.3	0.0	0.0	27.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.7	0.0	36.7	0.0	0.0	2.5	3.2	4.0	1.0	9.7	3.6	2.3	4.7	3.4	5.0	3.8
MAGI2	"ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2"	ENSG00000187391	"Membrane associated guanylate kinase, WW and PDZ domain containing 2"	Q86UL8	7	78017057-79453574	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.7;parathyroid gland: 31.8"	"Cell line enriched"	"Detected in some"	4	"Karpas-707: 42.0"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013650	Approved									"HPA013650: AB_1853501"	"unprognostic (4.32e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"prognostic favourable (1.08e-4)"	"unprognostic (4.34e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	5.4	8.3	21.0	2.2	20.5	1.8	3.9	43.7	36.8	5.5	3.2	17.7	2.5	3.1	5.6	5.6	3.6	4.8	4.6	3.9	21.8	12.7	7.6	2.5	4.4	1.6	13.6	19.5	11.5	5.1	31.8	7.7	2.3	16.5	11.9	3.0	3.5	2.8	11.6	2.9	2.3	3.2	4.1	15.1	3.1	2.9	5.1	24.4	0.0	9.0	0.0	1.4	4.1	2.9	2.0	1.4	3.8	0.9	1.0	0.9	0.2	0.0	0.3	10.1	0.2	2.1	3.3	0.1	1.8	3.3	0.4	0.5	0.0	0.1	0.0	0.0	1.1	0.1	0.6	0.0	0.5	0.5	0.4	0.1	0.2	0.5	3.1	0.2	0.5	2.5	0.1	0.2	0.1	0.4	0.3	42.0	0.9	0.4	0.1	0.2	2.2	0.1	0.1	0.1	0.7	0.1	0.1	1.5	2.6	0.4	0.1	0.9	0.2	0.3	0.5	1.5	0.5	4.1	0.2	0.2	0.0	0.1	0.9	0.1	0.6	2.7	0.7	0.8	0.9	0.6	0.6	1.1	0.6	0.5	0.4	2.0	0.6	0.8	3.8	1.0	0.9	1.4	0.6	0.2	21.0	20.5	43.7	34.5	21.8	12.7	13.6	19.5	16.5	24.4
MAP9	"ASAP, FLJ21159"	ENSG00000164114	"Microtubule associated protein 9"	Q49MG5	4	155342658-155376970	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.3;parathyroid gland: 43.5"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 25.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"																		"unprognostic (8.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.54e-2)"	3.5	5.1	8.9	3.3	16.3	1.6	3.9	7.5	19.0	5.4	3.8	2.2	7.2	1.1	6.5	6.7	2.8	8.3	6.8	5.7	8.9	13.3	8.4	0.9	4.3	2.7	11.2	10.3	5.5	4.8	43.5	25.7	4.4	31.3	10.9	1.8	3.3	2.5	8.0	0.6	0.8	1.9	5.1	7.6	2.1	5.2	10.2	4.8	1.6	12.9	0.4	2.2	3.7	2.4	6.7	4.1	0.2	0.6	1.3	4.6	0.9	0.0	6.0	6.6	5.6	7.0	8.5	1.3	6.5	6.0	4.0	3.4	0.0	0.0	4.3	8.8	4.8	0.0	6.8	7.0	6.5	0.0	5.6	2.7	0.0	0.0	5.2	0.0	0.0	7.1	3.9	5.5	3.4	0.0	0.0	0.0	4.4	2.7	5.0	0.0	5.0	7.8	0.0	0.0	0.1	13.2	5.1	9.0	25.5	0.0	11.4	0.3	9.3	0.0	0.9	5.3	9.7	0.1	4.8	5.3	0.0	4.7	15.4	0.0	8.5	0.0	0.0	0.0	4.6	0.6	3.7	5.1	2.6	4.1	0.1	6.7	2.4	3.1	0.2	1.3	0.0	4.1	1.5	0.9	8.9	16.3	7.5	19.0	8.9	13.3	11.2	10.3	31.3	4.8
MAPK4	"Erk3-related, Erk4, PRKM4"	ENSG00000141639	"Mitogen-activated protein kinase 4"	P31152	18	50560078-50731824	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.0;HeLa: 4.4;NTERA-2: 3.0;SCLC-21H: 15.4;SH-SY5Y: 3.7"	"Group enriched"	"Detected in many"	5	"glioma: 15.2;melanoma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007461			Approved	"Nucleoplasm,Golgi apparatus,Midbody"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA007461: "	"unprognostic (4.12e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.96e-4)"	"unprognostic (5.99e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	1.9	26.4	16.9	1.1	33.4	0.9	1.8	15.9	23.9	1.4	2.6	9.5	3.8	1.6	1.8	4.5	3.5	1.5	3.0	16.9	13.0	14.3	4.5	7.0	3.5	0.9	17.1	9.1	4.2	2.5	43.5	8.3	3.7	20.5	5.3	1.8	4.1	1.8	12.4	1.7	1.0	1.9	5.2	11.8	1.1	1.3	3.5	12.4	1.7	7.8	0.0	0.9	2.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	1.5	1.4	4.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.1	15.4	3.7	0.0	1.1	2.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	33.4	15.9	14.5	13.0	14.3	17.1	9.1	20.5	12.4
MARC2	"FLJ20605, MOSC2"	ENSG00000117791	"Mitochondrial amidoxime reducing component 2"	Q969Z3	1	220748225-220784815	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.3;parathyroid gland: 63.3"	"Cell line enhanced"	"Detected in many"		"T-47d: 21.6;TIME: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 14.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015085, HPA017572"	Enhanced									"HPA015085: AB_1848780, HPA017572: AB_1848778"	"unprognostic (8.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.20e-2)"	"prognostic favourable (1.40e-10)"	"unprognostic (4.78e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.05e-2)"	"prognostic favourable (3.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.23e-2)"	8.1	8.2	5.5	4.6	5.9	0.1	9.5	2.7	5.6	4.4	19.4	3.7	5.0	16.7	4.8	6.6	6.7	3.8	10.3	10.2	5.0	3.7	38.2	73.3	12.5	2.2	4.0	5.7	9.2	12.7	63.3	4.3	3.5	8.0	6.4	5.9	6.9	24.3	3.9	8.8	2.0	36.4	8.1	1.9	4.5	9.1	7.4	2.7	0.4	19.6	6.2	2.9	5.5	9.0	2.2	0.0	14.1	0.1	0.0	0.0	0.1	5.5	4.6	2.5	3.2	6.2	2.9	1.9	4.0	7.0	4.9	4.9	3.1	7.0	0.0	2.8	3.8	0.7	0.0	5.5	4.6	0.0	9.5	0.0	9.0	6.4	5.8	2.6	0.0	4.9	8.6	1.8	0.0	13.2	3.5	0.0	3.0	1.3	0.0	9.1	4.0	4.7	0.0	7.8	0.1	17.1	6.0	1.4	3.7	6.3	0.0	8.6	21.6	3.4	20.0	0.0	3.0	6.4	7.0	1.2	0.0	0.0	1.0	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	5.9	2.7	5.6	5.0	3.7	4.0	5.7	8.0	2.7
MBOAT2	"FLJ14415, FLJ90298, OACT2"	ENSG00000143797	"Membrane bound O-acyltransferase domain containing 2"	Q6ZWT7	2	8852690-9003813	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014836	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA014836: AB_1854745"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (2.13e-9)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.97e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.66e-2)"	"prognostic unfavourable (5.32e-4)"	2.3	2.9	12.8	2.9	18.0	24.2	10.1	10.1	20.2	6.0	8.2	16.6	1.2	3.1	5.3	3.5	14.2	3.7	4.3	5.1	14.7	12.4	8.0	1.3	10.9	2.9	23.3	10.3	6.8	2.1	34.7	5.5	3.8	16.2	16.1	9.3	6.4	5.6	4.1	1.2	12.3	4.3	4.6	18.5	2.5	6.9	2.7	17.8	1.9	5.3	16.1	10.3	4.4	7.5	0.0	0.8	6.7	0.7	0.0	0.2	0.3	8.3	2.5	7.8	3.3	3.5	7.9	4.6	4.0	1.4	5.2	3.5	0.7	13.3	2.4	4.8	9.5	6.4	6.9	8.1	7.9	7.4	11.9	10.0	3.7	0.0	4.4	0.0	3.2	5.7	4.8	5.0	3.4	2.7	8.5	1.9	4.5	2.1	2.9	0.2	3.1	9.9	4.4	12.3	0.1	7.7	1.2	4.7	14.3	4.2	25.1	3.9	4.7	2.8	1.5	9.2	4.9	7.1	11.4	0.7	0.2	2.6	14.5	1.4	3.1	6.3	0.7	2.8	0.0	0.2	0.0	0.0	0.2	0.1	0.8	0.0	0.2	0.1	6.7	0.0	0.2	0.1	0.0	0.3	12.8	18.0	10.1	15.8	14.7	12.4	23.3	10.3	16.2	17.8
MFSD14B	"FLJ14753, HIATL1"	ENSG00000148110	"Major facilitator superfamily domain containing 14B"	Q5SR56	9	94374551-94461042	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 86.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017978			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA017978: "	"unprognostic (3.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.96e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.01e-2)"	15.1	18.9	13.3	14.3	14.7	9.0	20.2	11.6	12.8	14.9	14.2	19.7	15.5	9.9	18.6	16.1	28.1	14.4	12.5	13.4	13.3	12.4	14.7	9.0	25.7	21.5	14.6	7.8	15.9	21.5	86.0	9.2	24.2	28.3	14.5	15.4	21.6	15.9	14.2	7.3	21.8	16.0	12.8	19.1	19.3	13.0	9.2	13.2	24.0	16.7	14.2	23.9	14.1	18.8	4.6	7.8	10.4	11.4	3.6	7.1	3.6	25.9	16.8	13.1	10.3	28.9	20.7	20.9	25.3	22.0	22.6	22.2	8.4	31.2	31.3	15.1	21.8	57.6	15.6	16.2	22.0	22.3	8.4	10.8	16.1	12.6	20.5	33.9	20.0	19.0	24.4	23.9	18.4	19.3	20.3	18.7	30.0	19.7	24.8	19.5	19.2	13.5	12.5	30.2	10.1	24.0	20.1	12.6	16.7	21.6	25.5	26.8	11.6	20.1	20.6	23.7	16.7	36.3	23.4	20.7	25.6	8.6	21.1	16.6	21.1	0.6	7.9	5.9	5.6	11.4	5.1	4.6	5.1	5.6	7.8	2.9	5.1	7.1	10.4	3.6	7.7	7.7	5.1	3.6	13.3	14.7	11.6	12.8	13.3	12.4	14.6	7.8	28.3	13.2
MPP2	"DKFZp761D0712, DLG2"	ENSG00000108852	"Membrane palmitoylated protein 2"	Q14168	17	43875357-43909711	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.3;epididymis: 31.0;parathyroid gland: 31.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026486	Approved		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA026486: AB_1854085"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-5)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (4.37e-2)"	"unprognostic (2.86e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.89e-4)"	2.1	5.0	12.1	2.1	11.8	1.1	3.1	19.5	26.3	3.5	5.1	19.8	2.7	1.9	4.6	31.0	4.1	3.3	3.0	9.0	13.8	14.2	2.0	0.9	2.0	1.2	15.3	14.4	2.8	4.4	31.1	8.4	3.4	11.5	7.1	2.0	6.5	2.3	10.7	1.7	2.0	2.0	6.5	20.3	1.3	2.5	13.8	12.3	0.0	4.5	0.0	1.4	3.6	2.8	0.1	0.0	0.0	0.1	0.0	1.9	0.7	4.9	7.3	7.8	11.3	1.1	0.7	4.3	1.7	0.2	6.8	6.5	2.5	3.3	7.1	4.0	1.7	2.0	10.5	4.1	5.3	0.0	8.1	0.6	6.7	0.1	0.2	0.0	2.1	1.1	0.3	4.9	0.0	0.4	2.7	0.0	2.0	1.9	1.0	0.5	14.0	4.5	5.0	11.2	0.5	0.1	0.1	8.4	7.8	2.1	0.7	2.9	17.2	3.4	0.1	7.6	9.6	2.9	3.1	2.4	4.9	0.0	11.4	4.8	1.4	0.0	0.1	0.0	1.4	0.0	0.2	0.0	0.5	1.2	0.0	0.1	1.6	1.9	0.0	0.0	0.0	0.0	0.1	0.7	12.1	11.8	19.5	22.5	13.8	14.2	15.3	14.4	11.5	12.3
MTMR7		ENSG00000003987	"Myotubularin related protein 7"	Q9Y216	8	17298030-17413528	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8;parathyroid gland: 17.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.3;SCLC-21H: 14.0;SH-SY5Y: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA075682			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA075682: "	"unprognostic (1.01e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.66e-3)"	1.4	4.9	10.9	1.9	16.7	3.4	0.9	16.2	25.8	1.2	1.3	16.0	0.0	2.0	1.8	0.8	1.5	1.5	1.6	1.7	7.5	7.8	2.4	2.2	1.4	1.7	9.2	9.5	3.5	2.6	17.9	10.3	1.8	19.5	1.2	1.3	4.7	1.4	1.1	2.1	2.6	1.9	1.1	11.2	1.4	1.8	2.9	9.4	0.0	6.5	0.0	0.8	1.4	0.7	0.7	0.2	0.8	0.2	0.3	1.4	0.1	0.7	0.6	1.1	1.0	0.0	0.0	0.9	1.8	0.0	0.0	0.0	0.9	0.2	0.8	0.5	0.0	0.4	4.1	0.0	0.0	0.1	3.0	1.2	1.6	0.5	1.0	0.7	0.9	0.2	0.0	0.0	0.0	0.2	0.6	0.7	0.0	0.6	1.3	1.7	5.3	0.5	0.4	1.8	0.5	0.0	3.3	14.0	8.1	0.6	0.8	0.9	0.4	0.9	1.5	0.9	0.5	2.0	1.1	0.4	0.4	0.6	2.6	1.3	0.7	0.0	0.1	0.7	0.2	0.2	0.1	0.7	0.1	0.2	0.1	0.0	0.5	0.3	0.8	0.3	0.2	0.2	1.4	0.1	10.9	16.7	16.2	15.2	7.5	7.8	9.2	9.5	19.5	9.4
MYO3B		ENSG00000071909	"Myosin IIIB"	Q8WXR4	2	170178145-170655171	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.0;parathyroid gland: 12.6;retina: 21.6"	"Group enriched"	"Detected in some"	10	"HDLM-2: 11.0;HEL: 10.1;RT4: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdTCR: 1.4;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Region enriched"	"Detected in single"	5	"basal ganglia: 4.7"	"Not detected"	"Not detected"			HPA045483	Approved									"HPA045483: AB_2679344"	"unprognostic (1.65e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.61e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.25e-5)"	"unprognostic (2.34e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	0.2	0.2	0.3	0.0	0.3	0.0	0.2	0.2	0.3	0.6	0.2	0.0	4.6	0.0	0.3	20.0	0.3	0.5	0.0	0.3	0.3	0.5	8.5	0.2	0.3	0.5	0.3	0.3	0.4	2.2	12.6	1.0	0.0	0.3	0.3	0.0	21.6	1.4	1.1	0.2	0.5	0.2	0.5	0.2	0.3	0.2	4.2	0.0	0.0	2.2	0.0	0.8	4.4	0.3	0.1	0.3	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.3	0.3	0.0
MYO5A	"GS1, MYH12, MYO5, MYR12"	ENSG00000197535	"Myosin VA"	Q9Y4I1	15	52307283-52529050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5;parathyroid gland: 47.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 58.9;RPMI-8226: 39.9"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001356	Enhanced		Approved	"Focal adhesion sites,Centriolar satellite"				"Focal adhesion sites, Centriolar satellite"	"Focal adhesion sites, Centriolar satellite"	"HPA001356: AB_1079441"	"unprognostic (1.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.74e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (4.22e-4)"	8.4	7.1	16.6	9.5	27.5	15.7	5.5	27.4	34.5	6.2	4.4	7.8	0.4	3.3	4.2	3.2	5.0	3.6	7.3	4.6	15.9	15.4	4.6	2.7	7.3	11.2	15.6	17.6	5.4	4.3	47.6	10.5	5.2	29.3	4.5	5.2	9.9	4.0	3.4	4.1	10.4	3.9	7.7	10.1	7.3	4.1	4.6	7.1	3.1	6.8	2.7	10.3	7.3	4.2	2.3	5.2	6.3	4.4	0.7	4.5	1.9	5.4	9.6	5.1	6.1	5.2	6.4	5.5	9.9	9.0	5.3	4.2	0.9	2.2	5.2	2.6	11.8	4.5	11.7	10.2	6.6	29.4	2.7	4.8	2.5	1.1	2.7	2.5	4.7	4.2	6.4	7.8	15.5	30.8	0.1	58.9	10.2	9.6	2.2	0.3	2.3	7.7	4.1	8.2	39.9	4.4	3.9	3.8	2.2	9.2	7.6	18.0	4.0	2.8	14.7	10.7	4.6	5.0	9.6	6.1	13.5	6.3	11.7	7.3	15.4	0.9	4.4	5.4	2.9	3.6	4.5	2.3	2.9	1.9	5.2	1.6	0.5	1.0	6.3	0.7	2.6	3.1	4.1	1.9	16.6	27.5	27.4	34.5	15.9	15.4	15.6	17.6	29.3	7.1
NCR3LG1	"B7-H6, DKFZp686O24166"	ENSG00000188211	"Natural killer cell cytotoxicity receptor 3 ligand 1"	Q68D85	11	17351726-17377341	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.9;parathyroid gland: 15.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 28.8;K-562: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.5"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.5"									HPA024137	Uncertain					7300	7300			"HPA024137: AB_1859534"	"unprognostic (1.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.03e-5)"	"unprognostic (6.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.36e-1)"	"prognostic favourable (4.21e-12)"	"unprognostic (7.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.52e-3)"	"unprognostic (1.36e-1)"	2.4	1.4	1.6	2.2	9.4	3.1	1.4	14.9	14.1	1.7	6.2	1.1	0.0	8.1	2.1	1.1	2.0	3.5	2.4	2.4	1.9	2.9	5.0	1.3	2.7	1.1	1.5	5.3	3.2	2.2	15.4	7.9	0.9	4.3	1.5	9.6	3.6	2.0	1.4	1.2	2.0	10.1	2.1	1.2	1.3	2.4	4.2	0.4	0.4	4.9	1.0	1.4	1.6	2.1	0.0	0.3	0.0	0.6	0.0	2.5	0.1	2.1	0.7	4.9	0.7	1.7	4.7	0.3	1.5	2.9	2.1	5.1	3.9	0.8	12.2	0.2	1.7	2.2	8.0	2.0	1.7	2.1	13.3	11.1	5.1	3.9	7.2	28.8	0.5	3.8	1.0	3.0	7.3	2.3	16.3	0.0	0.7	0.2	2.7	2.5	0.2	1.2	0.9	2.6	0.1	1.7	0.7	5.3	2.0	1.7	0.4	1.5	1.2	6.4	3.3	0.4	0.7	1.2	0.8	1.3	2.4	14.1	2.2	9.7	1.0	0.0	0.6	0.0	0.6	0.3	2.5	0.0	0.1	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.1	1.6	9.4	14.9	14.1	1.9	2.9	1.5	5.3	4.3	0.4
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925485	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;parathyroid gland: 9.0"	"Group enriched"	"Detected in some"	9	"HAP1: 6.5;Karpas-707: 10.5;SiHa: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA000407: AB_2665984"	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.6	3.0	5.4	0.7	6.2	0.4	1.3	10.2	9.4	1.7	1.9	0.7	1.0	0.6	1.7	0.9	1.8	1.3	0.5	0.3	5.0	6.2	2.4	0.2	0.9	0.5	1.8	5.0	1.7	4.4	9.0	7.5	0.5	1.9	3.2	1.1	1.1	2.5	2.5	0.4	1.8	1.1	2.6	1.2	0.6	1.6	0.9	1.5	0.0	1.5	0.0	0.5	0.7	2.8	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.3	0.1	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	9.3	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.2	10.2	6.8	5.0	6.2	1.8	5.0	1.9	1.5
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.1;HEL: 10.6;Hep G2: 23.4;THP-1: 8.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.1;T-cells: 2.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favourable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.8	15.6	14.4	0.5	11.4	1.3	2.3	20.4	27.6	1.9	1.4	0.8	0.3	2.4	4.9	1.3	1.4	2.8	2.2	1.5	13.0	13.8	2.9	1.3	2.0	1.0	14.9	15.7	0.8	7.4	40.2	7.8	0.9	7.2	4.7	1.4	3.7	3.1	1.8	0.8	2.0	1.4	4.0	3.0	7.5	2.0	3.1	2.4	0.1	23.2	0.0	0.8	1.4	0.8	0.4	0.0	4.1	0.0	0.0	2.2	0.1	2.8	0.4	0.1	0.2	0.7	0.0	1.2	0.3	0.4	1.8	3.7	1.2	2.7	0.0	0.9	0.0	13.1	0.3	0.0	1.1	0.1	0.3	10.6	0.7	23.4	2.4	1.4	1.0	0.4	1.8	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	2.8	0.5	0.3	0.2	1.0	0.6	4.4	0.0	2.8	0.2	0.0	0.0	3.5	0.5	8.3	0.0	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.9	0.0	2.2	0.0	0.9	2.1	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	1.4	0.1	14.4	11.4	20.4	27.6	13.0	13.8	14.9	15.7	7.2	2.4
NUAK1	"ARK5, KIAA0537, NuaK1"	ENSG00000074590	"NUAK family kinase 1"	O60285	12	106063340-106140033	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.3;parathyroid gland: 18.6"	"Cell line enhanced"	"Detected in many"		"AF22: 23.0;EFO-21: 23.0;Karpas-707: 16.8;RH-30: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA057143: AB_2683349"	"unprognostic (4.20e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.71e-2)"	"prognostic unfavourable (9.83e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.91e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.47e-2)"	8.2	1.8	4.2	2.0	13.0	0.0	5.5	9.9	20.1	4.6	1.7	24.3	1.1	1.0	5.8	1.6	1.9	3.6	2.7	11.3	5.1	3.3	2.5	2.4	4.9	1.5	8.7	8.4	3.2	1.2	18.6	1.9	2.5	7.6	3.6	2.2	2.3	1.8	3.7	9.4	11.6	1.5	6.3	5.5	1.1	1.5	1.3	9.3	1.1	1.8	1.1	1.4	3.4	3.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.9	3.4	23.0	0.2	9.2	1.0	10.6	5.7	3.9	4.4	3.3	1.7	0.8	0.0	23.0	10.3	4.8	4.8	4.6	2.0	0.0	1.3	0.0	3.6	1.8	1.9	0.0	0.0	4.7	3.1	2.5	0.8	8.3	0.0	16.8	3.1	0.5	0.1	0.2	4.5	1.4	0.0	33.0	4.0	2.5	5.9	2.7	0.1	2.6	0.7	0.2	1.2	0.1	6.2	3.8	12.8	1.4	6.8	0.0	0.0	0.3	1.1	0.0	3.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.0	9.9	17.5	5.1	3.3	8.7	8.4	7.6	9.3
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383967-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 68.7"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 18.2;HSkMC: 8.1;MOLT-4: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"T-reg: 5.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	190000000	190000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavourable (2.03e-4)"	35.6	3.9	0.7	7.1	1.3	0.0	14.7	2.0	2.2	47.8	15.2	0.7	11.7	1.5	25.2	19.8	11.7	12.9	47.5	27.6	0.9	0.7	1.9	1.0	7.8	1.3	2.8	1.6	26.1	1.9	68.7	7.1	9.7	2.9	27.7	5.7	10.7	2.9	4.9	2.4	1.6	5.9	31.1	6.0	0.8	9.4	10.7	0.8	1.3	5.9	7.0	1.5	32.0	10.0	0.6	0.3	0.0	0.0	0.4	5.1	0.2	0.0	0.0	0.0	0.0	3.9	18.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.5	0.3	0.6	0.1	0.1	0.0	0.4	0.0	0.1	5.1	0.2	0.7	1.3	2.0	2.2	0.9	0.7	2.8	1.6	2.9	0.8
OR2A12	OR2A12P	ENSG00000221858	"Olfactory receptor family 2 subfamily A member 12"	Q8NGT7	7	144086278-144098953	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"parathyroid gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.1			0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0		0.5	0.3	1.0	0.0	0.1		0.1	0.2		0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.6			0.5		0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.5	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0										
PAQR4	FLJ30002	ENSG00000162073	"Progestin and adipoQ receptor family member 4"	Q8N4S7	16	2969245-2973489	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.4;parathyroid gland: 32.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"non-classical monocyte: 6.7"	"Lineage enriched"	"Detected in single"	8	"monocytes: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068394			Approved	Vesicles				Vesicles	Vesicles	"HPA068394: AB_2685980"	"unprognostic (1.93e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.30e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavourable (6.86e-4)"	"unprognostic (2.62e-2)"	"unprognostic (7.59e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.59e-2)"	"prognostic unfavourable (3.01e-6)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.06e-3)"	3.1	3.2	14.1	5.2	19.2	10.3	2.3	8.0	26.3	2.4	4.8	49.6	1.3	4.9	1.8	1.0	4.2	3.0	5.5	4.2	24.1	11.7	1.7	1.6	3.9	6.3	30.6	11.1	0.4	6.6	32.8	0.9	2.2	19.1	9.6	4.5	16.8	17.0	1.3	12.3	12.3	4.9	2.8	54.4	3.2	7.4	1.6	20.3	3.6	1.5	3.5	7.8	2.1	1.7	0.5	0.9	0.1	6.7	0.0	0.4	0.5	12.7	10.9	12.3	17.8	2.0	3.7	4.1	4.8	5.9	9.0	8.6	6.5	13.7	12.8	6.6	5.6	18.0	12.8	7.6	3.7	13.5	5.6	3.9	21.3	8.9	0.2	8.3	14.2	0.9	4.0	4.9	1.2	5.9	7.6	34.7	7.7	25.6	11.9	8.9	10.4	7.5	23.9	16.2	41.2	6.1	4.4	28.4	13.2	18.0	17.5	13.1	18.7	12.9	3.6	15.8	9.7	7.3	6.8	15.2	10.5	17.0	7.0	11.3	17.3	0.0	1.0	0.1	0.4	0.5	0.0	0.5	0.2	0.1	0.9	0.1	0.0	0.3	0.1	0.0	6.7	0.5	0.1	0.5	14.1	19.2	8.0	21.2	24.1	11.7	30.6	11.1	19.1	20.3
PBX3		ENSG00000167081	"PBX homeobox 3"	P40426	9	125747345-125967377	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 86.7"	"Cell line enhanced"	"Detected in many"		"THP-1: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 16.1"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 16.1"	"Region enhanced"	"Detected in all"		"olfactory region: 205.0"	"Region enriched"	"Detected in many"	4	"olfactory region: 287.4"	HPA003881	Supported		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA003881: AB_1855020"	"unprognostic (1.97e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.03e-2)"	"unprognostic (6.29e-2)"	8.0	25.0	4.4	16.2	11.6	3.0	10.4	6.6	3.4	16.6	18.9	3.7	6.5	3.1	10.7	10.9	9.1	5.9	22.8	16.1	2.9	6.3	3.4	7.6	9.4	6.1	9.5	3.4	35.0	12.9	86.7	6.8	3.1	13.0	18.8	6.1	7.1	10.5	12.3	3.6	8.2	6.0	21.2	17.6	5.5	10.0	5.1	6.2	6.8	14.7	5.5	3.8	13.3	12.0	1.8	16.1	2.9	1.8	3.8	2.1	1.0	4.6	4.5	20.5	19.0	5.7	9.3	3.7	12.3	7.0	8.6	6.2	5.8	9.3	4.6	1.5	9.8	3.6	11.5	5.0	17.0	4.9	8.2	3.9	3.5	2.3	7.3	4.4	7.2	4.8	5.6	6.7	4.3	9.6	0.2	4.4	17.7	2.5	4.0	2.0	15.1	3.1	7.6	30.6	0.5	6.5	2.8	11.0	19.2	8.5	1.6	3.7	7.0	36.0	11.5	17.4	4.8	10.2	22.9	3.2	4.9	4.9	8.3	6.2	8.9	2.9	1.8	2.3	0.9	1.6	1.2	1.4	1.2	1.0	2.1	1.8	2.1	1.0	1.7	3.8	1.3	16.1	1.8	1.0	4.4	11.6	6.6	3.4	2.9	6.3	9.5	3.4	13.0	6.2
PCDHA11	"CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11"	ENSG00000249158	"Protocadherin alpha 11"	Q9Y5I1	5	140868183-141012344	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.3;parathyroid gland: 4.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.5;EFO-21: 8.6;MCF7: 4.4;T-47d: 5.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077160			Approved	"Vesicles,Cell Junctions,Cytoplasmic bodies"				"Vesicles, Cell Junctions"	"Vesicles, Cell Junctions"	"HPA077160: AB_2686827"	"unprognostic (1.54e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.98e-3)"		"unprognostic (1.36e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.13e-4)"	"unprognostic (9.91e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.26e-2)"	0.1	0.6	1.0	0.1	1.6	0.0	0.2	7.0	9.3	1.3	0.0			0.0	0.6	0.1	0.0	0.2	1.0	0.0	0.8	1.0	1.2	0.0	0.8	0.0	0.3		0.0	3.3	4.7	1.6	0.0		0.1	0.0		1.3	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	1.6			1.5		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.9	16.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	8.6	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.1	0.0	4.4	0.0	0.0	3.6	3.1	0.0	0.0	0.0	0.4	1.9	0.8	2.2	0.0	1.8	0.4	5.8	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PCDHA13	"CNR5, CNRN5, CNRS5, CRNR5, PCDH-ALPHA13"	ENSG00000239389	"Protocadherin alpha 13"	Q9Y5I0	5	140882208-141012344	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 5.6;parathyroid gland: 12.2"	"Group enriched"	"Detected in some"	5	"AN3-CA: 2.7;PC-3: 8.8;WM-115: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.07e-1)"			"unprognostic (5.25e-2)"	"unprognostic (5.58e-2)"		"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.64e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.36e-1)"		1.0	0.9	2.1	0.6	2.3	0.2	0.6	5.6	5.3	1.0	0.2	2.3	0.0	0.3	0.8	1.2	0.2	0.5	2.4	0.3	1.7	1.6	0.7	1.2	0.8	0.6	1.1	3.8	0.2	1.9	12.2	1.2	0.2	1.0	0.6	0.2	2.7	1.0	0.2	0.3	0.2	0.2	0.5	1.1	0.3	0.3	1.6	1.0	0.0	1.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	8.8	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.3	5.6	5.3	1.7	1.6	1.1	3.8	1.0	1.0
PCDHB6	PCDH-BETA6	ENSG00000113211	"Protocadherin beta 6"	Q9Y5E3	5	141150022-141153287	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 13.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 16.5;SH-SY5Y: 7.0;T-47d: 5.3;U-2197: 7.5;WM-115: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029566	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA029566: AB_10601385"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.05e-2)"	"unprognostic (7.65e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.64e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (8.60e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.08e-3)"	"unprognostic (6.52e-2)"	2.5	2.4	3.9	1.0	5.1	0.4	2.5	4.2	8.4	2.3	1.5	2.6	0.0	0.6	4.5	3.7	0.7	2.1	1.4	1.6	3.5	1.9	1.6	1.4	1.7	0.7	2.6	3.6	3.7	1.5	13.4	6.4	1.5	2.9	1.5	0.9	0.7	2.5	1.5	1.4	2.4	1.0	3.0	3.3	1.5	0.9	5.4	3.1	0.0	1.1	1.0	0.7	1.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	16.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	7.0	0.0	0.1	3.5	5.3	2.1	0.0	0.6	1.3	7.5	0.0	0.0	0.0	0.0	3.8	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.1	4.2	8.4	3.5	1.9	2.6	3.6	2.9	3.1
PCDHGB5	PCDH-GAMMA-B5	ENSG00000276547	"Protocadherin gamma subfamily B, 5"	Q9Y5G0	5	141397987-141512979	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 11.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.2;ASC TERT1: 24.3;BJ hTERT+ SV40 Large T+: 13.9;BJ hTERT+ SV40 Large T+ RasG12V: 15.6"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"gdTCR: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (2.71e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.69e-4)"	"unprognostic (9.63e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-4)"	2.1	1.9	0.8	0.3	3.2	0.0	3.6	2.0	4.3	1.4	0.4	2.5	1.9	0.0	2.1	2.5	1.1	2.1	0.8	1.9	0.0		1.6	3.1	6.8	2.6	0.9	1.5	4.9	2.8	11.2	2.1	9.5	1.5	2.2	0.2	3.7	3.2	3.2	1.4	2.6	0.0	1.9	3.0	0.5	0.7	1.0	2.2	0.8	3.5	0.0	0.7	1.9	1.4	0.5	0.2	0.0	0.3	0.0	1.9	0.1	0.0	1.1	0.1	0.0	32.2	24.3	0.6	8.5	0.0	13.9	15.6	1.3	4.6	4.8	11.1	9.4	6.4	0.0	3.5	7.8	0.0	1.4	0.0	0.0	0.0	3.3	0.0	3.1	8.5	0.7	0.8	4.5	4.2	0.1	0.0	0.4	3.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.0	9.0	0.0	4.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.3	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1										
PDE11A		ENSG00000284741	"Phosphodiesterase 11A"		2	177628069-178108339	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"breast: 1.2;parathyroid gland: 1.5;testis: 3.6;thyroid gland: 1.6"	"Cell line enhanced"	"Detected in single"		"fHDF/TERT166: 2.9"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA034560	Uncertain									"HPA034560: AB_10602140"																		0.0	0.0		0.0		0.0	1.2		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	1.5		0.0		0.9	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.6			1.6		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828953-186988981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 52.6;parathyroid gland: 63.5;seminal vesicle: 56.1"	"Cell line enhanced"	"Detected in many"		"A549: 16.7;HeLa: 24.3;RPMI-8226: 30.2;U-2197: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 7.1;eosinophil: 7.7;intermediate monocyte: 8.4;myeloid DC: 7.8;non-classical monocyte: 3.9;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 7.7;monocytes: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Cytosol		78000	78000	Cytosol	Cytosol	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: "	"prognostic favourable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favourable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	6.0	8.6	3.4	3.5	5.3	2.2	3.8	1.5	4.7	8.5	10.9	2.9	52.6	5.4	7.7	7.4	7.0	12.3	4.2	6.6	3.3	2.5	6.7	1.1	4.9	5.2	6.5	1.4	5.1	3.8	63.5	2.7	2.9	5.6	10.9	4.2	2.9	5.8	56.1	0.6	6.1	10.3	14.6	7.5	4.2	5.1	2.7	5.3	0.4	2.7	5.9	2.3	19.4	9.4	0.0	7.8	7.7	8.4	1.1	0.2	1.5	0.0	16.7	0.0	0.0	10.5	4.2	0.0	0.6	6.4	0.8	1.4	0.1	6.6	0.0	0.0	0.0	1.2	10.4	3.1	0.3	5.1	0.2	3.1	24.3	0.0	6.5	4.5	1.6	2.3	2.2	8.4	1.7	7.0	6.8	2.5	0.0	0.0	0.0	0.0	0.9	2.2	0.0	0.0	30.2	0.0	2.3	0.1	0.0	2.5	0.8	2.9	0.3	6.2	1.4	6.2	0.8	28.5	1.3	1.0	0.0	0.0	2.3	13.6	8.8	0.1	7.1	7.7	0.0	8.4	0.2	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.6	1.1	3.9	3.2	0.0	1.5	3.4	5.3	1.5	4.7	3.3	2.5	6.5	1.4	5.6	5.3
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42175233-42207724	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 132.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.8;HMC-1: 55.1;LHCN-M2: 55.6;U-2197: 58.0;WM-115: 115.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.1;T-reg: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	12000	12000	"Actin filaments"	"Actin filaments"	"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favourable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	19.3	14.9	5.2	12.9	6.8	0.4	13.3	2.2	6.2	24.5	17.1	9.1	19.0	11.2	35.5	28.1	18.1	19.1	18.5	7.3	6.0	5.9	67.6	2.8	15.9	1.9	8.2	3.6	18.4	5.8	132.2	5.1	15.5	9.4	27.4	12.2	39.4	6.1	12.7	5.8	2.0	31.7	23.0	7.0	1.0	14.6	12.2	3.8	0.6	11.2	14.7	7.4	47.9	13.7	0.3	0.1	1.6	0.0	0.0	2.3	0.3	0.5	0.2	4.2	1.0	7.7	10.5	0.1	18.0	32.0	7.7	6.6	0.2	85.8	0.0	0.6	2.3	1.4	0.0	4.0	15.9	7.8	1.4	0.1	0.1	0.1	37.9	0.0	55.1	10.5	0.0	18.8	0.7	14.4	0.5	0.1	55.6	0.0	0.0	0.0	5.6	7.6	0.0	15.6	0.0	2.5	0.0	0.0	0.9	0.0	0.1	24.5	0.1	0.0	27.5	1.5	5.7	58.0	1.8	0.0	0.1	0.0	1.2	0.0	115.3	1.6	0.0	0.0	0.3	0.0	1.0	0.3	2.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.3	0.3	5.2	6.8	2.2	6.2	6.0	5.9	8.2	3.6	9.4	3.8
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 56.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.6;Hep G2: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		5400	5400	"Plasma membrane"	"Plasma membrane"	"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552"	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	5.6	7.0	13.8	4.4	27.7	3.4	5.9	7.5	31.1	6.5	9.9	2.1	20.6	5.5	8.0	10.3	4.5	7.4	6.6	8.6	15.7	9.1	10.0	3.1	4.0	1.6	9.3	14.5	3.2	10.8	56.7	4.6	14.2	5.5	10.4	3.6	1.3	19.7	22.2	9.8	2.3	4.5	12.3	4.0	2.9	5.5	2.6	8.0	4.1	3.1	1.9	1.1	8.6	6.3	0.5	0.8	2.8	3.3	2.4	5.2	0.4	0.0	0.6	2.3	0.1	4.3	8.1	3.1	9.7	6.4	2.5	1.5	21.6	2.4	1.0	4.1	1.8	0.0	1.7	0.0	1.9	0.0	2.1	0.4	1.6	32.5	1.1	0.5	0.3	0.5	0.4	3.4	0.0	5.1	3.3	12.6	0.0	2.9	0.4	1.5	7.3	3.5	6.9	0.0	5.7	1.9	8.0	8.3	3.6	0.0	2.0	0.4	9.6	3.1	0.9	8.3	3.7	0.6	6.0	9.5	11.0	16.3	4.2	5.9	14.3	0.8	3.3	2.8	3.6	0.7	5.2	0.2	1.0	1.3	0.4	0.5	0.5	1.1	2.1	2.4	0.4	0.8	0.2	0.4	13.8	27.7	7.5	30.8	15.7	9.1	9.3	14.5	5.5	8.0
PLSCR5		ENSG00000231213	"Phospholipid scramblase family member 5"	A0PG75	3	146576555-146606216	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.8;intestine: 1.8;parathyroid gland: 5.6"	"Cell line enhanced"	"Detected in single"		"HSkMC: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047249	Uncertain									"HPA047249: AB_2679997"																		0.1	0.0	0.5	0.1	1.8	0.0	0.1	0.1	0.3	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.2	0.1	0.4	0.1	0.1	0.1	5.6	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.8	0.1	0.1	0.1	0.0	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.1	0.3	0.1	0.5	0.4	0.1	0.1	0.1
PPM1H	"ARHCL1, FLJ13253, KIAA1157, NERPP-2C"	ENSG00000111110	"Protein phosphatase, Mg2+/Mn2+ dependent 1H"	Q9ULR3	12	62643982-62935037	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.1;parathyroid gland: 36.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 35.1;HMC-1: 28.3;SK-BR-3: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.3;granulocytes: 5.3;monocytes: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020694, HPA044244, HPA058777"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB020694: , HPA044244: AB_2678871, HPA058777: "	"unprognostic (3.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.19e-1)"	"prognostic favourable (2.72e-5)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.14e-1)"	2.6	2.1	10.6	1.6	12.4	3.1	5.7	37.1	16.3	8.5	2.8	14.0	12.4	3.6	6.9	7.7	1.1	7.5	9.1	2.2	13.0	12.2	11.7	3.9	3.2	1.5	14.3	9.0	9.4	4.9	36.6	13.3	7.1	8.5	15.0	3.6	7.7	10.2	11.6	1.5	1.2	2.1	2.2	8.9	1.3	6.2	1.4	15.0	0.5	3.8	0.1	2.1	3.4	1.2	0.0	2.3	5.3	1.7	0.2	0.0	0.3	0.5	5.4	1.0	0.0	0.2	0.0	11.9	1.3	1.3	0.8	0.2	35.1	2.5	0.0	1.2	0.6	0.7	3.8	0.1	0.5	0.1	1.9	6.6	1.0	7.9	0.0	2.0	28.3	0.0	0.1	0.0	0.3	0.1	1.7	0.0	0.6	4.0	0.6	0.9	7.1	2.6	0.9	2.5	9.8	8.1	12.4	3.1	0.0	2.2	16.0	5.2	8.7	1.1	0.1	0.2	0.7	0.1	0.4	1.4	9.0	1.8	0.1	0.0	0.5	5.3	1.7	3.0	0.0	1.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.2	0.2	1.4	0.0	0.0	0.3	10.6	12.4	37.1	16.3	13.0	12.2	14.3	9.0	8.5	15.0
PPME1	PME-1	ENSG00000214517	"Protein phosphatase methylesterase 1"	Q9Y570	11	74171099-74254703	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 69.0"	"Cell line enhanced"	"Detected in all"		"RH-30: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004541, HPA043900, HPA064396"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		16000	16000	Nucleoplasm	Nucleoplasm	"CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: "	"unprognostic (2.99e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavourable (4.45e-6)"	"unprognostic (2.31e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.33e-3)"	9.4	16.1	13.3	6.2	27.6	8.4	9.3	27.4	38.5	11.4	9.2	13.5	9.4	7.1	13.1	16.5	13.5	15.2	8.9	12.8	14.6	18.3	12.3	6.5	8.2	5.5	13.6	18.6	12.4	10.4	69.0	13.6	15.5	22.4	15.1	9.8	9.6	11.9	15.9	21.0	16.2	7.4	13.4	12.7	5.0	8.3	22.9	9.3	8.6	14.9	7.9	8.5	11.4	10.2	7.5	11.3	10.9	9.6	12.2	14.0	8.4	9.9	13.0	8.9	9.4	9.3	7.7	8.8	14.6	9.6	27.7	22.0	28.6	6.6	5.3	10.2	10.8	16.6	13.2	10.0	26.1	7.4	5.0	7.9	14.1	12.2	18.6	5.7	7.0	7.4	8.2	14.7	6.4	8.1	18.4	4.5	48.4	6.6	6.7	6.1	7.0	10.4	8.0	90.6	8.0	10.4	6.9	12.2	10.4	17.5	8.0	20.5	14.7	5.9	4.9	11.1	13.3	10.6	11.2	8.5	10.8	9.4	8.2	5.2	9.0	1.3	8.6	10.9	10.8	9.6	13.3	6.9	13.8	12.7	10.8	7.5	14.0	11.2	5.0	12.2	8.5	11.3	9.7	8.4	13.3	27.6	27.4	38.5	14.6	18.3	13.6	18.6	22.4	9.3
PTCH2		ENSG00000117425	"Patched 2"	Q9Y6C5	1	44819844-44843063	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"parathyroid gland: 82.4;salivary gland: 44.3;testis: 32.0"	"Cell line enhanced"	"Detected in many"		"U-266/84: 15.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (6.54e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.89e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.67e-2)"	"prognostic favourable (5.74e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.81e-2)"	2.5	1.9	8.0	2.4	5.2	6.0	2.2	9.7	7.2	2.5	2.0	1.2	1.3	1.5	6.7	1.9	1.3	2.7	2.4	3.3	6.2	6.1	1.0	1.2	1.2	2.2	2.5	5.8	19.1	1.1	82.4	6.8	1.0	6.0	1.8	1.4	4.6	44.3	1.7	2.0	2.3	1.3	6.6	5.5	1.8	1.2	32.0	5.2	0.0	3.1	2.4	1.3	2.2	2.3	3.4	7.6	3.3	3.8	2.0	2.4	0.5	0.3	0.4	1.5	3.6	1.2	1.3	1.4	1.1	2.4	0.7	0.7	0.4	0.5	1.5	0.7	0.5	0.1	1.5	0.1	0.3	3.1	2.8	0.9	1.2	1.1	0.4	0.9	1.7	0.5	0.6	1.4	0.1	0.2	1.0	1.6	0.1	0.8	1.8	2.9	0.5	0.5	1.4	0.3	0.7	0.3	0.1	2.2	0.9	0.4	0.6	1.0	0.3	1.7	0.2	0.3	0.8	1.8	0.7	2.7	15.0	4.4	0.8	4.3	0.5	3.3	3.8	0.3	1.1	2.0	2.4	2.2	1.4	1.4	2.5	3.4	1.7	1.3	1.3	2.0	1.8	7.6	0.7	0.5	8.0	5.2	9.7	7.2	6.2	6.1	2.5	5.8	6.0	5.2
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343865	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 160.7"	"Cell line enriched"	"Detected in some"	12	"AF22: 186.3"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	1800000	1800000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favourable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	7.8	6.6	55.5	2.0	43.3	0.9	27.7	38.6	58.5	30.7	7.2	26.9	9.9	2.5	25.2	18.7	25.0	7.2	18.2	29.4	42.3	29.7	12.7	3.4	6.5	2.6	31.6	27.0	7.2	3.4	160.7	52.5	11.8	31.4	38.5	7.7	19.0	12.0	18.1	1.5	3.6	4.0	17.7	23.4	12.4	5.4	16.8	23.3	1.3	5.1	8.7	5.3	7.7	18.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	186.3	2.2	0.0	0.1	15.2	4.8	14.3	2.7	3.7	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	14.4	0.1	0.0	0.3	0.0	0.0	0.0	0.8	12.7	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.6	0.1	10.3	0.0	0.0	0.0	13.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	43.3	38.6	42.0	42.3	29.7	31.6	27.0	31.4	23.3
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase, receptor type D"	P23468	9	8314246-10612723	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;parathyroid gland: 37.5"	"Cell line enhanced"	"Detected in some"		"AF22: 23.0;HAP1: 5.0;HSkMC: 7.8;NTERA-2: 5.6;RH-30: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	2500000	2500000	Vesicles	Vesicles	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favourable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.6	1.7	19.7	1.5	19.2	1.1	1.1	27.9	32.1	5.6	5.4	21.7	0.2	4.0	3.6	1.8	1.5	3.6	2.6	3.0	18.0	13.5	11.4	4.2	3.4	0.9	17.9	22.3	12.7	1.7	37.5	4.4	9.4	15.1	3.3	5.3	1.9	1.1	2.0	1.0	1.2	4.6	2.8	29.7	1.4	1.7	2.5	18.5	0.0	3.2	0.0	1.0	2.7	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	23.0	0.0	0.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	2.6	4.7	0.6	0.0	0.0	0.0	0.2	7.8	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	2.7	0.0	5.6	1.4	2.8	8.5	0.0	2.1	0.0	3.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.7	19.2	27.9	32.1	18.0	13.5	17.9	22.3	15.1	18.5
PYGO1		ENSG00000171016	"Pygopus family PHD finger 1"	Q9Y3Y4	15	55538890-55588947	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 26.6"	"Cell line enhanced"	"Detected in many"		"U-698: 25.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042248	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042248: AB_10794272"	"unprognostic (5.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-6)"	"unprognostic (3.36e-4)"	"unprognostic (4.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.80e-2)"	3.0	3.8	3.8	1.6	8.2	0.6	3.1	10.1	5.1	10.8	5.1	2.8	8.2	0.9	9.8	5.8	3.3	4.2	3.9	2.6	5.2	4.3	1.8	0.6	3.2	1.0	4.2	2.8	14.2	2.3	26.6	6.9	3.2	5.0	7.9	1.9	5.5	1.9	9.4	18.7	1.5	1.8	7.9	5.2	0.8	2.8	6.0	3.2	0.0	10.1	5.7	1.0	7.6	9.2	0.6	0.2	0.9	0.2	0.3	0.4	0.0	2.7	5.0	8.8	4.6	3.3	7.6	3.7	6.0	6.6	4.8	5.5	3.3	0.0	0.0	1.8	3.8	0.0	9.0	0.0	6.1	0.0	3.0	1.3	1.4	0.2	4.8	4.9	0.0	4.0	4.7	4.3	0.6	2.4	0.0	0.0	7.4	0.1	0.2	0.0	2.4	2.6	0.0	11.2	0.0	1.5	1.9	4.8	5.7	5.4	0.0	4.2	1.7	1.4	0.0	11.9	5.4	0.2	7.0	0.1	0.1	25.5	3.7	0.0	2.7	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.3	0.0	0.0	0.6	0.3	0.4	0.9	0.3	0.1	0.2	0.1	0.0	3.8	8.2	10.1	2.8	5.2	4.3	4.2	2.8	5.0	3.2
RAB6C	WTH3	ENSG00000222014	"RAB6C, member RAS oncogene family"	Q9H0N0	2	129979664-129982738	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 17.2"	"Group enriched"	"Detected in some"	6	"BEWO: 4.4;HMC-1: 3.9;REH: 9.1;T-47d: 5.7;U-266/70: 3.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA059131	Uncertain		Uncertain	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA059131: AB_2683916"	"unprognostic (3.84e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.78e-1)"	1.7	3.3	5.1	1.4	6.2	1.1	9.9	1.3	10.3	7.6	2.0	4.0	1.3	1.1	3.3	1.4	2.2	1.6	1.5	1.5	7.6	5.3	1.4	3.8	1.2	1.2	5.2	4.9	1.5	4.2	17.2	1.6	2.8	8.6	7.0	1.3	2.1	2.0	2.8	1.7	1.2	4.4	1.3	5.3	2.7	1.3	4.0	1.5	0.8	1.5	0.9	1.3	1.2	1.5	0.2	0.3	0.8	0.5	0.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.0	9.1	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.7	0.2	5.7	0.0	0.0	0.0	0.7	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.9	0.4	0.3	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.6	0.5	0.2	0.4	0.3	5.1	6.2	1.3	10.3	7.6	5.3	5.2	4.9	8.6	1.5
RALB		ENSG00000144118	"RAS like proto-oncogene B"	P11234	2	120240064-120294713	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 155.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 69.6"	"Group enriched"	"Detected in all"	4	"granulocytes: 69.6;monocytes: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026010, HPA065232"	Enhanced					10000000	10000000			"CAB026010: , HPA065232: AB_2685440"	"unprognostic (5.16e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (1.67e-4)"	"unprognostic (2.29e-2)"	"unprognostic (8.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.72e-2)"	21.1	16.1	21.5	19.6	18.9	16.9	17.6	9.1	32.7	17.1	20.0	11.2	7.0	18.0	16.5	9.4	28.0	16.4	16.3	19.6	20.3	16.4	23.2	11.7	18.3	19.7	23.7	18.9	14.8	11.0	155.9	9.8	21.0	15.0	18.1	16.7	9.8	16.7	11.9	12.3	11.1	20.0	15.6	16.1	23.7	13.6	13.4	11.6	7.5	15.3	12.6	12.6	17.2	24.5	9.8	12.2	69.6	28.6	4.3	4.2	9.1	38.1	11.0	10.3	6.6	16.5	25.4	15.0	27.5	23.6	21.0	15.9	22.1	26.1	1.5	14.6	28.9	14.1	5.0	20.2	17.3	63.8	5.8	18.2	8.4	15.5	10.6	9.4	32.4	14.0	21.7	21.9	16.4	59.3	14.2	5.8	22.5	20.1	1.2	18.7	6.7	22.9	0.2	13.1	7.9	19.7	10.2	2.9	7.0	11.2	30.5	17.3	9.6	13.6	37.9	20.8	15.7	21.3	10.5	3.6	2.0	2.8	16.4	12.1	20.9	15.7	14.7	41.4	3.7	20.6	3.7	8.5	3.5	3.6	12.2	9.8	2.3	2.7	69.6	4.3	28.6	1.2	4.2	9.1	21.5	18.9	9.1	32.7	20.3	16.4	23.7	18.9	15.0	11.6
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 64.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.3;EFO-21: 10.9;REH: 12.0;RPMI-8226: 26.8;RPTEC TERT1: 10.7;U-698: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7"	HPA041650	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA041650: AB_2677598"	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.9	10.4	8.6	2.5	11.2	1.2	1.6	0.4	18.2	2.5	2.1	18.8	3.7	1.2	0.9	0.9	16.9	2.2	1.8	0.8	11.8	4.9	7.4	0.9	0.9	1.7	7.3	10.9	0.8	1.4	64.0	3.9	1.0	4.0	0.9	1.7	0.0	22.4	7.4	0.8	8.0	1.1	0.9	1.8	1.0	9.6	1.1	8.4	0.0	8.0	6.0	5.0	1.0	3.7	0.4	0.2	1.3	0.2	0.3	1.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.1	8.3	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.3	0.0	12.0	0.0	26.8	10.7	0.0	0.3	0.0	0.0	4.0	0.0	1.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	1.3	0.2	0.1	0.1	0.0	1.6	0.2	0.9	0.4	0.0	0.4	1.2	0.5	0.4	0.3	0.0	0.2	0.4	0.3	8.6	11.2	0.4	18.2	11.8	4.9	7.3	10.9	4.0	8.4
RCAN1	DSCR1	ENSG00000159200	"Regulator of calcineurin 1"	P53805	21	34513142-34615142	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 220.2"	"Group enriched"	"Detected in many"	4	"SK-MEL-30: 153.1;WM-115: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037218, HPA068436"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB037218: AB_2179743, HPA068436: "	"unprognostic (3.83e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.27e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.60e-3)"	21.5	7.9	22.2	15.8	25.8	2.8	20.7	14.8	19.6	29.3	12.2	27.7	3.2	10.6	10.6	7.4	10.1	4.2	18.8	18.6	22.4	22.4	27.1	77.3	15.0	7.5	27.2	11.1	5.0	20.3	220.2	11.2	30.4	18.1	8.9	13.3	12.6	6.9	5.9	10.9	9.7	13.5	15.4	41.3	5.2	13.1	3.7	19.4	19.9	19.8	12.2	6.9	19.8	6.9	1.6	5.2	8.0	3.9	0.2	1.9	0.9	5.6	1.1	5.9	3.7	3.2	2.0	3.6	21.4	22.1	8.8	8.8	6.5	5.4	0.1	1.0	12.5	0.5	4.2	4.3	11.9	3.2	2.6	1.1	2.0	3.0	12.5	1.8	3.7	5.2	3.9	10.4	7.3	2.9	2.1	5.6	5.8	2.7	17.0	1.4	3.3	2.8	6.4	4.6	2.6	2.8	9.9	2.8	1.2	15.6	10.1	153.1	13.7	3.0	3.1	29.8	3.1	4.9	5.2	4.9	3.0	1.0	9.8	5.3	99.9	0.0	2.0	8.0	1.3	3.4	1.9	1.6	1.6	1.2	2.7	1.2	0.7	1.3	1.0	0.2	3.9	5.2	1.8	0.9	22.2	25.8	14.8	19.6	22.4	22.4	27.2	11.1	18.1	19.4
RELL2	"C5orf16, FLJ90583"	ENSG00000164620	"RELT like 2"	Q8NC24	5	141636950-141641077	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;parathyroid gland: 27.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077928			Uncertain	Vesicles				Vesicles	Vesicles	"HPA077928: "	"unprognostic (3.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.76e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.85e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.31e-2)"	"unprognostic (6.58e-2)"	2.0	4.5	6.9	2.4	12.3	2.2	2.3	12.5	27.6	1.4	2.3	2.3	0.0	2.5	1.3	1.8	2.7	1.2	2.4	1.6	10.8	14.5	3.3	1.8	2.7	4.7	17.8	8.4	1.1	2.2	27.6	9.4	7.4	24.9	2.2	2.1	1.7	3.7	1.8	1.0	4.2	1.8	2.2	3.8	5.4	2.3	4.6	2.5	4.6	2.8	1.7	5.0	2.9	0.9	2.5	7.8	1.2	3.5	0.1	5.4	1.9	0.9	3.0	3.0	5.7	2.4	0.7	1.4	2.6	4.8	8.4	12.5	11.3	1.1	0.1	1.2	3.9	4.6	2.8	10.9	2.2	2.7	1.8	6.9	6.5	5.6	3.9	2.2	20.0	1.6	6.8	7.8	5.7	2.3	2.4	3.6	1.9	1.4	4.0	0.8	3.5	1.5	0.2	0.6	4.7	2.7	2.7	5.0	5.5	2.3	11.0	1.8	3.8	5.2	2.0	6.5	2.9	5.1	4.4	2.1	5.7	16.2	3.5	9.6	4.1	0.0	1.4	0.0	3.0	3.5	1.1	2.5	3.2	3.0	2.3	1.5	2.9	1.6	1.2	0.1	2.5	7.8	5.4	1.9	6.9	12.3	12.5	27.6	10.8	14.5	17.8	8.4	24.9	2.5
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077027-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 63.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 17.6;NB-4: 11.6;SH-SY5Y: 89.7;THP-1: 26.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.1;monocytes: 6.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"midbrain: 95.5"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		260000	260000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	15.2	1.1	1.8	1.3	0.7	1.2	4.1	9.0	1.9	3.1	0.9	1.1	1.5	0.9	0.6	1.2	0.7	1.0	1.2	1.5	5.8	1.0	11.7	0.7	0.8	17.5	1.2	0.8	1.3	63.9	6.3	0.8	16.8	2.2	1.5	2.8	13.6	2.0	4.5	1.1	2.6	1.1	2.8	0.6	2.1	2.0	0.0	0.1	0.8	5.1	0.6	1.9	1.4	0.2	2.1	0.0	6.7	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	11.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	89.7	0.0	0.0	0.0	1.2	26.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.7	2.1	0.3	0.4	1.1	1.3	4.1	9.0	1.5	5.8	17.5	1.2	16.8	0.0
RGL3	FLJ32585	ENSG00000205517	"Ral guanine nucleotide dissociation stimulator like 3"	Q3MIN7	19	11384341-11419342	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.1;thyroid gland: 38.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.5;CACO-2: 8.2;RT4: 17.0;SK-BR-3: 7.6;T-47d: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Region enriched"	"Detected in single"	6	"cerebellum: 10.1"					"HPA042763, HPA043615, HPA064578"	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: "	"prognostic favourable (7.35e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.19e-3)"	"unprognostic (5.99e-2)"	"prognostic favourable (6.61e-4)"	"unprognostic (4.17e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.12e-3)"	4.3	6.2	5.3	1.2	7.9	0.7	4.3	1.9	6.8	7.6	1.9	3.4	23.3	1.8	4.9	14.5	1.1	5.3	6.5	5.2	8.2	1.3	20.7	6.0	7.5	1.2	6.7	3.0	1.6	12.1	65.1	9.1	5.8	7.9	4.1	1.8	7.3	3.5	23.9	5.0	1.1	1.2	1.4	9.5	5.1	6.8	1.1	7.3	0.0	38.2	0.4	0.9	4.5	4.5	0.3	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.1	14.5	0.9	1.1	0.5	1.6	8.2	5.9	0.0	5.2	1.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	3.0	2.5	2.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.6	1.6	5.0	17.0	0.8	4.3	0.2	7.6	2.5	12.5	0.0	0.0	2.6	0.0	2.0	0.6	0.0	0.4	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	5.3	7.9	1.9	6.8	8.2	1.3	6.7	3.0	7.9	7.3
RIMBP2	"KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2"	ENSG00000060709	"RIMS binding protein 2"	O15034	12	130396137-130716281	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 17.2;SH-SY5Y: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"B-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041494, HPA044114"			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA041494: , HPA044114: AB_2678815"	"unprognostic (4.15e-4)"	"unprognostic (9.77e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.82e-3)"	"prognostic favourable (4.16e-4)"	"unprognostic (2.86e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.73e-2)"	0.9	11.9	14.1	1.1	13.0	0.6	0.6	1.1	24.7	6.1	1.5	1.6	0.0	2.5	2.5	2.4	0.8	6.6	1.1	0.4	15.3	11.0	2.8	0.6	0.7	0.5	5.6	12.9	2.1	2.3	49.1	42.7	0.4	4.9	1.3	1.8	4.1	0.6	1.4	0.5	2.4	2.3	2.3	5.6	1.1	5.2	2.3	1.6	0.0	0.9	0.0	0.5	0.8	0.7	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.2	4.1	0.0	0.0	17.2	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	13.0	1.1	24.7	15.3	11.0	5.6	12.9	4.9	1.6
RLN3	"H3, RXN3, ZINS4"	ENSG00000171136	"Relaxin 3"	Q8WXF3	19	14028148-14031042	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 2.7;parathyroid gland: 5.6;testis: 5.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;K-562: 4.0;SCLC-21H: 1.5;THP-1: 2.2;U-266/70: 1.0;U-698: 1.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"midbrain: 14.0;pons and medulla: 28.5"	"Region enriched"	"Detected in some"	9	"pons and medulla: 34.0"						"Secreted to blood"													"unprognostic (1.96e-2)"		"unprognostic (2.54e-2)"					"unprognostic (3.94e-1)"			0.3	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.9	1.3		0.1	0.0	5.6	0.2	0.0		0.7	0.0		0.8	0.0	0.1	0.0	0.3	0.0	0.0	1.0	0.1	5.0			0.0		0.4	0.2	0.0	2.7	1.8	0.0	1.3	0.0	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	1.1	0.0	0.9	0.9	1.8	2.7	2.0	1.2	0.0	0.0	0.3	0.0	0.2	0.5										
RNF180		ENSG00000164197	"Ring finger protein 180"	Q86T96	5	64165844-64372869	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 54.0"	"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 24.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006897	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA006897: AB_1856348"	"unprognostic (7.46e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.68e-2)"	"prognostic favourable (6.81e-5)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.81e-3)"	8.1	8.1	9.9	3.1	12.8	1.6	6.3	6.0	13.0	10.1	7.1	5.5	20.1	3.4	12.7	11.8	6.9	8.1	7.3	10.4	7.4	10.6	12.4	7.2	6.1	3.4	9.4	9.3	12.0	6.6	54.0	16.1	2.0	10.7	11.5	3.0	11.3	7.3	16.4	4.4	6.6	3.2	15.0	11.0	5.1	5.0	8.1	7.1	0.0	20.6	2.5	2.4	10.9	7.9	2.4	1.0	4.2	1.8	2.0	4.2	0.3	0.0	0.1	1.3	0.0	0.0	0.0	0.3	1.1	0.5	1.1	0.6	0.0	0.1	0.0	0.1	0.8	0.2	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.2	0.1	2.6	0.0	0.1	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.5	1.3	0.1	3.3	24.9	1.8	0.3	0.3	0.1	0.0	0.3	0.0	1.3	0.1	0.1	0.0	3.2	0.1	2.8	0.0	0.0	0.0	0.5	0.0	3.5	3.0	1.8	4.2	1.9	0.6	2.5	1.4	3.0	3.2	0.6	2.4	4.2	3.9	2.6	2.0	0.8	1.0	1.8	0.3	9.9	12.8	6.0	11.7	7.4	10.6	9.4	9.3	10.7	7.1
ROR1	NTRKR1	ENSG00000185483	"Receptor tyrosine kinase like orphan receptor 1"	Q01973	1	63774022-64181498	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 31.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.4;ASC TERT1: 24.3;CACO-2: 16.6;HHSteC: 18.5;HSkMC: 19.9;NTERA-2: 20.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 13.0"	"Group enriched"	"Detected in some"	5	"NK-cell: 3.3;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;NK-cells: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA057016			Approved	Microtubules	"Intracellular and membrane"	2800000	2800000	Microtubules	Microtubules	"HPA057016: "	"unprognostic (5.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.15e-2)"	5.5	1.7	1.3	3.5	2.7	0.4	3.4	13.0	2.8	16.7	8.8	2.2	4.4	2.0	14.2	5.0	4.9	5.5	10.7	10.6	1.3	1.1	3.6	0.8	9.7	1.1	1.0	2.4	8.3	9.8	31.2	3.6	2.9	3.0	10.9	3.9	7.9	2.8	6.3	2.1	4.5	4.1	17.8	1.1	3.1	9.2	2.7	0.9	1.8	1.5	4.6	2.1	10.2	8.8	0.4	1.1	0.1	0.1	3.3	0.1	0.0	7.0	5.5	2.8	0.3	19.4	24.3	1.9	1.3	3.8	0.7	2.0	16.6	2.2	0.1	3.2	3.2	1.5	0.0	1.3	0.5	0.0	1.7	0.0	0.7	0.2	18.5	0.0	0.0	19.9	5.1	10.2	12.0	0.3	0.0	0.1	5.1	0.1	0.1	0.0	20.2	2.8	0.1	0.1	4.3	4.1	0.1	1.6	6.5	0.4	0.1	2.9	0.0	0.0	3.8	1.5	2.9	10.8	2.8	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	3.3	0.1	1.1	0.0	0.0	1.3	2.7	13.0	2.8	1.3	1.1	1.0	2.4	3.0	0.9
RYR3		ENSG00000198838	"Ryanodine receptor 3"	Q15413	15	33310945-33866121	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 28.8;skeletal muscle: 26.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.0;RH-30: 10.6;RPTEC TERT1: 5.0"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	31	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 4.0"	"Low region specificity"	"Detected in many"							HPA062004			Approved	Vesicles				Vesicles	Vesicles	"HPA062004: AB_2797267"	"unprognostic (5.85e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.03e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.10e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	1.8	2.0	9.9	1.1	15.4	2.5	2.9	4.9	12.4	2.8	4.5	6.0	0.2	1.5	10.2	1.0	2.7	3.9	1.6	1.0	13.3	3.5	1.2	0.9	1.2	0.9	5.6	6.9	1.7	0.8	28.8	1.2	1.0	10.7	1.8	2.9	0.6	1.4	3.9	26.8	1.2	1.3	7.4	5.9	1.4	1.6	1.6	7.9	0.0	1.1	1.5	1.4	2.1	2.6	0.1	0.0	4.0	0.0	0.0	0.1	0.0	0.3	7.0	1.5	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.6	0.1	0.4	0.6	0.0	0.2	0.0	0.0	0.0	0.4	0.2	1.4	0.2	0.0	0.0	1.0	0.7	0.0	0.0	0.1	0.0	0.0	0.4	2.6	0.0	0.4	0.2	0.3	1.1	0.1	0.5	10.6	0.2	5.0	0.5	0.1	0.5	0.8	0.0	0.2	0.1	0.3	0.9	0.2	0.1	0.0	0.7	0.3	1.2	0.7	0.5	2.3	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	15.4	4.9	12.4	13.3	3.5	5.6	6.9	10.7	7.9
SACS	"ARSACS, DKFZp686B15167, DNAJC29, KIAA0730, PPP1R138, SPAX6"	ENSG00000151835	"Sacsin molecular chaperone"	Q9NZJ4	13	23328826-23433740	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 38.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			CAB017714	Uncertain									"CAB017714: "	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.02e-3)"	"prognostic unfavourable (9.04e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (6.21e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.65e-4)"	6.3	6.0	15.9	7.9	20.3	9.6	7.1	7.7	20.2	5.6	6.4	7.8	2.6	2.8	8.8	6.3	5.5	5.1	5.2	7.4	13.5	10.2	2.8	2.8	4.0	8.1	12.5	11.5	8.6	4.6	38.5	7.5	3.4	21.4	8.0	4.0	2.4	6.0	5.4	13.6	4.8	4.3	13.5	11.6	8.3	4.7	7.8	15.2	6.6	3.2	8.7	7.4	6.9	6.7	2.5	2.0	1.0	0.9	1.3	2.8	0.5	3.8	5.1	10.6	3.2	3.3	12.6	1.6	8.9	11.5	3.5	2.9	2.4	2.1	2.7	3.8	19.0	0.8	15.3	5.3	11.5	6.2	6.2	10.0	3.9	3.6	2.5	18.2	4.0	4.0	1.2	22.2	10.8	11.3	5.7	1.3	15.7	1.8	6.5	7.0	8.7	4.1	7.7	19.5	8.0	6.0	0.4	7.7	7.4	4.9	1.8	3.9	0.9	4.9	24.5	10.7	8.8	5.7	16.8	2.5	2.7	6.6	5.0	6.5	9.3	0.0	0.8	1.0	1.1	0.9	2.0	1.1	1.7	0.8	2.0	2.5	1.2	1.4	0.0	1.3	0.3	1.7	2.8	0.5	15.9	20.3	7.7	20.2	13.5	10.2	12.5	11.5	21.4	15.2
SALL2	"Hsal2, KIAA0360, ZNF795"	ENSG00000165821	"Spalt like transcription factor 2"	Q9Y467	14	21521081-21537216	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9;parathyroid gland: 36.0"	"Cell line enhanced"	"Detected in many"		"AF22: 46.1;NTERA-2: 34.8;SCLC-21H: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004162	Approved		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA004162: AB_2667155"	"unprognostic (5.73e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavourable (3.97e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (1.23e-4)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	2.6	4.7	11.5	1.6	12.7	0.5	5.3	30.9	21.9	7.5	4.5	10.4	2.9	2.3	10.5	6.0	3.5	11.6	4.0	3.7	11.7	8.9	4.2	1.7	4.8	1.9	7.4	9.3	19.5	3.7	36.0	10.9	1.5	13.5	5.8	2.4	4.3	3.3	10.0	2.1	2.2	3.1	10.5	9.5	2.1	3.2	1.9	11.4	3.7	12.0	0.1	1.9	4.6	4.8	0.3	1.7	0.0	0.0	0.5	3.8	0.6	0.0	0.8	46.1	11.5	0.8	0.7	0.0	1.0	1.4	3.6	3.0	0.8	0.6	0.0	1.0	1.3	0.1	11.2	1.2	4.3	0.7	6.4	0.0	0.4	1.0	1.4	0.0	0.0	3.1	0.3	1.5	0.0	0.9	7.5	0.0	2.9	0.8	7.1	0.0	34.8	0.2	6.7	1.1	0.0	3.3	4.8	15.7	8.8	0.0	0.2	0.1	4.6	0.1	0.0	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.8	0.0	1.0	0.1	1.5	1.2	0.2	0.3	1.8	3.8	0.0	0.5	0.0	1.7	1.6	0.6	11.5	12.7	30.9	14.3	11.7	8.9	7.4	9.3	13.5	11.4
SALL4	"dJ1112F19.1, ZNF797"	ENSG00000101115	"Spalt like transcription factor 4"	Q9UJQ4	20	51782331-51802520	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 8.8;testis: 11.7;thyroid gland: 8.6"	"Cell line enhanced"	"Detected in some"		"AF22: 13.6;AN3-CA: 9.5;BEWO: 18.2;NTERA-2: 32.7;SiHa: 8.3"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 22.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"NK-cell: 6.3"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015291, HPA015791"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA015291: AB_1856548, HPA015791: AB_1856547"	"unprognostic (1.30e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.42e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-5)"	"unprognostic (7.41e-2)"	0.3	0.4	0.3	0.3	0.9	1.2	0.3	0.8	0.9	0.4	0.7	0.3	2.2	0.1	0.3	0.8	0.3	0.2	0.3	0.3	0.3	0.1	0.5	1.9	0.3	0.3	0.3	0.3	0.3	4.6	8.8	0.6	0.3	0.9	3.1	0.2	4.5	2.2	0.4	0.3	0.3	0.7	0.3	0.3	0.8	0.3	11.7	0.3	0.3	8.6	0.3	0.3	0.9	0.3	0.1	0.1	0.6	0.1	6.3	0.2	0.0	0.0	0.9	13.6	9.5	0.0	0.1	18.2	0.0	0.1	0.0	0.1	4.7	0.1	0.0	0.1	0.1	2.3	0.1	0.0	0.2	0.2	0.0	0.0	3.2	0.2	0.1	0.0	1.0	0.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	32.7	0.2	1.2	0.0	0.0	0.0	0.3	3.1	1.7	8.3	0.0	0.8	0.0	0.5	0.0	0.5	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.6	6.3	0.1	0.1	0.0	0.0	0.3	0.9	0.8	0.9	0.3	0.1	0.3	0.3	0.9	0.3
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.1;pancreas: 63.5;parathyroid gland: 60.1;pituitary gland: 74.6"	"Cell line enhanced"	"Detected in some"		"HHSteC: 14.7;HSkMC: 18.2;NTERA-2: 8.2;SCLC-21H: 16.8;SH-SY5Y: 19.5;U-87 MG: 25.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 82.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 2.8;naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	22000	22000			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavourable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.2	30.7	24.0	2.2	47.2	0.9	2.5	36.4	71.1	1.0	4.4	13.0	0.0	9.0	3.4	21.8	1.0	2.4	3.4	1.0	30.5	36.9	1.2	2.2	2.5	1.3	25.2	23.1	2.0	63.5	60.1	74.6	0.9	30.5	3.2	5.5	15.4	0.7	1.2	0.7	1.3	3.3	3.9	24.1	1.0	21.0	3.0	9.5	0.0	1.8	0.0	0.9	2.5	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.2	0.1	0.0	0.1	0.3	2.5	0.0	2.2	0.2	0.2	0.2	0.0	0.0	0.2	1.0	0.2	0.6	0.3	0.1	0.6	0.3	0.1	0.3	0.0	0.0	14.7	0.1	0.4	18.2	0.1	0.4	0.2	0.3	0.1	0.3	0.4	0.0	0.1	0.1	8.2	0.4	0.0	0.2	0.3	0.2	0.0	16.8	19.5	0.1	0.0	0.1	0.0	0.2	0.0	2.8	1.9	0.1	0.2	0.3	1.1	0.2	25.5	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	24.0	47.2	36.4	50.8	30.5	36.9	25.2	23.1	30.5	9.5
SCPEP1	RISC	ENSG00000121064	"Serine carboxypeptidase 1"	Q9HB40	17	56978105-57006768	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 113.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 60.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039102, HPA057200"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"	"Golgi apparatus"	"HPA039102: AB_10673605, HPA057200: AB_2683365"	"unprognostic (5.83e-3)"	"unprognostic (7.43e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.96e-5)"	"unprognostic (1.00e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	29.5	54.1	14.7	12.6	10.2	17.8	25.8	8.8	14.8	21.5	17.6	12.8	50.1	8.8	17.5	24.1	25.9	14.6	20.7	25.0	10.2	11.8	24.8	8.7	25.6	24.5	12.2	14.3	19.9	9.4	113.9	13.6	7.6	14.2	24.6	9.5	13.4	31.5	37.6	6.4	17.8	15.9	23.2	13.9	22.3	20.8	7.7	10.8	2.4	62.7	14.1	25.3	24.7	20.8	14.1	23.4	60.8	44.8	4.6	3.0	20.3	9.5	5.8	9.1	8.5	79.3	17.8	5.1	4.6	23.2	8.1	16.2	2.7	6.1	12.9	27.1	10.9	9.3	4.3	20.8	8.6	17.4	7.5	3.8	5.9	1.6	18.1	7.9	39.5	21.5	8.9	10.5	8.1	13.5	1.1	46.4	11.6	4.1	3.6	19.8	4.1	8.5	5.0	11.2	8.3	1.8	29.6	2.8	7.1	11.7	8.8	6.9	4.0	20.3	7.2	24.7	6.6	14.5	5.2	52.4	38.3	7.1	17.3	5.6	6.7	0.3	44.8	60.8	3.0	27.1	1.9	12.9	2.1	1.9	23.4	14.1	2.9	2.9	7.3	4.6	25.3	4.5	2.5	20.3	14.7	10.2	8.8	14.8	10.2	11.8	12.2	14.3	14.2	10.8
SEC14L6		ENSG00000214491	"SEC14 like lipid binding 6"	B5MCN3	22	30522799-30546682	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 15.4;parathyroid gland: 20.9"	"Group enriched"	"Detected in some"	4	"K-562: 11.0;RPTEC TERT1: 20.6;SiHa: 6.1"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.6"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA067695			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA067695: AB_2685889"	"unprognostic (3.49e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.25e-2)"	"unprognostic (8.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.02e-2)"	0.7	0.7	3.3	0.0	3.6	1.1	2.4	1.1	2.1	2.3	0.0			0.1	2.0	15.4	0.0	0.9	2.8	0.0	2.4	3.4	7.2	0.0	7.9	0.0	4.0		1.7	3.5	20.9	1.8	0.0		1.0	0.0		0.0	1.6	0.0	7.3	0.0	1.3	3.9	0.0	0.6	3.8			0.0		0.1	0.1	0.0	1.2	0.9	2.7	0.8	1.9	2.2	0.3	0.2	0.1	0.9	0.3	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.2	0.5	0.3	1.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	2.8	0.3	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.0	11.0	0.2	0.0	0.4	0.1	0.4	0.5	0.1	0.2	0.0	0.1	20.6	0.2	0.2	0.1	6.1	0.1	0.0	1.6	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.3	0.1	1.9	0.8	0.7	0.6	0.6	1.6	0.7	0.5	0.5	0.2	1.2	0.6	0.9	2.7	1.9	0.7	0.9	2.2	0.3										
SEPT5	"H5, HCDCREL-1, PNUTL1"	ENSG00000184702	"Septin 5"	Q99719	22	19714464-19724224	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.2;parathyroid gland: 86.4"	"Cell line enhanced"	"Detected in many"		"K-562: 65.7;THP-1: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"eosinophil: 11.9;neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	46	"granulocytes: 11.9"									"CAB016120, HPA029095, HPA063885"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Cytosol"		1600000	1600000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB016120: AB_628240, HPA029095: AB_2672904, HPA063885: "	"unprognostic (4.07e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.39e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavourable (6.87e-6)"	"unprognostic (3.39e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.30e-2)"	4.2	6.4	60.7	2.3	62.9	12.5	5.1	31.2	86.2	12.2	3.0	5.5	1.1	2.2	7.4	17.0	15.0	14.1	5.5	50.9	52.9	14.6	2.0	1.1	3.7	3.0	12.4	38.7	9.0	5.5	86.4	11.1	4.4	14.9	4.3	2.7	5.3	3.6	4.0	2.8	42.9	2.5	6.4	3.6	2.2	3.4	6.2	9.5	1.9	6.7	4.1	3.1	3.5	5.6	0.0	0.2	11.9	0.1	0.0	0.2	6.3	0.1	3.0	12.0	18.5	1.1	3.9	0.1	4.6	5.8	5.2	3.0	0.2	1.6	0.4	1.8	10.2	1.7	8.7	1.7	2.6	3.1	1.0	0.2	0.6	0.0	4.8	0.2	12.7	5.2	2.1	1.7	0.7	2.1	65.7	0.1	8.1	1.2	1.3	7.3	1.6	3.2	13.3	0.3	2.0	0.3	0.4	19.2	15.6	0.6	0.9	0.8	4.8	21.1	0.8	13.7	18.4	0.5	0.9	1.3	0.0	0.1	1.7	0.6	4.4	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	4.4	0.0	0.0	0.2	0.0	6.3	60.7	62.9	31.2	86.2	52.9	14.6	12.4	38.7	14.9	9.5
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 141.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 50.1;RPTEC TERT1: 76.9;SK-MEL-30: 49.8;TIME: 59.8;U-266/84: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.7;eosinophil: 45.9;neutrophil: 26.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 45.9;monocytes: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favourable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	45.6	35.5	16.8	12.8	43.2	15.8	22.9	10.6	25.0	18.4	62.3	51.7	10.8	14.2	14.9	11.2	30.0	16.1	47.8	12.5	22.9	9.6	37.5	51.1	31.2	8.4	48.8	16.6	47.2	47.8	141.3	4.7	19.2	28.3	18.3	11.3	45.8	26.2	18.4	12.4	25.8	131.8	13.6	40.3	7.6	31.1	12.2	50.1	6.2	22.3	24.8	20.4	26.1	31.7	0.6	4.0	45.9	11.7	0.9	0.7	3.1	0.6	1.1	0.7	0.0	8.6	2.1	0.9	12.3	25.7	16.1	13.2	1.9	1.7	2.0	1.8	12.7	0.4	1.1	1.9	11.9	0.0	0.5	0.1	30.7	1.4	50.1	0.1	1.1	12.9	12.4	15.8	20.6	27.0	3.9	31.4	5.7	0.1	0.1	0.4	0.7	1.3	0.3	1.4	0.2	76.9	0.2	0.3	3.0	38.7	0.1	49.8	0.0	0.3	59.8	4.7	2.0	28.9	2.7	5.9	54.8	6.3	4.4	1.9	6.3	0.6	11.7	45.9	0.2	6.8	0.5	0.6	0.4	0.2	4.0	0.4	0.5	0.6	26.2	0.9	3.7	0.2	0.7	3.1	16.8	43.2	10.6	25.0	22.9	9.6	48.8	16.6	28.3	50.1
SGSM1	"KIAA1941, RUTBC2"	ENSG00000167037	"Small G protein signaling modulator 1"	Q2NKQ1	22	24806169-24927578	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1;parathyroid gland: 20.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 2.3;RPMI-8226: 5.4;SCLC-21H: 5.3;SH-SY5Y: 3.4;U-266/84: 2.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003986	Approved									"HPA003986: AB_1856513"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.40e-4)"	"unprognostic (4.79e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.61e-6)"	"unprognostic (1.46e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.93e-2)"	1.3	6.2	8.2	1.3	15.4	0.8	2.2	22.1	15.8	2.5	2.6	3.5	0.2	1.3	1.6	2.4	1.2	8.5	1.7	17.2	6.5	18.4	3.4	0.8	2.4	1.2	7.9	9.2	3.7	6.4	20.7	9.4	2.3	12.7	2.7	3.3	1.6	1.7	2.1	1.5	5.7	1.9	2.5	5.9	1.1	5.7	3.2	4.3	0.0	2.9	0.0	1.1	1.7	5.0	1.1	0.2	0.6	0.1	1.4	2.5	0.4	0.1	1.4	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.1	0.6	0.9	0.0	0.0	5.4	0.0	0.9	5.3	3.4	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.3	0.1	0.0	2.5	0.0	0.0	0.8	0.6	1.1	0.0	1.1	1.3	1.0	0.6	1.4	0.0	0.2	0.2	0.4	8.2	15.4	22.1	12.9	6.5	18.4	7.9	9.2	12.7	4.3
SIX4	AREC3	ENSG00000100625	"SIX homeobox 4"	Q9UIU6	14	60709528-60724348	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.4;salivary gland: 16.4;skeletal muscle: 19.3"	"Cell line enhanced"	"Detected in many"		"A-431: 21.0;RH-30: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA031794	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA031794: AB_10602928"	"unprognostic (2.23e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.63e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.08e-1)"	2.0	1.5	0.9	0.6	0.9	0.3	4.8	4.3	4.5	3.3	0.7	0.1	3.3	0.4	1.6	1.3	0.5	3.5	1.1	1.5	1.0	1.0	1.4	0.5	2.1	0.2	1.0	2.2	2.9	3.3	20.4	6.3	2.1	3.6	4.0	0.3	0.8	16.4	2.7	19.3	0.5	0.5	0.9	1.8	0.3	2.0	0.7	1.1	0.8	3.9	2.4	1.4	1.7	14.3	0.2	0.1	1.0	0.1	0.3	0.2	0.0	21.0	1.6	1.3	5.6	5.0	6.3	9.9	4.8	7.2	1.4	2.1	1.0	6.7	0.0	3.2	2.4	8.0	5.7	3.9	3.3	1.7	4.6	0.6	2.1	1.4	1.6	2.1	0.2	2.9	1.8	1.3	6.7	1.2	4.1	0.0	7.3	5.2	0.0	0.2	3.6	9.1	1.3	21.3	0.0	2.5	12.1	3.4	0.3	3.0	4.8	1.3	6.5	0.1	4.1	4.4	9.8	3.0	4.3	1.4	0.0	0.0	1.5	0.0	0.8	0.3	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.9	0.9	4.3	4.5	1.0	1.0	1.0	2.2	3.6	1.1
SLC22A16	"CT2, FLIPT2, OAT6, OKB1"	ENSG00000004809	"Solute carrier family 22 member 16"	Q86VW1	6	110424687-110476641	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.5;bone marrow: 16.0;parathyroid gland: 9.6;testis: 26.4"	"Group enriched"	"Detected in some"	18	"NB-4: 9.5;REH: 8.8;THP-1: 30.6;U-937: 18.0"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 9.5"	"Group enriched"	"Detected in many"	66	"dendritic cells: 5.1;granulocytes: 5.0;monocytes: 9.5"					"Low region specificity"	"Detected in all"			HPA036902	Uncertain									"HPA036902: AB_10672274"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.19e-3)"	"unprognostic (2.70e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-6)"	"unprognostic (5.78e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.65e-2)"	3.5	0.2	0.2	0.4	0.2	16.0	0.2	0.1	0.2	0.1	0.7	0.0	0.0	0.0	4.9	0.8	0.1	0.3	0.7	0.1	0.2	0.1	1.1	0.3	1.6	0.0	0.2	0.0	0.9	0.1	9.6	0.1	0.3	0.2	0.2	0.0	0.0	0.6	0.0	0.2	0.3	0.1	1.6	0.2	0.8	0.2	26.4	0.0	2.2	0.1	0.8	0.1	0.1	0.1	0.0	5.1	5.0	9.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	18.0	0.0	5.0	9.5	1.6	0.0	2.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.2	0.0
SLC2A13	HMIT	ENSG00000151229	"Solute carrier family 2 member 13"	Q96QE2	12	39755021-40106089	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.7;parathyroid gland: 43.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006584	Approved		Approved	"Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA006584: AB_1849755"	"unprognostic (1.66e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.12e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.16e-2)"	3.8	7.2	9.8	3.3	18.0	1.2	3.0	4.0	27.7	13.0	7.4	2.8	0.3	6.0	5.9	5.3	3.7	2.9	4.0	4.9	8.2	14.1	10.7	6.2	3.7	1.9	14.9	11.0	3.1	5.0	43.0	11.1	4.6	4.8	3.0	6.8	2.4	4.2	2.6	1.2	2.1	8.3	4.7	2.7	2.3	5.6	2.0	4.1	0.6	2.2	0.9	1.4	3.9	3.9	2.0	0.1	1.5	0.5	0.6	0.9	0.0	0.6	3.5	2.5	1.1	18.2	7.5	5.2	5.7	4.0	2.6	3.3	0.0	1.7	2.1	4.2	4.5	0.3	1.7	1.8	2.1	1.9	5.4	1.7	9.0	1.2	2.9	4.9	2.9	3.7	1.7	1.1	2.2	1.2	0.6	5.6	5.8	0.6	0.7	4.0	2.8	2.4	0.0	3.9	1.2	4.7	2.2	3.3	3.4	2.3	4.5	1.4	2.5	4.3	1.0	3.4	1.3	12.2	3.3	4.4	0.1	1.4	6.2	2.8	2.2	0.0	0.5	1.5	0.4	0.2	0.3	0.1	0.4	0.9	0.0	2.0	0.2	0.5	0.8	0.6	0.1	0.1	0.1	0.0	9.8	18.0	4.0	19.8	8.2	14.1	14.9	11.0	4.8	4.1
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 66.3;RT4: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Plasma membrane"	"HPA009277: AB_2668229"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (2.65e-7)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	10.6	3.8	8.6	1.4	3.4	0.1	18.0	2.5	8.3	11.5	2.5	2.4	2.9	0.8	6.4	11.8	3.7	13.6	5.1	9.7	6.8	0.9	3.8	68.1	3.3	2.8	4.4	3.5	35.1	32.2	78.2	3.0	29.0	9.1	4.9	1.5	13.0	2.4	3.3	57.8	3.3	2.0	4.3	10.9	1.8	3.3	7.7	3.5	0.0	14.3	10.4	1.2	3.4	6.4	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	10.1	0.0	0.1	11.1	0.0	6.8	0.5	0.6	3.3	0.0	0.0	2.3	0.0	0.0	7.3	1.7	2.3	0.0	3.8	0.0	8.0	7.0	66.3	3.0	0.0	8.9	1.4	8.6	8.2	3.1	0.0	0.0	7.7	10.7	0.3	3.5	3.7	0.9	0.0	5.1	5.3	0.8	17.0	0.1	1.3	0.5	0.2	3.1	0.0	0.3	7.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.6	3.4	2.5	8.3	6.8	0.9	4.4	3.5	9.1	3.5
SRGAP2C	SRGAP2P1	ENSG00000171943	"SLIT-ROBO Rho GTPase activating protein 2C"	P0DJJ0	1	121184810-121392822	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 16.5"	"Cell line enhanced"	"Detected in many"		"WM-115: 39.1"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA078079			Approved	Cytosol				Cytosol	Cytosol	"HPA078079: "	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.48e-6)"	"unprognostic (2.40e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.18e-4)"	"unprognostic (6.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.71e-7)"	"unprognostic (4.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.66e-2)"	4.7	4.5	3.5	2.8	4.4	4.2	2.7	7.8	6.0	3.5	2.0	8.5	3.3	1.0	3.5	1.2	5.4	3.2	3.0	2.9	3.3		4.6	2.9	5.5	2.5	6.3	4.0	4.8	1.1	16.5	4.6	6.5	6.2	2.1	1.7	2.1	1.3	3.2	1.3	10.9	1.7	3.9	6.4	7.0	1.8	1.3	4.7	4.5	2.0	1.9	2.2	3.1	2.7	1.7	4.2	5.2	7.7	1.0	2.3	1.4	5.1	6.8	15.0	3.3	11.7	10.2	8.3	5.9	4.8	5.1	6.6	0.1	5.3	3.2	5.3	8.1	2.8	5.3	4.3	6.7	4.3	5.5	4.7	11.8	5.2	6.7	3.1	5.6	7.6	4.4	6.4	8.3	11.9	4.3	6.2	3.7	3.1	2.0	4.0	4.7	3.2	2.9	17.7	2.9	4.7	3.1	2.9	1.8	10.3	3.6	18.4	4.7	9.3	10.6	9.5	9.4	14.2	8.6	3.6	2.6	2.0	8.3	6.5	39.1	0.5	5.9	1.0	1.9	4.6	1.3	1.7	2.3	2.1	4.2	1.7	1.1	1.6	5.2	1.0	7.7	3.8	2.0	1.4										
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3A, catalytic subunit of the oligosaccharyltransferase complex"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 202.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favourable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavourable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	20.6	20.5	8.3	13.1	11.7	8.3	16.9	10.7	13.9	27.8	19.3	17.7	39.6	12.0	30.5	41.4	19.6	20.8	15.1	19.5	8.3	9.1	26.2	67.1	18.7	14.9	9.3	7.7	30.1	59.0	202.3	27.5	35.9	11.6	22.2	17.4	20.8	50.7	41.4	9.5	12.9	19.8	17.1	12.3	21.8	17.7	17.1	6.7	19.2	38.6	13.6	20.8	19.5	18.0	15.0	53.2	27.0	15.5	17.2	27.5	13.4	20.7	18.9	24.2	33.2	45.6	35.4	26.0	38.0	45.4	31.0	38.8	57.5	56.2	27.1	46.2	55.9	38.4	33.5	33.3	41.2	21.1	17.8	63.8	13.1	39.7	50.5	38.1	29.9	27.3	24.2	42.8	83.7	34.5	26.8	40.6	39.0	15.3	15.3	12.2	15.5	20.6	18.2	20.6	40.7	33.8	32.3	15.1	13.0	26.9	44.0	13.5	51.5	27.5	30.8	44.6	16.1	18.8	29.8	12.8	14.9	20.9	17.2	38.6	35.4	27.0	15.5	11.6	19.7	14.8	27.5	15.0	19.1	18.2	21.6	11.6	13.8	16.0	5.4	17.2	13.0	53.2	14.1	13.4	8.3	11.7	10.7	13.9	8.3	9.1	9.3	7.7	11.6	6.7
STXBP5	"LLGL3, tomosyn"	ENSG00000164506	"Syntaxin binding protein 5"	Q5T5C0	6	147204425-147390476	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 82.7"	"Cell line enhanced"	"Detected in many"		"HEL: 55.4;HMC-1: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039991, HPA049727, CAB079016"	Enhanced	Supported	Enhanced	Cytosol		11000	11000	Cytosol	Cytosol	"CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863"	"prognostic unfavourable (4.48e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.56e-4)"	"unprognostic (6.01e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavourable (2.74e-7)"	"unprognostic (8.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.35e-3)"	4.4	9.1	4.3	6.6	5.9	14.0	9.0	7.8	9.0	6.7	17.6	2.0	22.1	3.9	4.6	6.5	10.2	3.8	9.2	3.5	3.6	4.3	2.0	2.4	3.8	3.5	3.3	4.7	3.0	10.9	82.7	15.5	3.1	4.3	5.7	7.8	6.5	5.7	21.0	7.0	10.9	35.1	5.3	2.7	4.7	4.0	9.6	2.3	2.2	4.2	5.6	4.6	5.3	9.1	0.9	0.5	11.2	0.6	0.5	1.7	0.3	2.8	2.5	1.3	4.5	6.5	13.8	1.5	6.5	9.8	4.9	5.5	2.1	1.9	2.0	1.5	13.0	3.4	3.8	5.8	6.0	4.4	3.0	55.4	7.3	2.3	7.5	18.9	60.6	10.0	4.1	9.7	20.0	6.2	14.9	2.6	9.6	4.1	3.0	4.9	1.0	5.8	0.4	6.9	0.7	2.6	4.9	2.9	2.1	5.1	3.6	2.2	1.0	7.4	7.2	7.0	2.5	3.4	5.9	2.1	0.0	2.4	3.9	6.9	5.0	4.7	0.3	11.2	1.2	0.5	1.3	0.5	0.7	1.4	0.5	0.9	1.2	1.7	4.0	0.5	0.6	0.4	0.3	0.3	4.3	5.9	7.8	9.0	3.6	4.3	3.3	4.7	4.3	2.3
SV2A	"KIAA0736, SV2"	ENSG00000159164	"Synaptic vesicle glycoprotein 2A"	Q7L0J3	1	149903318-149917882	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.3;parathyroid gland: 34.0"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 26.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 27.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002226, HPA007863"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB002226: AB_564144, HPA007863: AB_1080135"	"unprognostic (8.05e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.24e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.81e-3)"	2.0	7.3	20.4	2.8	24.7	4.5	1.5	36.8	75.3	3.2	2.3	4.8	0.9	1.9	5.6	18.0	2.0	3.2	3.2	1.5	22.3	30.5	1.7	1.2	1.8	2.3	21.6	25.1	2.6	1.9	34.0	7.2	1.9	32.9	3.1	2.2	3.1	1.7	3.7	1.1	1.5	2.2	6.6	16.8	2.0	2.0	1.6	6.0	0.3	4.0	0.0	2.0	2.5	1.2	1.2	0.8	2.1	0.7	1.7	2.5	0.6	0.1	0.0	10.2	0.0	1.0	3.0	1.1	4.3	15.1	12.9	18.7	0.3	0.4	0.1	3.9	6.5	0.2	0.1	0.9	11.2	0.0	2.4	13.4	0.7	0.7	9.9	0.1	0.2	6.7	0.1	20.6	1.5	1.1	0.1	14.0	8.5	0.1	12.9	0.6	26.0	0.0	4.5	6.5	0.2	0.1	0.3	21.5	17.3	0.0	0.1	9.8	0.1	8.1	0.0	12.0	12.1	0.5	15.7	0.1	0.1	0.0	21.1	0.1	4.7	1.5	0.7	0.4	1.8	0.3	1.9	0.7	1.9	1.1	0.2	1.2	1.0	2.2	2.1	1.7	0.3	0.8	2.5	0.6	20.4	24.7	36.8	40.0	22.3	30.5	21.6	25.1	32.9	6.0
SVOPL	MGC46715	ENSG00000157703	"SVOP like"	Q8N434	7	138594285-138701352	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"parathyroid gland: 13.9;salivary gland: 6.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.1;NTERA-2: 2.3;RT4: 1.9;T-47d: 8.2"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	41	"eosinophil: 4.1"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018035	Uncertain									"HPA018035: AB_2197028"	"unprognostic (6.70e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.51e-2)"	0.0	2.1	0.5	0.0	1.1	0.0	1.2	0.0	0.1	0.3	0.9			0.0	0.0	0.7	0.0	2.3	0.0	0.0	1.0	0.8	2.7	0.0	0.2	0.0	0.2		0.7	0.3	13.9	1.8	0.5		0.1	0.1		6.5	0.7	0.0	0.4	0.0	0.0	0.8	0.0	0.0	1.5			1.0		0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.3	0.0	0.9	0.0	0.3	0.0	1.9	0.1	0.9	0.0	0.7	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TANC2	"DKFZP564D166, FLJ10215, FLJ11824, KIAA1148, KIAA1636, rols, ROLSA"	ENSG00000170921	"Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2"	Q9HCD6	17	63009556-63427699	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 31.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023274	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA023274: AB_2199727"	"unprognostic (8.37e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.57e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.09e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.01e-1)"	3.4	3.9	4.4	3.1	8.5	6.2	2.7	2.1	19.5	4.5	1.5	2.8	1.5	1.0	2.7	7.0	3.4	2.5	3.1	2.0	5.2	5.4	3.1	1.5	7.9	1.5	5.2	3.5	3.0	2.3	31.6	5.1	2.8	2.7	2.6	1.1	1.9	3.5	3.4	1.5	4.8	2.0	4.1	7.5	2.7	1.8	10.9	3.4	4.6	2.1	4.4	1.9	6.4	2.9	0.8	1.6	1.1	0.1	2.9	2.2	0.1	12.0	11.4	7.1	1.2	3.6	8.8	13.7	7.7	7.6	7.6	9.5	0.6	3.5	0.0	2.4	13.2	1.7	11.4	22.7	17.4	4.7	5.2	17.7	16.8	0.6	3.2	4.7	0.0	13.4	13.3	8.9	25.9	2.4	2.1	0.0	10.9	9.3	3.1	0.8	0.8	7.4	2.4	14.2	0.9	6.8	16.8	12.0	13.1	4.3	8.2	3.3	3.7	1.2	12.3	18.7	9.8	1.2	9.4	0.0	0.0	0.0	6.9	1.3	6.7	0.0	0.1	0.0	2.2	0.1	1.7	0.1	1.2	1.7	0.1	0.8	0.5	1.1	1.1	2.9	0.0	1.6	0.0	0.1	4.4	8.5	2.1	19.5	5.2	5.4	5.2	3.5	2.7	3.4
TBXT	T	ENSG00000164458	"T-box transcription factor T"	O15178	6	166157656-166168700	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"parathyroid gland: 12.2;pituitary gland: 5.0"	"Cell line enriched"	"Detected in some"	4	"HeLa: 18.1"	"Cancer enriched"	"Detected in single"	22	"testis cancer: 6.2"	"Region enhanced"	"Detected in single"		"pons and medulla: 3.0"	"Group enriched"	"Detected in some"	24	"naive B-cell: 2.3;NK-cell: 2.5"	"Group enriched"	"Detected in many"	24	"B-cells: 2.3;NK-cells: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003322	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003322: AB_1080176"						"unprognostic (5.68e-2)"		"unprognostic (4.59e-2)"						"unprognostic (6.21e-3)"	"unprognostic (8.64e-3)"	"unprognostic (9.34e-3)"		0.3	0.0	0.1	2.0	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.2	5.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.4	0.0	1.9	0.0	0.0	1.2	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	18.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.9	0.1	0.0	0.0	3.0	0.0
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 46.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol				Cytosol	Cytosol	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.7	3.5	8.8	4.2	10.9	1.6	4.6	18.0	9.9	2.6	3.3	6.3	7.5	2.5	2.0	6.2	2.1	2.4	2.3	3.6	8.8	8.9	3.1	3.7	4.4	5.4	8.1	7.8	1.4	3.5	46.5	5.5	3.7	15.9	6.2	4.3	2.9	6.4	6.7	4.5	2.5	2.5	3.1	7.6	5.9	3.1	19.3	4.9	8.0	7.3	1.0	5.2	3.7	2.0	3.8	5.3	5.3	7.0	7.3	13.1	4.2	6.3	5.5	4.9	11.4	0.3	0.5	4.8	1.1	0.6	3.4	2.3	3.6	9.2	7.4	10.1	0.4	3.9	7.2	7.5	5.3	19.2	5.1	7.4	1.6	2.5	2.2	1.4	1.2	0.6	3.0	7.3	3.1	3.6	5.7	6.7	1.0	17.2	11.7	2.2	3.8	9.6	1.4	3.1	15.4	6.0	3.1	7.2	11.8	8.0	6.4	7.4	14.0	5.6	1.4	1.6	2.9	5.0	6.1	13.8	16.9	8.3	7.4	6.0	2.2	5.3	0.9	1.9	8.8	4.3	13.1	3.8	8.2	8.8	2.0	3.6	6.0	7.5	0.7	7.3	7.0	5.3	9.4	4.2	8.8	10.9	18.0	9.9	8.8	8.9	8.1	7.8	15.9	4.9
TENM4	"KIAA1302, ODZ4, Ten-M4"	ENSG00000149256	"Teneurin transmembrane protein 4"	Q6N022	11	78652831-79440948	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 23.0;parathyroid gland: 44.4"	"Cell line enhanced"	"Detected in many"		"HSkMC: 8.2;PC-3: 9.4;REH: 8.9;SH-SY5Y: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019521, HPA065961"	Approved									"HPA019521: AB_2670171, HPA065961: AB_2685588"	"unprognostic (2.81e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.40e-3)"	"unprognostic (5.64e-2)"	"unprognostic (7.07e-2)"	"unprognostic (9.81e-3)"	3.2	2.8	14.7	2.2	13.0	1.0	1.6	1.4	16.9	4.4	1.4	3.6	0.0	1.1	2.7	1.2	3.1	3.7	1.5	1.3	11.4	6.3	2.9	1.0	1.4	1.5	3.3	5.7	23.0	1.3	44.4	12.0	1.1	8.3	1.4	1.4	4.8	1.5	1.3	1.4	5.1	1.2	2.2	12.5	1.3	1.5	2.9	5.7	0.6	8.2	2.1	2.5	1.6	2.3	0.3	1.4	0.6	0.6	0.3	0.1	0.0	0.0	0.0	3.0	0.0	3.4	5.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.9	5.7	1.8	4.5	4.6	0.0	3.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	8.2	2.1	2.2	4.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	1.6	9.4	8.9	0.0	0.0	5.9	1.0	6.4	15.7	0.0	0.0	0.0	0.0	0.1	0.4	0.1	1.1	0.1	5.2	0.0	0.0	0.1	6.2	0.0	0.0	0.5	0.6	0.0	0.1	0.3	0.1	0.2	0.1	0.1	1.4	0.3	0.0	0.0	0.6	0.3	0.3	0.3	0.1	0.0	14.7	13.0	1.4	16.9	11.4	6.3	3.3	5.7	8.3	5.7
TMEM178B	DKFZp547G036	ENSG00000261115	"Transmembrane protein 178B"	H3BS89	7	141074232-141480380	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 6.9;HDLM-2: 6.3;NTERA-2: 5.9;RPTEC TERT1: 9.6;SCLC-21H: 7.6;WM-115: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048771	Uncertain		Approved	Nucleoli,Vesicles				Vesicles	Vesicles	"HPA048771: AB_2680517"	"unprognostic (7.33e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.79e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.05e-1)"	"prognostic favourable (4.10e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.35e-3)"	"unprognostic (8.98e-2)"	0.9	1.7	5.2	0.7	7.4	0.1	0.7	3.2	13.4	0.5	0.8	1.0	2.3	0.1	1.1	0.6	1.8	0.3	0.7	11.6	4.8	5.8	2.9	0.6	0.4	1.5	4.9	1.0	0.2	2.6	20.6	18.5	0.1	1.8	2.8	0.4	0.5	4.4	0.8	4.5	0.2	1.2	1.3	2.4	0.8	0.5	0.8	0.4	1.0	9.5	0.1	3.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.6	0.3	1.8	0.1	2.7	0.8	1.0	0.0	0.0	2.2	2.3	0.2	0.0	6.9	0.0	2.3	6.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	5.9	0.0	0.4	1.1	2.9	9.6	2.7	7.6	4.6	0.1	0.3	1.0	1.0	0.0	0.0	0.1	1.1	3.1	0.0	0.1	0.0	0.0	0.5	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	7.4	3.2	9.6	4.8	5.8	4.9	1.0	1.8	0.4
TMEM184C	"FLJ10846, TMEM34"	ENSG00000164168	"Transmembrane protein 184C"	Q9NVA4	4	147617383-147672044	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 107.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054013	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA054013: AB_2682343"	"unprognostic (5.45e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (6.37e-4)"	"unprognostic (1.13e-1)"	"prognostic favourable (2.31e-7)"	"unprognostic (4.68e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.31e-3)"	10.4	18.4	11.3	9.6	13.1	5.5	10.0	12.3	15.9	11.8	13.0	12.3	14.3	11.8	12.4	9.8	10.7	10.0	9.6	14.3	11.8	11.3	18.0	18.7	9.2	7.7	16.1	11.8	15.7	11.6	107.2	10.5	14.0	12.7	12.0	11.6	9.3	12.1	12.8	16.2	9.5	14.8	10.1	14.0	10.0	10.6	8.3	14.1	11.7	32.9	10.3	9.4	11.8	11.2	12.8	17.3	17.7	18.1	14.7	22.8	11.6	9.1	14.3	18.2	13.9	24.9	24.3	11.9	17.1	20.1	12.8	14.8	11.8	17.5	8.5	8.6	13.3	11.0	14.7	13.1	14.1	18.9	8.5	11.0	11.1	8.5	19.2	14.6	16.4	18.1	17.7	14.0	14.7	16.4	14.0	24.0	17.8	13.7	12.7	5.3	11.7	8.4	12.7	6.3	14.7	14.2	17.1	14.2	18.3	9.3	14.6	14.9	14.5	9.2	16.1	16.2	8.8	13.2	10.9	26.3	34.4	11.4	19.0	8.8	17.5	17.7	14.1	15.5	18.0	18.0	22.8	12.3	16.7	16.4	17.3	12.8	15.9	14.8	11.0	14.7	18.1	11.9	15.3	11.6	11.3	13.1	12.3	15.9	11.8	11.3	16.1	11.8	12.7	14.1
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 91.8"	"Cell line enhanced"	"Detected in all"		"U-2197: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	13.3	10.8	6.6	14.7	9.0	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11.0	8.2	19.1	5.5	4.9	16.0	20.0	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10.0	14.5	12.6	6.9	12.6	12.9	12.3	7.0	4.7	4.4	3.4	5.7	7.6	2.0	8.3	8.3	7.0	7.7	20.2	15.2	8.5	10.6	14.7	6.7	8.9	11.4	4.6	18.2	5.2	12.2	14.1	9.3	7.8	9.7	10.1	5.6	14.5	12.8	6.0	18.4	15.0	11.3	14.1	9.2	7.6	14.4	5.4	16.4	14.0	12.2	13.1	9.6	7.3	5.3	5.1	10.6	9.7	8.9	9.4	19.8	5.8	7.4	7.3	11.6	14.2	7.3	16.3	8.2	10.7	5.1	49.9	12.1	9.5	21.0	17.5	11.7	30.7	9.9	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7.0	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2.0	6.6	9.0	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10.0
TUBB8	bA631M21.2	ENSG00000261456	"Tubulin beta 8 class VIII"	Q3ZCM7	10	46892-74163	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.2;parathyroid gland: 2.3;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;MCF7: 5.3;NTERA-2: 1.8"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"					"Cell type enhanced"	"Detected in some"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in many"											"HPA043640, HPA046280"	Uncertain									"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.75e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.15e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.86e-3)"	0.0	0.0		0.5		0.0	1.1		0.1	0.0	0.0			0.0	0.4	0.1	0.0	1.2	0.0	0.1			0.1	0.0	0.0	0.4			0.0	0.0	2.3		0.4		0.0	0.0		0.0	0.0	0.0	0.1	0.1	0.0		0.0	0.0	2.5			0.3		0.1	0.5		1.0	0.1	2.2	0.3	0.2	0.5	0.1	0.5	0.0	0.0	0.3	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.3	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.3	0.1	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.1	0.6	0.2	1.0	0.4	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.2	0.1	2.2	0.5	0.2	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.7	0.2	0.3	0.1	0.1	0.1										
TXNRD3NB	"TR2IT1, TXNRD3IT1, TXNRD3NT1"	ENSG00000283374	"Thioredoxin reductase 3 neighbor"	Q6F5E7	3	126571779-126608555	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"parathyroid gland: 1.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;PC-3: 1.3"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058257	Uncertain									"HPA058257: AB_2683655"																		0.1	0.0		0.1		0.0	0.0		0.0	0.0	0.0			0.0	0.2	0.0	0.0	0.5	0.0	0.0			0.2	0.0	0.2	0.0			0.7	0.0	1.1		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.1	0.0		0.0	0.0	0.7			0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.6	0.0	0.7	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
USP35	KIAA1372	ENSG00000118369	"Ubiquitin specific peptidase 35"	Q9P2H5	11	78188812-78214711	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 32.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"eosinophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055213, HPA058592"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA055213: AB_2682740, HPA058592: AB_2683766"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	4.9	17.1	5.1	5.4	9.3	3.8	5.2	10.4	15.0	6.4	5.8	8.0	6.3	5.5	6.8	5.4	5.6	5.4	5.6	8.7	6.1	6.7	5.0	13.8	5.6	4.8	6.7	8.8	6.6	6.4	32.4	12.0	7.1	15.0	5.0	3.4	7.7	4.0	5.6	5.6	3.2	5.3	7.8	4.5	4.6	3.9	5.3	4.0	1.9	7.7	2.9	4.1	5.2	6.6	0.0	0.1	3.4	0.6	0.1	0.3	0.2	2.1	3.3	5.7	6.0	9.8	9.0	3.9	4.9	5.8	5.8	4.1	8.3	4.6	1.7	5.1	9.2	5.7	3.8	7.6	3.4	12.2	2.0	2.8	8.6	4.8	7.6	1.8	8.3	7.6	5.1	12.1	3.5	7.1	3.9	4.2	4.5	1.9	4.6	7.2	1.7	5.3	2.8	5.3	2.1	4.6	3.9	2.8	5.4	3.8	5.0	1.8	4.2	1.5	8.6	10.7	6.1	12.6	2.6	5.7	1.9	2.6	3.2	1.9	6.2	0.0	0.2	3.4	0.1	0.6	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.2	5.1	9.3	10.4	15.0	6.1	6.7	6.7	8.8	15.0	4.0
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 57.1;parathyroid gland: 45.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 22.7;HDLM-2: 32.0;U-937: 31.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0"	"Region enhanced"	"Detected in single"		"olfactory region: 2.5"	"Low region specificity"	"Detected in some"			"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"				Nucleoplasm	Nucleoplasm	"CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favourable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.0	9.2	0.2	10.0	0.3	2.5	7.8	0.3	0.6	3.5	40.9	0.4	4.1	21.2	1.2	7.7	10.2	1.1	10.7	1.5	0.5	0.3	13.0	0.6	8.3	3.8	0.5	0.1	1.3	6.5	45.8	11.7	4.4	0.6	2.1	12.6	0.4	4.9	2.8	5.3	15.2	57.1	1.2	1.5	3.1	2.6	1.5	0.2	2.0	1.9	9.4	8.2	4.0	5.2	0.7	5.7	7.5	7.0	0.2	0.8	1.2	5.4	0.9	0.0	0.0	4.7	6.9	0.1	6.7	3.4	5.7	5.0	4.0	4.6	1.4	7.3	4.6	10.2	0.2	22.7	2.7	32.0	1.6	2.4	1.3	0.3	3.5	4.8	7.7	9.3	10.6	6.3	10.4	0.4	0.7	1.5	2.6	3.7	0.1	2.3	0.0	7.4	0.1	0.0	3.5	5.2	5.5	2.6	0.1	5.7	16.5	2.0	18.6	2.7	0.4	11.0	2.9	3.2	3.8	0.9	0.0	1.2	3.4	31.4	2.7	0.2	3.7	2.1	0.0	7.0	0.1	0.7	0.3	0.0	5.7	0.1	0.1	0.0	7.5	0.2	6.9	0.6	0.8	1.2	0.2	0.3	0.3	0.6	0.5	0.3	0.5	0.1	0.6	0.2
WDR17		ENSG00000150627	"WD repeat domain 17"	Q8IZU2	4	176065834-176182818	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9;parathyroid gland: 19.0;pituitary gland: 22.5"	"Cell line enhanced"	"Detected in many"		"AF22: 8.9;SCLC-21H: 10.3;SH-SY5Y: 7.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042766, HPA054501"	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA042766: AB_10806372, HPA054501: AB_2732586"	"unprognostic (3.41e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.43e-7)"	"unprognostic (3.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-3)"	"unprognostic (6.04e-4)"	"unprognostic (3.66e-4)"	"unprognostic (9.25e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.24e-3)"	2.1	5.8	12.4	2.2	22.1	1.5	3.3	12.2	23.9	2.0	2.9	3.4	0.0	1.6	4.5	6.2	1.9	3.5	3.0	1.3	9.7	7.1	6.2	1.0	3.6	1.8	4.4	16.3	4.0	3.0	19.0	22.5	0.7	7.9	2.3	3.1	6.0	1.7	2.2	0.7	1.2	1.8	2.8	4.0	2.9	3.1	4.1	6.9	0.1	10.2	0.0	1.6	1.9	1.5	1.1	0.7	2.6	1.6	1.3	0.8	0.2	0.0	3.7	8.9	0.1	0.2	0.6	0.3	0.2	0.0	0.8	3.1	0.2	0.1	6.1	0.0	0.1	0.1	3.9	2.0	0.8	0.0	3.2	0.0	0.7	0.0	0.3	3.3	4.8	1.4	1.2	0.1	0.5	0.0	0.0	0.3	0.6	1.6	3.4	0.1	2.0	1.9	0.0	3.8	0.0	0.5	0.0	10.3	7.4	0.0	2.4	6.2	0.4	0.0	0.0	1.2	1.7	0.1	5.8	4.4	2.9	3.5	7.0	0.0	2.4	2.6	0.6	0.3	0.6	1.6	0.3	1.1	0.6	0.4	0.2	0.8	0.7	0.8	1.7	1.3	0.3	0.7	0.3	0.2	12.4	22.1	12.2	21.8	9.7	7.1	4.4	16.3	7.9	6.9
WNT8B		ENSG00000075290	"Wnt family member 8B"	Q93098	10	100463041-100483744	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.3;parathyroid gland: 3.8"	"Cell line enhanced"	"Detected in some"		"AF22: 6.5;MOLT-4: 2.2;RPMI-8226: 2.6;SCLC-21H: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036570	Uncertain				"Secreted to extracellular matrix"					"HPA036570: AB_10670113"	"unprognostic (6.92e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.24e-2)"	0.2	3.3	0.2	0.2	0.5	0.0	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.4	2.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	3.8	0.5	0.2	0.2	0.7	0.0	0.2	2.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.1	2.6	0.2	2.2	0.2	0.2	0.2	1.6	0.2	0.0	0.3	0.7	0.0	0.0	1.3	0.3	0.0	0.0	6.5	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	1.0	0.2	0.0	0.0	0.6	1.3	0.0	0.0	0.2	0.0	1.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	1.8	2.2	0.0	0.0	0.4	0.7	0.0	2.6	0.0	1.9	3.0	0.8	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.7	0.0	0.0	0.3	0.0	0.3	0.2	0.5	0.3	0.2	0.2	0.4	0.2	0.2	0.2	0.2
ZNF676		ENSG00000196109	"Zinc finger protein 676"	Q8N7Q3	19	22179091-22196951	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 6.5"	"Cell line enriched"	"Detected in some"	8	"NTERA-2: 12.4"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 9.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (7.77e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.45e-1)"	"unprognostic (6.76e-3)"	"unprognostic (9.98e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-3)"	1.4	0.1	0.0	0.2	0.1	0.0	1.6	0.0	1.3	1.2	1.3			0.0	2.4	1.1	0.1	2.3	0.5	2.1	0.1	0.2	1.4	0.0	0.1	0.1	0.4		2.4	1.6	6.5	1.9	0.0		0.6	0.2		0.2	0.5	0.0	0.4	0.2	1.8	0.8	0.8	0.1	4.6			4.3		0.0	0.3	0.8	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
